Document

0000891024-17-000020.txt : 20171206 0000891024-17-000020.hdr.sgml : 20171206 20171206152147 ACCESSION NUMBER: 0000891024-17-000020 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 48 CONFORMED PERIOD OF REPORT: 20171028 FILED AS OF DATE: 20171206 DATE AS OF CHANGE: 20171206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PATTERSON COMPANIES, INC. CENTRAL INDEX KEY: 0000891024 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047] IRS NUMBER: 410886515 STATE OF INCORPORATION: MN FISCAL YEAR END: 0426 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-20572 FILM NUMBER: 171242172 BUSINESS ADDRESS: STREET 1: 1031 MENDOTA HEIGHTS RD CITY: ST PAUL STATE: MN ZIP: 55120-1401 BUSINESS PHONE: 6516861600 MAIL ADDRESS: STREET 1: 1031 MENDOTA HEIGHTS RD CITY: ST PAUL STATE: MN ZIP: 55120-1401 FORMER COMPANY: FORMER CONFORMED NAME: PATTERSON DENTAL CO DATE OF NAME CHANGE: 19950111 10-Q 1 pdco1028201710-q.htm 10-Q Document

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________________

FORM 10-Q

______________________________



x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED OCTOBER 28, 2017.



¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File No. 0-20572

_____________________________

PATTERSON COMPANIES, INC.

(Exact Name of Registrant as Specified in Its Charter)

______________________________



Minnesota	41-0886515
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification Number)

1031 Mendota Heights Road St. Paul, Minnesota	55120
(Address of Principal Executive Offices)	(Zip Code)

(651) 686-1600

(Registrant’s Telephone Number, Including Area Code)

______________________________

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):



Large accelerated filer	x	Accelerated filer	¨	Non-accelerated filer	¨

Smaller reporting company	¨	Emerging growth company	¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

As of November 30, 2017, there were 94,824,000 shares of Common Stock of the registrant issued and outstanding.

Table of Contents

PATTERSON COMPANIES, INC.

INDEX



	Page
PART I - FINANCIAL INFORMATION

Item 1- Financial Statements	3

Condensed Consolidated Balance Sheets as of October 28, 2017 and April 29, 2017	3

Condensed Consolidated Statements of Income and Other Comprehensive Income for the Three and Six Months Ended October 28, 2017 and October 29, 2016	4

Condensed Consolidated Statements of Cash Flows for the Six Months Ended October 28, 2017 and October 29, 2016	5

Notes to Condensed Consolidated Financial Statements	6

Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations	13

Item 3 - Quantitative and Qualitative Disclosures about Market Risk	18

Item 4 - Controls and Procedures	18

PART II - OTHER INFORMATION

Item 1 - Legal Proceedings	19

Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds	20

Item 6 - Exhibits	20

Signatures	21

Exhibit Index	22

Table of Contents

PART I—FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)



	October 28, 2017			April 29, 2017
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	101,456		$	94,959
Receivables, net of allowance for doubtful accounts	849,205			884,803
Inventory	796,369			711,903
Prepaid expenses and other current assets	96,578			111,928
Total current assets	1,843,608			1,803,593
Property and equipment, net	286,715			298,452
Long-term receivables, net	111,184			101,529
Goodwill	814,224			813,547
Identifiable intangibles, net	406,641			425,436
Other	66,107			65,356
Total assets	$	3,528,479		$	3,507,913
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	634,594		$	616,859
Accrued payroll expense	57,151			56,881
Other accrued liabilities	152,132			156,437
Current maturities of long-term debt	14,754			14,754
Borrowings on revolving credit	92,000			59,000
Total current liabilities	950,631			903,931
Long-term debt	991,232			998,272
Other non-current liabilities	219,676			211,277
Total liabilities	2,161,539			2,113,480
Stockholders’ equity:
Common stock	949			966
Additional paid-in capital	88,069			72,973
Accumulated other comprehensive loss	(83,675		)	(92,669		)
Retained earnings	1,429,668			1,481,234
Unearned ESOP shares	(68,071		)	(68,071		)
Total stockholders’ equity	1,366,940			1,394,433
Total liabilities and stockholders’ equity	$	3,528,479		$	3,507,913

See accompanying notes

Table of Contents

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

AND OTHER COMPREHENSIVE INCOME

(In thousands, except per share amounts)

(Unaudited)



	Three Months Ended						Six Months Ended
	October 28, 2017			October 29, 2016			October 28, 2017			October 29, 2016
Net sales	$	1,385,737		$	1,418,241		$	2,689,852		$	2,750,677
Cost of sales	1,069,994			1,099,281			2,075,061			2,114,539
Gross profit	315,743			318,960			614,791			636,138
Operating expenses	243,984			239,157			486,199			490,919
Operating income	71,759			79,803			128,592			145,219
Other income (expense):
Other income, net	1,160			1,622			2,672			3,986
Interest expense	(11,468		)	(10,097		)	(22,671		)	(20,259		)
Income before taxes	61,451			71,328			108,593			128,946
Income tax expense	21,207			25,572			37,502			44,284
Net income	$	40,244		$	45,756		$	71,091		$	84,662
Earnings per share:
Basic	$	0.43		$	0.48		$	0.76		$	0.89
Diluted	$	0.43		$	0.48		$	0.76		$	0.88
Weighted average shares:
Basic	92,722			95,290			93,037			95,510
Diluted	93,351			95,904			93,683			96,138
Dividends declared per common share	$	0.26		$	0.24		$	0.52		$	0.48
Comprehensive income
Net income	$	40,244		$	45,756		$	71,091		$	84,662
Foreign currency translation gain (loss)	(3,965		)	(14,001		)	8,119			(34,258		)
Cash flow hedges, net of tax	438			437			875			870
Comprehensive income	$	36,717		$	32,192		$	80,085		$	51,274

See accompanying notes

Table of Contents

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)



	Six Months Ended
	October 28, 2017			October 29, 2016
Operating activities:
Net income	$	71,091		$	84,662
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation	22,458			18,010
Amortization	19,375			23,997
Bad debt expense	3,716			58
Non-cash employee compensation	16,635			14,693
Change in assets and liabilities, net of acquired	(56,167		)	(196,726		)
Net cash provided by (used in) operating activities	77,108			(55,306		)
Investing activities:
Additions to property and equipment	(16,431		)	(29,377		)
Collection of deferred purchase price receivables	24,581			26,210
Other investing activities	11,626			(3,095		)
Net cash provided by (used in) investing activities	19,776			(6,262		)
Financing activities:
Dividends paid	(49,969		)	(47,655		)
Repurchases of common stock	(71,254		)	(50,000		)
Retirement of long-term debt	(7,377		)	(8,250		)
Draw on revolver	33,000			143,000
Other financing activities	3,561			974
Net cash provided by (used in) financing activities	(92,039		)	38,069
Effect of exchange rate changes on cash	1,652			(3,567		)
Net change in cash and cash equivalents	6,497			(27,066		)
Cash and cash equivalents at beginning of period	94,959			137,453
Cash and cash equivalents at end of period	$	101,456		$	110,387

See accompanying notes

Table of Contents

PATTERSON COMPANIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars, except per share amounts, and shares in thousands)

(Unaudited)

Note 1. General

Basis of Presentation

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Patterson Companies, Inc. (referred to herein as "Patterson" or in the first person notations "we," "our," and "us") as of October 28, 2017, and our results of operations and cash flows for the periods ended October 28, 2017 and October 29, 2016. Such adjustments are of a normal recurring nature. The results of operations for the periods ended October 28, 2017 and October 29, 2016 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the financial statements included in our 2017 Annual Report on Form 10-K filed on June 28, 2017.

The unaudited condensed consolidated financial statements include the assets and liabilities of PDC Funding Company, LLC ("PDC Funding") and PDC Funding Company II, LLC ("PDC Funding II"), which are our wholly owned subsidiaries and separate legal entities formed under Minnesota law. PDC Funding and PDC Funding II are fully consolidated special purpose entities established to sell customer installment sale contracts to outside financial institutions in the normal course of their business. The assets of PDC Funding and PDC Funding II would be available first and foremost to satisfy the claims of its creditors. There are no known creditors of PDC Funding or PDC Funding II.

Fiscal Year End

We operate with a 52-53 week accounting convention with our fiscal year ending on the last Saturday in April. The second quarter of fiscal 2018 and 2017 represents the 13 weeks ended October 28, 2017 and the 13 weeks ended October 29, 2016, respectively. The six months ended October 28, 2017 and October 29, 2016 each included 26 weeks. Fiscal 2018 will include 52 weeks and fiscal 2017 included 52 weeks.

Comprehensive Income

Comprehensive income is computed as net income including certain other items that are recorded directly to stockholders’ equity. Significant items included in comprehensive income are foreign currency translation adjustments and the effective portion of cash flow hedges, net of tax. Foreign currency translation adjustments do not include a provision for income tax because earnings from foreign operations are considered to be indefinitely reinvested outside the U.S. The income tax expense related to cash flow hedges was $265 and $265 for the three months ended October 28, 2017 and October 29, 2016, respectively. The income tax expense related to cash flow hedges was $530 and $527 for the six months ended October 28, 2017 and October 29, 2016, respectively.

Earnings Per Share

The following table sets forth the computation of the weighted average shares outstanding used to calculate basic and diluted earnings per share ("EPS"):



	Three Months Ended		Six Months Ended
	October 28, 2017	October 29, 2016	October 28, 2017	October 29, 2016
Denominator for basic earnings per share – weighted average shares	92,722	95,290	93,037	95,510
Effect of dilutive securities – stock options, restricted stock and stock purchase plans	629	614	646	628
Denominator for diluted earnings per share – weighted average shares	93,351	95,904	93,683	96,138

Table of Contents

Potentially dilutive securities representing 1,581 and 1,272 shares for the three and six months ended October 28, 2017, respectively, and 1,453 and 1,218 shares for the three and six months ended October 29, 2016, respectively, were excluded from the calculation of diluted earnings per share because their effects were anti-dilutive.

Recently Issued Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-09, "Revenue from Contracts with Customers (Topic 606)". ASU No. 2014-09 supersedes the revenue recognition requirements in "Revenue Recognition (Topic 605)," and requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In July 2015, the FASB deferred the effective date of this pronouncement by one year to December 15, 2017 for annual reporting periods beginning after that date. Companies may use either a full retrospective or a modified retrospective approach to adopt the standard. We plan to adopt the new guidance in the first quarter of fiscal 2019 and are currently evaluating the standard, including the method we will use for adoption and the effect it will have on our financial statements. We do not expect the standard to materially affect our consolidated net earnings, financial position, or cash flows. We are currently evaluating the new standard as it relates to certain sales transactions in which products are shipped directly from the vendor to our customers. We currently report these sales on a gross basis, and are evaluating if we will be required to report these sales on a net basis. Such sales represent approximately 2% of our consolidated net sales. Any change to net presentation would not impact gross margin or earnings.

In July 2015, the FASB issued ASU No. 2015-11, "Inventory (Topic 330), Simplifying the Measurement of Inventory." ASU 2015-11 requires inventory measured using any method other than LIFO or the retail inventory method to be subsequently measured at the lower of cost or net realizable value, rather than at the lower of cost or market. Subsequent measurement of inventory using the LIFO and retail inventory method is unchanged. During the first quarter of fiscal 2018, we adopted ASU No. 2015-11 and it had no material impact to the condensed consolidated financial statements.

In January 2016, the FASB issued ASU No. 2016-01, "Financial Instruments- Recognition and Measurement of Financial Assets and Financial Liabilities (Subtopic 825-10)", which amends certain aspects of recognition, measurement, presentation and disclosure of financial instruments, including the requirement to measure certain equity investments at fair value with changes in fair value recognized in net income. We are required to adopt the ASU No. 2016-01 in the first quarter of fiscal 2019, with early adoption permitted. We are evaluating the impact of adopting this pronouncement.

In February 2016, the FASB issued ASU No. 2016-02, "Leases (Topic 842)," which requires lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by most leases, as well as requires additional qualitative and quantitative disclosures. We are required to adopt ASU 2016-02 in the first quarter of fiscal 2020, with early adoption permitted. We are evaluating the impact of adopting this pronouncement.

Note 2. Customer Financing

As a convenience to our customers, we offer several different financing alternatives, including a third party program and a Patterson-sponsored program. For the third party program, we act as a facilitator between the customer and the third party financing entity with no on-going involvement in the financing transaction. Under the Patterson-sponsored program, equipment purchased by creditworthy customers may be financed up to a maximum of $1,000. We generally sell our customers’ financing contracts to outside financial institutions in the normal course of our business. These financing arrangements are accounted for as a sale of assets under the provisions of ASC 860, Transfers and Servicing. We currently have two arrangements under which we sell these contracts.

First, we operate under an agreement to sell a portion of our equipment finance contracts to commercial paper conduits with The Bank of Tokyo-Mitsubishi UFJ, Ltd. ("BTMU") serving as the agent. We utilize PDC Funding to fulfill a requirement of participating in the commercial paper conduit. We receive the proceeds of the contracts upon sale to BTMU. At least 9.5% of the proceeds are held by the conduit as security against eventual performance of the portfolio. This percentage can be greater and is based upon certain ratios defined in the agreement with BTMU. The capacity under the agreement with BTMU at October 28, 2017 was $575,000.

Second, we maintain an agreement with Fifth Third Bank ("Fifth Third") whereby Fifth Third purchases customers’ financing contracts. PDC Funding II sells its financing contracts to Fifth Third. We receive the proceeds of the contracts

Table of Contents

upon sale to Fifth Third. At least 11.0% of the proceeds are held by the conduit as security against eventual performance of the portfolio. This percentage can be greater and is based upon certain ratios defined in the agreement with Fifth Third. The capacity under the agreement with Fifth Third at October 28, 2017 was $100,000.

We service the financing contracts under both arrangements, for which we are paid a servicing fee. The servicing fees we receive are considered adequate compensation for services rendered. Accordingly, no servicing asset or liability has been recorded.

The portion of the purchase price for the receivables held by the conduits is deemed a deferred purchase price receivable, which is paid to the applicable special purpose entity as payments on the customers’ financing contracts are collected by Patterson from customers. The difference between the carrying amount of the receivables sold under these programs and the sum of the cash and fair value of the deferred purchase price receivables received at time of transfer is recognized as a gain on sale of the related receivables and recorded in net sales in the condensed consolidated statements of income and other comprehensive income. Expenses incurred related to customer financing activities are recorded in operating expenses in our condensed consolidated statements of income and other comprehensive income.

During the three months ended October 28, 2017 and October 29, 2016, we sold $95,588 and $62,663 of contracts under these arrangements, respectively. During the six months ended October 28, 2017 and October 29, 2016, we sold $151,711 and $172,257 of contracts under these arrangements, respectively. We recorded net sales in the condensed consolidated statements of income and other comprehensive income of $5,967 and $4,331 during the three months ended October 28, 2017 and October 29, 2016, respectively, related to these contracts sold. We recorded net sales in the condensed consolidated statements of income and other comprehensive income of $10,227 and $14,516 during the six months ended October 28, 2017 and October 29, 2016, respectively, related to these contracts sold.

Included in cash and cash equivalents in the condensed consolidated balance sheets are $32,187 and $17,902 as of October 28, 2017 and April 29, 2017, respectively, which represent cash collected from previously sold customer financing contracts that have not yet been settled. Included in current receivables in the condensed consolidated balance sheets are $70,193, net of unearned income of $0, and $124,098, net of unearned income of $940, as of October 28, 2017 and April 29, 2017, respectively, of finance contracts we have not yet sold. A total of $612,216 of finance contracts receivable sold under the arrangements was outstanding at October 28, 2017. The deferred purchase price receivable under the arrangements was $129,098 and $119,798 as of October 28, 2017 and April 29, 2017, respectively. Since the internal financing program began in 1994, bad debt write-offs have amounted to less than 1% of the loans originated.

The arrangements require us to maintain a minimum current ratio and maximum leverage ratio. We were in compliance with those covenants at October 28, 2017.

Note 3. Derivative Financial Instruments

We are a party to certain offsetting and identical interest rate cap agreements entered into to fulfill certain covenants of the equipment finance contract sale agreements. The interest rate cap agreements also provide a credit enhancement feature for the financing contracts sold by PDC Funding and PDC Funding II to the commercial paper conduit.

The interest rate cap agreements are canceled and new agreements are entered into periodically to maintain consistency with the dollar maximum of the sale agreements and the maturity of the underlying financing contracts. As of October 28, 2017, PDC Funding had purchased an interest rate cap from a bank with a notional amount of $575,000 and a maturity date of July 2025. We sold an identical interest rate cap to the same bank. As of October 28, 2017, PDC Funding II had purchased an interest rate cap from a bank with a notional amount of $100,000 and a maturity date of July 2025. We sold an identical interest rate cap to the same bank.

These interest rate cap agreements do not qualify for hedge accounting treatment and, accordingly, we record the fair value of the agreements as an asset or liability and the change as income or expense during the period in which the change occurs.

Table of Contents

interest rate swap agreements and recorded a $1,000 increase, net of income taxes, to other comprehensive income (loss), which is being amortized as a reduction to interest expense over the life of the related debt.

In January 2014, we entered into a forward interest rate swap agreement with a notional amount of $250,000 and accounted for as cash flow hedge, to hedge interest rate fluctuations in anticipation of refinancing the 5.17% senior notes due March 25, 2015. These notes were repaid on March 25, 2015 and replaced with new $250,000 3.48% senior notes due March 24, 2025. A cash payment of $29,003 was made in March 2015 to settle the interest rate swap. This amount is recorded in other comprehensive income (loss), net of tax, and is recognized as interest expense over the life of the related debt.

The following presents the fair value of derivative instruments included in the condensed consolidated balance sheets:



Derivative type	Classification	October 28, 2017		April 29, 2017
Assets:
Interest rate cap agreements	Other noncurrent assets	$	967	$	1,188
Liabilities:
Interest rate cap agreements	Other noncurrent liabilities	967		1,188

The following table presents the pre-tax effect of derivative instruments in cash flow hedging relationships on the condensed consolidated statements of income and other comprehensive income ("OCI"):



		Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income (Effective Portion)
		Three Months Ended						Six Months Ended
Derivatives in cash flow hedging relationships	Income statement location	October 28, 2017			October 29, 2016			October 28, 2017			October 29, 2016
Interest rate swap	Interest expense	$	(703	)	$	(702	)	$	(1,405	)	$	(1,397	)

We recorded no effective portion of gains or losses on derivative instruments in cash flow hedging relationships in OCI during the current period.

We recorded no ineffectiveness during the three and six month periods ended October 28, 2017 and October 29, 2016. As of October 28, 2017, the estimated pre-tax portion of accumulated other comprehensive loss that is expected to be reclassified into earnings over the next twelve months is $2,862, which will be recorded as an increase to interest expense.

Note 4. Fair Value Measurements

Fair value is the price at which an asset could be exchanged in a current transaction between knowledgeable, willing parties. The fair value hierarchy of measurements is categorized into one of three levels based on the lowest level of significant input used:

Level 1 - Quoted prices in active markets for identical assets and liabilities at the measurement date.

Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3 - Unobservable inputs for which there is little or no market data available. These inputs reflect management’s assumptions of what market participants would use in pricing the asset or liability.

Our hierarchy for assets and liabilities measured at fair value on a recurring basis is as follows:

Table of Contents



	October 28, 2017
	Total		Level 1		Level 2		Level 3
Assets:
Cash equivalents	$	3,000	$	3,000	$	—	$	—
Deferred purchase price receivable	129,098		—		—		129,098
Derivative instruments	967		—		967		—
Total assets	$	133,065	$	3,000	$	967	$	129,098
Liabilities:
Derivative instruments	$	967	$	—	$	967	$	—



	April 29, 2017
	Total		Level 1		Level 2		Level 3
Assets:
Cash equivalents	$	6,798	$	6,798	$	—	$	—
Deferred purchase price receivable	119,798		—		—		119,798
Derivative instruments	1,188		—		1,188		—
Total assets	$	127,784	$	6,798	$	1,188	$	119,798
Liabilities:
Derivative instruments	$	1,188	$	—	$	1,188	$	—

Cash equivalents – We value cash equivalents at their current market rates. The carrying value of cash equivalents approximates fair value and maturities are less than three months.

Deferred purchase price receivable – We value the deferred purchase price receivable based on a discounted cash flow analysis using unobservable inputs, which include a forward yield curve, the estimated timing of payments and the credit quality of the underlying creditor. Significant changes in any of the significant unobservable inputs in isolation would not result in a materially different fair value estimate. The interrelationship between these inputs is insignificant.

Derivative instruments – Our derivative instruments consist of interest rate cap agreements and interest rate swaps. These instruments are valued using inputs such as interest rates and credit spreads.

Certain assets are measured at fair value on a non-recurring basis. These assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments under certain circumstances, such as when there is evidence of impairment. There were no fair value adjustments to such assets during the six month periods ended October 28, 2017 or October 29, 2016.

Our debt is not measured at fair value in the condensed consolidated balance sheets. The estimated fair value of our debt as of October 28, 2017 and April 29, 2017 was $1,022,779 and $1,025,761, respectively, as compared to a carrying value of $1,005,986 and $1,013,026 at October 28, 2017 and April 29, 2017, respectively. The fair value of debt was measured using a discounted cash flow analysis based on expected market based yields (i.e., level 2 inputs).

The carrying amounts of receivables, net of allowances, accounts payable, and certain accrued and other current liabilities approximated fair value at October 28, 2017 and April 29, 2017.

Note 5. Income Taxes

The effective income tax rate for the three months ended October 28, 2017 was 34.5% compared to 35.9% for the three months ended October 29, 2016, and for the six months ended October 28, 2017 was 34.5% compared to 34.3% for the six months ended October 29, 2016. The decrease in the rate for the three months ended October 28, 2017 compared to the prior year was primarily due to a geographical shift in earnings.

Note 6. Segment Reporting

Table of Contents

We present three reportable segments: Dental, Animal Health and Corporate. Dental and Animal Health are strategic business units that offer similar products and services to different customer bases. Dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals throughout North America. Animal Health is a leading, full-line distributor in North America and the U.K. of animal health products, services and technologies to both the production-animal and companion-pet markets. Our Corporate segment is comprised of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources and facilities. In addition, customer financing and other miscellaneous sales are reported within Corporate results. Corporate assets consist primarily of cash and cash equivalents, accounts receivable, property and equipment and long-term receivables. We evaluate segment performance based on operating income. The costs to operate the fulfillment centers are allocated to the operating units based on the through-put of the unit.

The following table presents information about our reportable segments:



	Three Months Ended						Six Months Ended
	October 28, 2017			October 29, 2016			October 28, 2017			October 29, 2016
Net sales
Dental	$	553,630		$	601,553		$	1,072,437		$	1,156,568
Animal Health	823,583			807,146			1,599,719			1,569,777
Corporate	8,524			9,542			17,696			24,332
Consolidated net sales	$	1,385,737		$	1,418,241		$	2,689,852		$	2,750,677
Operating income (loss)
Dental	$	65,207		$	77,043		$	124,726		$	137,338
Animal Health	23,217			21,854			39,893			36,683
Corporate	(16,665		)	(19,094		)	(36,027		)	(28,802		)
Consolidated operating income	$	71,759		$	79,803		$	128,592		$	145,219



	October 28, 2017		April 29, 2017
Total assets
Dental	$	903,155	$	863,970
Animal Health	2,171,844		2,119,512
Corporate	453,480		524,431
Total assets	$	3,528,479	$	3,507,913

The following table presents sales information by product for all of our reportable segments:



	Three Months Ended				Six Months Ended
	October 28, 2017		October 29, 2016		October 28, 2017		October 29, 2016
Net sales
Consumable	$	1,116,091	$	1,112,232	$	2,196,196	$	2,188,453
Equipment and software	181,337		217,194		318,286		378,140
Other	88,309		88,815		175,370		184,084
Consolidated net sales	$	1,385,737	$	1,418,241	$	2,689,852	$	2,750,677

Note 7. Accumulated Other Comprehensive Loss ("AOCL")

The following table summarizes the changes in AOCL as of October 28, 2017:

Table of Contents



	Cash Flow Hedges			Currency Translation Adjustment			Total
AOCL at April 29, 2017	$	(14,989	)	$	(77,680	)	$	(92,669	)
Other comprehensive loss before reclassifications	—			8,119			8,119
Amounts reclassified from AOCL	875			—			875
AOCL at October 28, 2017	$	(14,114	)	$	(69,561	)	$	(83,675	)

The amounts reclassified from AOCL during fiscal 2018 represent gains and losses on cash flow hedges, net of taxes of $530. The impact to the condensed consolidated statements of income and other comprehensive income was an increase to interest expense of $1,405.

Note 8. Legal Proceedings

In September 2015, we were served with a summons and complaint in an action commenced in the U.S. District Court for the Eastern District of New York, entitled SourceOne Dental, Inc. v. Patterson Companies, Inc., Henry Schein, Inc. and Benco Dental Supply Company, Civil Action No. 15-cv-05440-JMA-GRB. SourceOne, as plaintiff, alleges that, through its website, it markets and sells dental supplies and equipment to dentists. SourceOne alleges in the complaint, among other things, that we, along with the defendants Henry Schein and Benco, conspired to eliminate plaintiff as a competitor and to exclude them from the market for the marketing, distribution and sale of dental supplies and equipment in the U.S. and that defendants unlawfully agreed with one another to boycott dentists, manufacturers, and state dental associations that deal with, or considered dealing with, plaintiff. Plaintiff asserts the following claims: (i) unreasonable restraint of trade in violation of state and federal antitrust laws; (ii) tortious interference with prospective business relations; (iii) civil conspiracy; and (iv) aiding and abetting the other defendants’ ongoing tortious and anticompetitive conduct. Plaintiff seeks equitable relief, compensatory and treble damages, jointly and severally, punitive damages, interest, and reasonable costs and expenses, including attorneys’ fees and expert fees. In June 2017, Henry Schein settled with SourceOne and was dismissed from this litigation with prejudice. We are vigorously defending ourselves in this litigation. We do not anticipate that this matter will have a material adverse effect on our financial condition.

Beginning in January 2016, purported class action complaints were filed against defendants Henry Schein, Inc., Benco Dental Supply Company and Patterson Companies, Inc. Although there were factual and legal variations among these complaints, each alleged that defendants conspired to foreclose and exclude competitors by boycotting manufacturers, state dental associations, and others that deal with defendants’ competitors. On February 9, 2016, the U.S. District Court for the Eastern District of New York ordered all of these actions, and all other actions filed thereafter asserting substantially similar claims against defendants, consolidated for pre-trial purposes. On February 26, 2016, a consolidated class action complaint was filed by Arnell Prato, D.D.S., P.L.L.C., d/b/a Down to Earth Dental, Evolution Dental Sciences, LLC, Howard M. May, DDS, P.C., Casey Nelson, D.D.S., Jim Peck, D.D.S., Bernard W. Kurek, D.M.D., Larchmont Dental Associates, P.C., and Keith Schwartz, D.M.D., P.A. (collectively, “putative class representatives”) in the U.S. District Court for the Eastern District of New York, entitled In re Dental Supplies Antitrust Litigation, Civil Action No. 1:16-CV-00696-BMC-GRB. Subject to certain exclusions, the putative class representatives seek to represent all persons who purchased dental supplies or equipment in the U.S. directly from any of the defendants, since August 31, 2008. In the consolidated class action complaint, putative class representatives allege a nationwide agreement among Henry Schein, Benco, Patterson and non-party Burkhart Dental Supply Company, Inc. not to compete on price. The consolidated class action complaint asserts a single count under Section 1 of the Sherman Act, and seeks equitable relief, compensatory and treble damages, jointly and severally, interest, and reasonable costs and expenses, including attorneys’ fees and expert fees. Putative class representatives have not specified a damage amount in their complaint. While the outcome of litigation is inherently uncertain, we believe the consolidated class action complaint is without merit, and we are vigorously defending ourselves in this litigation.

Table of Contents

Company, Inc. conspired to pressure and agreed to enlist their common suppliers, including the Danaher Defendants, to join a price-fixing conspiracy and boycott by reducing the distribution territory of, and eventually terminating, Archer. Archer seeks injunctive relief, and damages in an amount to be proved at trial, to be trebled with interest and costs, including attorneys’ fees, jointly and severally. Trial is currently scheduled for February 2018. We are vigorously defending ourselves in this litigation. We do not anticipate that this matter will have a material adverse effect on our financial statements.

On August 17, 2017, IQ Dental Supply, Inc. (“IQ Dental”) filed a complaint in the United States District Court for the Eastern District of New York, entitled IQ Dental Supply, Inc. v. Henry Schein, Inc., Patterson Companies, Inc. and Benco Dental Supply Company, Case No. 2:17-cv-4834. Plaintiff alleges that it is a distributor of dental supplies and equipment, and sells dental products through an online dental distribution platform operated by SourceOne Dental, Inc. IQ Dental alleges, among other things, that defendants conspired to suppress competition from IQ Dental and SourceOne for the marketing, distribution and sale of dental supplies and equipment in the United States, and that defendants unlawfully agreed with one another to boycott dentists, manufacturers and state dental associations that deal with, or considered dealing with, plaintiff and SourceOne. Plaintiff claims that this alleged conduct constitutes unreasonable restraint of trade in violation of Section 1 of the Sherman Act, New York’s Donnelly Act and the New Jersey Antitrust Act, and also makes pendant state law claims for tortious interference with prospective business relations, civil conspiracy and aiding and abetting. Plaintiff seeks injunctive relief, compensatory, treble and punitive damages, jointly and severally, and reasonable costs and expenses, including attorneys’ fees and expert fees. We are vigorously defending ourselves in this litigation. We do not anticipate that this matter will have a material adverse effect on our financial statements.

From time to time, we may become a party to other legal proceedings, including, without limitation, product liability claims, intellectual property claims, employment matters, commercial disputes, governmental inquiries and investigations (which may in some cases involve our entering into settlement arrangements or consent decrees), and other matters arising out of the ordinary course of our business. While the results of any legal proceeding cannot be predicted with certainty, in our opinion none of these other pending matters is anticipated to have a material adverse effect on our financial statements.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

This Form 10-Q for the period ended October 28, 2017, contains certain forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are information of a non-historical nature and are subject to risks and uncertainties that are beyond Patterson’s ability to control. Forward-looking statements generally can be identified by words such as “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. It is uncertain whether any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what impact they will have on the results of operations and financial condition of Patterson or the price of Patterson stock. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ materially from those indicated in such forward-looking statements. Such risks and uncertainties include, without limitation, the cautionary language set forth herein; operations disruptions attributable to our enterprise resource planning system implementation; our ability to attract or retain qualified sales representatives and service technicians who relate directly with our customers; the reduction, modification, cancellation or delay of purchases of innovative, high-margin equipment; material changes in our purchasing relationships with suppliers; changes in general market and economic conditions; and the other risks and important factors contained and identified in Patterson’s previous filings with the Securities and Exchange Commission, such as its Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K, any of which could cause actual results to differ materially from the forward-looking statements.

OVERVIEW

Our financial information for the first six months of fiscal 2018 is summarized in this Management’s Discussion and Analysis and the Condensed Consolidated Financial Statements and related Notes. The following background is provided to readers to assist in the review of our financial information.

Table of Contents

We present three reportable segments: Dental, Animal Health and Corporate. Dental and Animal Health are strategic business units that offer similar products and services to different customer bases. Dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout North America. Animal Health is a leading, full-line distributor in North America and the U.K. of animal health products, services and technologies to both the production-animal and companion-pet markets. Our Corporate segment is comprised of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources and facilities. In addition, customer financing and other miscellaneous sales are reported within Corporate results.

Operating margins of the animal health business are considerably lower than the dental business. While operating expenses run at a lower rate in the animal health business when compared to the dental business, gross margins in the animal health business are substantially lower due generally to the low margins experienced on the sale of pharmaceutical products.

We believe there are several important aspects of our business that are useful in analyzing it, including: (1) growth in the various markets in which we operate; (2) internal growth; (3) growth through acquisition; and (4) continued focus on controlling costs and enhancing efficiency. Management defines internal growth as the increase in net sales from period to period, adjusting for differences in the number of weeks in fiscal years, excluding the impact of changes in currency exchange rates, and excluding the net sales, for a period of twelve months following the transaction date, of businesses we have acquired.

FACTORS AFFECTING OUR RESULTS

Enterprise Resource Planning System Initiatives. In the third quarter of fiscal 2017, we completed the application development stage of our enterprise resource planning ("ERP") system, and we began depreciating our investment in such system. We incurred increased depreciation and other operating expenses of approximately $4.0 million in the three months ended October 28, 2017 as compared to the three months ended October 29, 2016, and $11.0 million in the six months ended October 28, 2017 as compared to the six months ended October 29, 2016.

RESULTS OF OPERATIONS

QUARTER ENDED OCTOBER 28, 2017 COMPARED TO QUARTER ENDED OCTOBER 29, 2016

The following table sets forth, for the periods indicated, the percentage of net sales represented by certain operational data:



	Three Months Ended
	October 28, 2017		October 29, 2016
Net sales	100.0	%	100.0	%
Cost of sales	77.2		77.5
Gross profit	22.8		22.5
Operating expenses	17.6		16.9
Operating income	5.2		5.6
Other income (expense)	(0.8	)	(0.6	)
Income before taxes	4.4		5.0
Income tax expense	1.5		1.8
Net income	2.9	%	3.2	%

Table of Contents

Net Sales. Consolidated net sales for the three months ended October 28, 2017 were $1,385.7 million, a decrease of 2.3% from $1,418.2 million for the three months ended October 29, 2016. Foreign exchange rate changes had a favorable impact of 0.5% on current quarter sales.

Dental segment sales for the three months ended October 28, 2017 were $553.6 million, a decrease of 8.0% from $601.6 million for the three months ended October 29, 2016. Foreign exchange rate changes had a favorable impact of 0.4% on current quarter sales. Current quarter sales of consumables decreased 4.0%, due primarily to lower sales volume. Sales of dental equipment and software decreased 17.3% to $169.5 million, due to a decrease in sales of digital technology products, which was driven by our decision to broaden our technology equipment portfolio. In addition, we believe that our customers are delaying equipment purchases as they evaluate new digital product offerings. Sales of other dental services and products increased 0.9%.

Animal Health segment sales for the three months ended October 28, 2017 were $823.6 million, an increase of 2.0% from $807.1 million for the three months ended October 29, 2016. Foreign exchange rate changes had a favorable impact of 0.6% on current quarter sales. Sales of certain products previously recognized on a gross basis were recognized on a net basis during the three months ended October 28, 2017, resulting in an estimated 2.3% unfavorable impact to sales. Positive end market fundamentals contributed to the current quarter sales growth.

Gross Profit. Consolidated gross profit margin rate for the three months ended October 28, 2017 increased 30 basis points from the prior year quarter to 22.8%. Gross profit margin rates improved in both the Dental and Animal Health segments during the three months ended October 28, 2017. Favorable sales mix in each segment drove the improved rates. In our Dental segment, a greater percentage of sales came from our higher margin consumables products. In our Animal Health segment, certain marketing initiatives are driving a greater percentage of sales from higher margin products.

Operating Expenses. Consolidated operating expenses for the three months ended October 28, 2017 were $244.0 million, a 2.0% increase from the prior year quarter of $239.2 million. The three months ended October 28, 2017 included increased depreciation and other operating expenses related to our ERP system initiatives. Operating expenses in the current quarter were favorably impacted by cost containment efforts. The consolidated operating expense ratio of 17.6% increased 70 basis points from the prior year quarter, which was primarily driven by lower net sales and higher operating expenses.

Operating Income. For the three months ended October 28, 2017, operating income was $71.8 million, or 5.2% of net sales, as compared to $79.8 million, or 5.6% of net sales for the three months ended October 29, 2016. The decrease in operating income was primarily driven by lower net sales and increased expenses related to our ERP system initiatives, partially offset by cost containment efforts. The decrease in operating income as a percent of sales was driven by these same factors. In addition, a greater percentage of sales came from our lower margin Animal Health segment during the three months ended October 28, 2017, which reduced operating income as a percent of sales.

Dental segment operating income was $65.2 million for the three months ended October 28, 2017, a decrease of $11.8 million from the prior year quarter. The decrease was primarily due to lower net sales and increased expenses related to our ERP system initiatives, partially offset by cost containment efforts.

Animal Health segment operating income was $23.2 million for the three months ended October 28, 2017, an increase of $1.4 million from the prior year quarter. The increase was primarily due to higher net sales and cost containment efforts, partially offset by increased expenses related to our ERP system initiatives.

Corporate segment operating loss was $16.7 million for the three months ended October 28, 2017, as compared to a loss of $19.1 million for the three months ended October 29, 2016. The change was driven primarily by an increase in the gain on sale related to our customer financing programs.

Other Income (Expense). Net other expense for the three months ended October 28, 2017 was $10.3 million, compared to $8.5 million for the three months ended October 29, 2016. The increase was mainly due to higher interest expense in the current quarter.

Income Tax Expense. The effective income tax rate for the three months ended October 28, 2017 was 34.5% compared to 35.9% for the three months ended October 29, 2016. The decrease in the rate was primarily due to a geographical shift in earnings.

Table of Contents

Net Income. Net income for the three months ended October 28, 2017 was $40.2 million, compared to $45.8 million for the three months ended October 29, 2016. Earnings per diluted share were $0.43 in the current quarter compared to $0.48 in the prior year quarter. Weighted average diluted shares outstanding in the current quarter were 93.4 million, compared to 95.9 million in the prior year quarter. The current quarter cash dividend was $0.26 per common share compared to $0.24 in the prior year quarter.

SIX MONTHS ENDED OCTOBER 28, 2017 COMPARED TO SIX MONTHS ENDED OCTOBER 29, 2016

The following table sets forth, for the periods indicated, the percentage of net sales represented by certain operational data:



	Six Months Ended
	October 28, 2017		October 29, 2016
Net sales	100.0	%	100.0	%
Cost of sales	77.1		76.9
Gross profit	22.9		23.1
Operating expenses	18.1		17.8
Operating income	4.8		5.3
Other income (expense)	(0.8	)	(0.6	)
Income before taxes	4.0		4.7
Income tax expense	1.4		1.6
Net income	2.6	%	3.1	%

Net Sales. Consolidated net sales for the six months ended October 28, 2017 were $2,689.9 million, a 2.2% decrease from $2,750.7 million for the six months ended October 29, 2016. Foreign exchange rate changes had an unfavorable impact of 0.2% on current period sales.

Dental segment sales for the six months ended October 28, 2017 were $1,072.4 million, a 7.3% decrease from $1,156.6 million for the six months ended October 29, 2016. Foreign exchange rate changes had a favorable impact of 0.1% on current period sales. Current period sales of consumables decreased 3.9%, due primarily to lower sales volume. The lower sales volume was partially due to a sales force realignment in the first quarter of fiscal 2017. Sales of dental equipment and software decreased 16.5% to $297.4 million for the six months ended October 28, 2017, due to a decrease in sales of digital technology products, which was driven by our decision to broaden our technology equipment portfolio. In addition, we believe that our customers are delaying equipment purchases as they evaluate new digital product offerings. Sales of other dental services and products increased 0.2% for the six months ended October 28, 2017.

Animal Health segment sales for the six months ended October 28, 2017 were $1,599.7 million, a 1.9% increase from $1,569.8 million for the six months ended October 29, 2016. Foreign exchange rate changes had an unfavorable impact of 0.5% on current period sales. Sales of certain products previously recognized on a gross basis were recognized on a net basis during the six months ended October 28, 2017, resulting in an estimated 2.4% unfavorable impact to sales. Positive end market fundamentals contributed to the current period sales growth.

Gross Profit. Consolidated gross profit margin rate for the six months ended October 28, 2017 decreased 20 basis points from the prior year period to 22.9%. Gross profit margin rates improved in both the Dental and Animal Health segment. In our Dental segment, a greater percentage of sales came from our higher margin consumables products. In our Animal Health segment, certain marketing initiatives are driving a greater percentage of sales from higher margin products. A greater percentage of sales came from our lower margin Animal Health segment during the six months ended October 28, 2017, resulting in a lower consolidated gross profit margin rate.

Operating Expenses. Consolidated operating expenses for the six months ended October 28, 2017 were $486.2 million, a 1.0% decrease from the prior year period of $490.9 million. The decrease was driven by cost containment

Table of Contents

efforts during the six months ended October 28, 2017, partially offset by increased depreciation and other operating expenses related to our ERP system initiatives. The consolidated operating expense ratio of 18.1% increased 30 basis points from the prior year period. The increase in this ratio was driven by lower net sales in the current period.

Operating Income. For the six months ended October 28, 2017, operating income was $128.6 million, or 4.8% of net sales, as compared to $145.2 million, or 5.3% of net sales for the six months ended October 29, 2016. The decrease in operating income was driven by lower net sales and increased expenses related to our ERP system initiatives, partially offset by cost containment efforts. The decrease in operating income as a percent of sales was driven by these same factors. In addition, a greater percentage of sales came from our lower margin Animal Health segment during the six months ended October 28, 2017, which reduced operating income as a percent of sales.

Dental segment operating income was $124.7 million for the six months ended October 28, 2017, a decrease of $12.6 million from the prior year period. The decrease was primarily due to lower net sales and increased expenses related to our ERP system initiatives, partially offset by cost containment efforts.

Animal Health segment operating income was $39.9 million for the six months ended October 28, 2017, an increase of $3.2 million from the prior year period. The increase was primarily due to higher net sales and cost containment efforts, partially offset by increased expenses related to our ERP system initiatives.

Corporate segment operating loss was $36.0 million for the six months ended October 28, 2017, as compared to a loss of $28.8 million for the six months ended October 29, 2016. The change was driven primarily by higher expenses due to a separation agreement with our former chief executive officer.

Other Income (Expense), Net. Net other expense was $20.0 million for the six months ended October 28, 2017, compared to $16.3 million for the six months ended October 29, 2016. The increase was mainly due to higher interest expense in the current period.

Income Tax Expense. The effective income tax rate for the six months ended October 28, 2017 was 34.5% compared to 34.3% for the six months ended October 29, 2016.

Net Income and Earnings Per Share. Net income for the six months ended October 28, 2017 was $71.1 million, compared to $84.7 million for the six months ended October 29, 2016. Earnings per diluted share were $0.76 in the current period compared to $0.88 in the prior year period. Weighted average diluted shares outstanding in the current period were 93.7 million compared to 96.1 million in the prior year period. The current period cash dividend was $0.52 per common share compared to $0.48 in the prior year period.

LIQUIDITY AND CAPITAL RESOURCES

For the six months ended October 28, 2017, net cash provided by operating activities were $77.1 million, compared to net cash used in operating activities of $55.3 million for the six months ended October 29, 2016. The net cash provided by operating activities during the six months ended October 28, 2017 was primarily driven by net income of $71.1 million. The improvement in operating cash flows for the six months ended October 28, 2017 was primarily due to increased collections of accounts receivable.

For the six months ended October 28, 2017, net cash provided by investing activities were $19.8 million, compared to net cash used in investing activities of $6.3 million for the six months ended October 29, 2016. The change in net cash flows was primarily driven by lower additions to property and equipment during the six months ended October 28, 2017, which was largely due to lower expenditures on our ERP system. Net cash flows for the six months ended October 28, 2017 were positive primarily due to the collection of $24.6 million of deferred purchase price receivables. We expect to use a total of approximately $40 million for capital expenditures in fiscal 2018.

Net cash used in financing activities for the six months ended October 28, 2017 was $92.0 million. Uses of cash consisted primarily of $71.3 million for share repurchases and $50.0 million for dividend payments. Cash proceeds included $33.0 million attributed to draws on our revolving line of credit. For the six months ended October 29, 2016, net cash provided by financing activities was $38.1 million. Cash proceeds included $143.0 million attributed to draws on our revolving line of credit. Uses of cash consisted primarily of $50.0 million for share repurchases and $47.7 million for dividend payments.

Table of Contents

During fiscal 2016, we entered into a credit agreement ("Credit Agreement"), under which the lenders provided us with senior unsecured lending facilities of up to $1.5 billion, consisting of a $1.0 billion unsecured term loan and a $500 million unsecured revolving line of credit. In fiscal 2017, we entered into an amendment of the Credit Agreement (“Amended Credit Agreement”), consisting of a $295.1 million term loan and a $750 million revolving line of credit. Interest on borrowings is variable and is determined as a base rate plus a spread. This spread, as well as a commitment fee on the unused portion of the facility, is based on our leverage ratio, as defined in the Amended Credit Agreement. The term loan and revolving credit facilities will mature no later than January 2022.

As of October 28, 2017, $284.0 million of the Amended Credit Agreement unsecured term loan was outstanding at an interest rate of 2.74%, and $92.0 million was outstanding under the Amended Credit Agreement revolving line of credit at an interest rate of 2.69%. At April 29, 2017, $291.4 million was outstanding under the Amended Credit Agreement unsecured term loan at an interest rate of 2.24%, and $59.0 million was outstanding under the Amended Credit Agreement revolving line of credit at an interest rate of 2.19%.

We expect funds generated from operations, existing cash balances and credit availability under existing debt facilities will be sufficient to meet our working capital needs and to finance strategic initiatives over the remainder of fiscal 2018.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

See Note 1 to the Condensed Consolidated Financial Statements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes in our exposure to market risk from that disclosed in Item 7A in our 2017 Annual Report on Form 10-K filed June 28, 2017.

ITEM 4. CONTROLS AND PROCEDURES

Under the supervision and with the participation of our management, including our President and Chief Executive Officer ("CEO") and our Chief Financial Officer ("CFO"), management evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of October 28, 2017. Based upon their evaluation of these disclosure controls and procedures, the CEO and CFO concluded that the disclosure controls and procedures were effective as of October 28, 2017.

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended October 28, 2017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II—OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

On August 31, 2012, Archer and White Sales, Inc. (“Archer”) filed a complaint against Henry Schein, Inc. as well as Danaher Corporation and its subsidiaries Instrumentarium Dental, Inc., Dental Equipment, LLC, Kavo Dental Technologies, LLC and Dental Imaging Technologies Corporation (collectively, the “Danaher Defendants”) in the United States District Court for the Eastern District of Texas, Civil Action No. 2:12-CV-00572-JRG, styled as an antitrust action under Section 1 of the Sherman Act, and the Texas Free Enterprise Antitrust Act. Archer alleges a conspiracy between Henry Schein, an unnamed company and the Danaher Defendants to terminate or limit Archer’s distribution rights. On August 1, 2017, Archer filed an amended complaint, adding Patterson Companies, Inc. and Benco Dental Supply Company as defendants, and alleging that Henry Schein, Patterson, Benco and non-defendant Burkhart Dental Supply Company, Inc. conspired to pressure and agreed to enlist their common suppliers, including the Danaher Defendants, to join a price-fixing conspiracy and boycott by reducing the distribution territory of, and eventually terminating, Archer. Archer seeks injunctive relief, and damages in an amount to be proved at trial, to be trebled with interest and costs, including attorneys’ fees, jointly and severally. Trial is currently scheduled for February 2018. We are vigorously defending ourselves in this litigation. We do not anticipate that this matter will have a material adverse effect on our financial statements.

Table of Contents

SourceOne for the marketing, distribution and sale of dental supplies and equipment in the United States, and that defendants unlawfully agreed with one another to boycott dentists, manufacturers and state dental associations that deal with, or considered dealing with, plaintiff and SourceOne. Plaintiff claims that this alleged conduct constitutes unreasonable restraint of trade in violation of Section 1 of the Sherman Act, New York’s Donnelly Act and the New Jersey Antitrust Act, and also makes pendant state law claims for tortious interference with prospective business relations, civil conspiracy and aiding and abetting. Plaintiff seeks injunctive relief, compensatory, treble and punitive damages, jointly and severally, and reasonable costs and expenses, including attorneys’ fees and expert fees. We are vigorously defending ourselves in this litigation. We do not anticipate that this matter will have a material adverse effect on our financial statements.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On March 19, 2013, our Board of Directors approved a share repurchase plan that replaced a previously existing share repurchase plan. Under the March 19, 2013 plan, up to 25 million shares may be purchased in open market transactions through March 19, 2018.

The following table presents activity under the stock repurchase plan during the second quarter of fiscal 2018:



	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number of Shares That May Yet Be Purchased Under the Plan
July 30, 2017 to August 26, 2017	—	$	—	—	12,818,968
August 27, 2017 to September 23, 2017	80,063	37.46		80,063	12,738,905
September 24, 2017 to October 28, 2017	874,971	38.29		874,971	11,863,934
	955,034	$	38.22	955,034	11,863,934

During fiscal 2016, we entered into a credit agreement ("Credit Agreement"), under which the lenders provided us with senior unsecured lending facilities of up to $1.5 billion, consisting of a $1.0 billion unsecured term loan and a $500 million unsecured revolving line of credit. The Credit Agreement was due to expire in fiscal 2021. In fiscal 2017, we entered into an amendment of the Credit Agreement (“Amended Credit Agreement”), consisting of a $295.1 million term loan and a $750 million revolving line of credit. The Amended Credit Agreement permits us to declare and pay dividends, and repurchase shares, provided that no default or unmatured default exists and that we are in compliance with applicable financial covenants.

ITEM 6. EXHIBITS

The exhibits listed in the accompanying Exhibit Index are filed as part of this Quarterly Report on Form 10-Q.

All other items under Part II have been omitted because they are inapplicable or the answers are negative, or were previously reported in the 2017 Annual Report on Form 10-K filed June 28, 2017.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



		PATTERSON COMPANIES, INC.
		(Registrant)

Dated: December 6, 2017

	By:	/s/ Ann B. Gugino
		Ann B. Gugino
		Executive Vice President, Chief Financial Officer and Treasurer
		(Principal Financial Officer and Principal Accounting Officer)

Table of Contents

EXHIBIT INDEX



Exhibit No.		Exhibit Description

10.1		Employment Agreement by and between Patterson Companies, Inc. and Mark S. Walchirk, dated October 23, 2017 (incorporated by reference to our Current Report on Form 8-K, filed October 24, 2017 (File No. 000-20572)).

10.2		Form of Inducement RSU Award Agreement by and between Patterson Companies, Inc. and Mark S. Walchirk (incorporated by reference to our Current Report on Form 8-K, filed October 24, 2017 (File No. 000-20572)).

31.1		Certification of the Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101		Financials in XBRL format.

EX-31.1 2 exhibit31110282017.htm EXHIBIT 31.1 Exhibit

Exhibit 31.1

Certification of the Chief Executive Officer Pursuant to

Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as

adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Mark S. Walchirk, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the period ended October 28, 2017 of Patterson Companies, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter ended (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: December 6, 2017

/s/ Mark S. Walchirk

Mark S. Walchirk

President and Chief Executive Officer

EX-31.2 3 exhibit31210282017.htm EXHIBIT 31.2 Exhibit

Exhibit 31.2

Certification of the Chief Financial Officer Pursuant to

Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as

adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Ann B. Gugino, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the period ended October 28, 2017 of Patterson Companies, Inc.;

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: December 6, 2017

/s/ Ann B. Gugino

Ann B. Gugino

Executive Vice President, Chief Financial Officer and Treasurer

EX-32.1 4 exhibit32110282017.htm EXHIBIT 32.1 Exhibit

Exhibit 32.1

Certification of the Chief Executive Officer

pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906

of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Patterson Companies, Inc., (the “Company”) on Form 10-Q for the quarterly period ended October 28, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

/s/ Mark S. Walchirk

Mark S. Walchirk

President and Chief Executive Officer

December 6, 2017

EX-32.2 5 exhibit32210282017.htm EXHIBIT 32.2 Exhibit

Exhibit 32.2

Certification of the Chief Financial Officer

pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906

of the Sarbanes-Oxley Act of 2002

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Ann B. Gugino

Ann B. Gugino

Executive Vice President, Chief Financial Officer and Treasurer

December 6, 2017

EX-101.INS 6 pdco-20171028.xml XBRL INSTANCE DOCUMENT 0000891024 2017-04-30 2017-10-28 0000891024 2017-11-30 0000891024 2017-04-29 0000891024 2017-10-28 0000891024 2016-05-01 2016-10-29 0000891024 2016-07-31 2016-10-29 0000891024 2017-07-30 2017-10-28 0000891024 2016-07-30 0000891024 2016-04-30 0000891024 pdco:FifthThirdNationalBankMember 2017-10-28 0000891024 pdco:UnsettledContractsMember 2017-10-28 0000891024 pdco:FifthThirdNationalBankMember 2017-04-30 2017-10-28 0000891024 pdco:BankOfTokyoMitsubishiUfjLimitedMember 2017-04-30 2017-10-28 0000891024 pdco:UnsettledContractsMember 2017-04-29 0000891024 pdco:BankOfTokyoMitsubishiUfjLimitedMember 2017-10-28 0000891024 us-gaap:InterestRateSwapMember 2017-04-30 2017-10-28 0000891024 us-gaap:InterestRateSwapMember 2016-05-01 2016-10-29 0000891024 us-gaap:InterestRateSwapMember 2016-07-31 2016-10-29 0000891024 us-gaap:InterestRateSwapMember 2017-07-30 2017-10-28 0000891024 pdco:SeniorNotesSevenMember pdco:InterestRateSwapAgreementMember 2015-03-25 2015-03-25 0000891024 pdco:SeniorNotesSevenMember pdco:InterestRateSwapAgreementMember 2015-03-25 0000891024 pdco:FivePointOneSevenPercentageSeniorNotesMember pdco:InterestRateSwapAgreementMember 2014-01-31 0000891024 us-gaap:InterestRateSwapMember 2008-03-31 0000891024 us-gaap:InterestRateCapMember 2017-10-28 0000891024 pdco:InterestRateSwapAgreementMember 2015-03-01 2015-03-31 0000891024 pdco:FivePointOneSevenPercentageSeniorNotesMember pdco:InterestRateSwapAgreementMember 2014-01-01 2014-01-31 0000891024 us-gaap:InterestRateSwapMember 2008-03-01 2008-03-31 0000891024 pdco:NewInterestRateCapAgreementMember 2017-10-28 0000891024 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateContractMember 2017-04-29 0000891024 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateContractMember 2017-10-28 0000891024 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateContractMember 2017-10-28 0000891024 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateContractMember 2017-04-29 0000891024 pdco:InterestRateSwapTwoMember 2008-03-31 0000891024 us-gaap:FairValueInputsLevel1Member 2017-04-29 0000891024 us-gaap:FairValueInputsLevel2Member 2017-04-29 0000891024 us-gaap:FairValueInputsLevel3Member 2017-04-29 0000891024 us-gaap:FairValueInputsLevel3Member 2017-10-28 0000891024 us-gaap:FairValueInputsLevel2Member 2017-10-28 0000891024 us-gaap:FairValueInputsLevel1Member 2017-10-28 0000891024 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2017-04-30 2017-10-28 0000891024 us-gaap:OperatingSegmentsMember pdco:AnimalHealthMember 2017-07-30 2017-10-28 0000891024 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2016-05-01 2016-10-29 0000891024 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2017-07-30 2017-10-28 0000891024 us-gaap:OperatingSegmentsMember pdco:AnimalHealthMember 2017-04-30 2017-10-28 0000891024 us-gaap:OperatingSegmentsMember pdco:AnimalHealthMember 2016-05-01 2016-10-29 0000891024 us-gaap:OperatingSegmentsMember pdco:DentalMember 2017-07-30 2017-10-28 0000891024 us-gaap:OperatingSegmentsMember pdco:DentalMember 2016-05-01 2016-10-29 0000891024 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2016-07-31 2016-10-29 0000891024 us-gaap:OperatingSegmentsMember pdco:DentalMember 2017-04-30 2017-10-28 0000891024 us-gaap:OperatingSegmentsMember pdco:AnimalHealthMember 2016-07-31 2016-10-29 0000891024 us-gaap:OperatingSegmentsMember pdco:DentalMember 2016-07-31 2016-10-29 0000891024 us-gaap:OperatingSegmentsMember pdco:DentalMember 2017-04-29 0000891024 us-gaap:OperatingSegmentsMember pdco:AnimalHealthMember 2017-04-29 0000891024 us-gaap:OperatingSegmentsMember pdco:AnimalHealthMember 2017-10-28 0000891024 us-gaap:OperatingSegmentsMember pdco:DentalMember 2017-10-28 0000891024 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2017-04-29 0000891024 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2017-10-28 0000891024 pdco:OtherProductMember 2017-07-30 2017-10-28 0000891024 pdco:ConsumablesMember 2017-04-30 2017-10-28 0000891024 pdco:EquipmentAndSoftwareMember 2016-07-31 2016-10-29 0000891024 pdco:OtherProductMember 2017-04-30 2017-10-28 0000891024 pdco:OtherProductMember 2016-07-31 2016-10-29 0000891024 pdco:EquipmentAndSoftwareMember 2017-04-30 2017-10-28 0000891024 pdco:ConsumablesMember 2016-07-31 2016-10-29 0000891024 pdco:OtherProductMember 2016-05-01 2016-10-29 0000891024 pdco:EquipmentAndSoftwareMember 2017-07-30 2017-10-28 0000891024 pdco:EquipmentAndSoftwareMember 2016-05-01 2016-10-29 0000891024 pdco:ConsumablesMember 2016-05-01 2016-10-29 0000891024 pdco:ConsumablesMember 2017-07-30 2017-10-28 0000891024 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-04-30 2017-10-28 0000891024 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-04-30 2017-10-28 0000891024 us-gaap:AccumulatedTranslationAdjustmentMember 2017-04-30 2017-10-28 0000891024 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-04-29 0000891024 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-10-28 0000891024 us-gaap:AccumulatedTranslationAdjustmentMember 2017-04-29 0000891024 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-10-28 0000891024 us-gaap:AccumulatedTranslationAdjustmentMember 2017-10-28 0000891024 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-04-29 xbrli:shares xbrli:pure iso4217:USD xbrli:shares pdco:finance_agreement iso4217:USD pdco:Segment pdco:agreement false --04-28 Q2 2018 2017-10-28 10-Q 0000891024 94824000 Large Accelerated Filer PATTERSON COMPANIES, INC. PDCO 100000000 575000000 250000000 3507913000 2119512000 863970000 524431000 3528479000 2171844000 903155000 453480000 575000000 100000000 119798000 129098000 119798000 0 0 119798000 129098000 0 0 129098000 940000 0 1000000 1405000 2 2 29003000 0.095 0.11 26210000 24581000 0.01 4331000 14516000 5967000 10227000

616859000

634594000

612216000

156437000

152132000

-92669000

-83675000

72973000

88069000

23997000

19375000

1453000

1218000

1581000

1272000

3507913000

3528479000

1803593000

1843608000

127784000

6798000

1188000

119798000

133065000

3000000

967000

129098000

137453000

110387000

94959000

17902000

101456000

32187000

6798000

3000000

-27066000

6497000

0.24

0.48

0.26000

0.52

966000

949000

32192000

51274000

36717000

80085000

1099281000

2114539000

1069994000

2075061000

1025761000

1022779000

2015-03-25

2025-03-24

18010000

22458000

100000000

1000000

-702000

-1397000

-703000

-2862000

-1405000

0.48

0.89

0.43

0.76

0.48

0.88

0.43

0.76

-3567000

1652000

0.359

0.343

0.345

56881000

57151000

813547000

814224000

318960000

636138000

315743000

614791000

71328000

128946000

61451000

108593000

25572000

44284000

21207000

37502000

196726000

56167000

614000

628000

629000

646000

425436000

406641000

10097000

20259000

11468000

22671000

1188000

967000

1188000

967000

711903000

796369000

2113480000

2161539000

3507913000

3528479000

903931000

950631000

59000000

92000000

1013026000

1005986000

14754000

998272000

991232000

0.0517

0.0348

250000000

38069000

-92039000

-6262000

19776000

-55306000

77108000

45756000

84662000

40244000

71091000

101529000

111184000

124098000

70193000

239157000

490919000

243984000

486199000

79803000

21854000

77043000

-19094000

145219000

36683000

137338000

-28802000

71759000

23217000

65207000

-16665000

128592000

39893000

124726000

-36027000

65356000

66107000

8119000

437000

870000

438000

875000

265000

527000

265000

530000

-14001000

-34258000

-3965000

8119000

211277000

219676000

1622000

3986000

1160000

2672000

3095000

-11626000

50000000

71254000

47655000

49969000

29377000

16431000

111928000

96578000

143000000

33000000

974000

3561000

298452000

286715000

58000

3716000

884803000

849205000

-875000

8250000

7377000

1481234000

1429668000

1418241000

807146000

601553000

9542000

1112232000

217194000

88815000

2750677000

1569777000

1156568000

24332000

2188453000

378140000

184084000

1385737000

823583000

553630000

8524000

1116091000

181337000

88309000

2689852000

1599719000

1072437000

17696000

2196196000

318286000

175370000

62663000

172257000

95588000

151711000

14693000

16635000

1394433000

-14989000

-92669000

-77680000

1366940000

-14114000

-83675000

-69561000

68071000

95904000

96138000

93351000

93683000

95290000

95510000

92722000

93037000

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Patterson Companies, Inc. (referred to herein as "Patterson" or in the first person notations "we," "our," and "us") as of </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;">, and our results of operations and cash flows for the periods ended </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">October 29, 2016</font><font style="font-family:Arial;font-size:10pt;">. Such adjustments are of a normal recurring nature. The results of operations for the periods ended </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">October 29, 2016</font><font style="font-family:Arial;font-size:10pt;"> are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the financial statements included in our 2017 Annual Report on Form 10-K filed on June 28, 2017.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The unaudited condensed consolidated financial statements include the assets and liabilities of PDC Funding Company, LLC ("PDC Funding") and PDC Funding Company II, LLC ("PDC Funding II"), which are our wholly owned subsidiaries and separate legal entities formed under Minnesota law. PDC Funding and PDC Funding II are fully consolidated special purpose entities established to sell customer installment sale contracts to outside financial institutions in the normal course of their business. The assets of PDC Funding and PDC Funding II would be available first and foremost to satisfy the claims of its creditors. There are no known creditors of PDC Funding or PDC Funding II.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">General</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Patterson Companies, Inc. (referred to herein as "Patterson" or in the first person notations "we," "our," and "us") as of </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;">, and our results of operations and cash flows for the periods ended </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">October 29, 2016</font><font style="font-family:Arial;font-size:10pt;">. Such adjustments are of a normal recurring nature. The results of operations for the periods ended </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">October 29, 2016</font><font style="font-family:Arial;font-size:10pt;"> are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the financial statements included in our 2017 Annual Report on Form 10-K filed on June 28, 2017.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The unaudited condensed consolidated financial statements include the assets and liabilities of PDC Funding Company, LLC ("PDC Funding") and PDC Funding Company II, LLC ("PDC Funding II"), which are our wholly owned subsidiaries and separate legal entities formed under Minnesota law. PDC Funding and PDC Funding II are fully consolidated special purpose entities established to sell customer installment sale contracts to outside financial institutions in the normal course of their business. The assets of PDC Funding and PDC Funding II would be available first and foremost to satisfy the claims of its creditors. There are no known creditors of PDC Funding or PDC Funding II.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Fiscal Year End</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We operate with a 52-53 week accounting convention with our fiscal year ending on the last Saturday in April. The </font><font style="font-family:Arial;font-size:10pt;">second</font><font style="font-family:Arial;font-size:10pt;"> quarter of fiscal 2018 and 2017 represents the 13 weeks ended </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;"> and the 13 weeks ended </font><font style="font-family:Arial;font-size:10pt;">October 29, 2016</font><font style="font-family:Arial;font-size:10pt;">, respectively. The </font><font style="font-family:Arial;font-size:10pt;">six</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">October 29, 2016</font><font style="font-family:Arial;font-size:10pt;"> each included 26 weeks. Fiscal 2018 will include 52 weeks and fiscal 2017 included 52 weeks.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Comprehensive Income</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Comprehensive income is computed as net income including certain other items that are recorded directly to stockholders’ equity. Significant items included in comprehensive income are foreign currency translation adjustments and the effective portion of cash flow hedges, net of tax. Foreign currency translation adjustments do not include a provision for income tax because earnings from foreign operations are considered to be indefinitely reinvested outside the U.S. The income tax expense related to cash flow hedges was </font><font style="font-family:Arial;font-size:10pt;">$265</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$265</font><font style="font-family:Arial;font-size:10pt;"> for the three months ended </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">October 29, 2016</font><font style="font-family:Arial;font-size:10pt;">, respectively. The income tax expense related to cash flow hedges was </font><font style="font-family:Arial;font-size:10pt;">$530</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$527</font><font style="font-family:Arial;font-size:10pt;"> for the </font><font style="font-family:Arial;font-size:10pt;">six</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">October 29, 2016</font><font style="font-family:Arial;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Earnings Per Share</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table sets forth the computation of the weighted average shares outstanding used to calculate basic and diluted earnings per share ("EPS"):</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Three Months Ended </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 28, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 29, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 28, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 29, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Denominator for basic earnings per share – weighted average shares</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">92,722</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">95,290</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">93,037</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">95,510</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Effect of dilutive securities – stock options, restricted stock and stock purchase plans</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">629</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">614</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">646</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">628</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Denominator for diluted earnings per share – weighted average shares</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">93,351</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">95,904</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">93,683</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">96,138</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Potentially dilutive securities representing </font><font style="font-family:Arial;font-size:10pt;">1,581</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">1,272</font><font style="font-family:Arial;font-size:10pt;"> shares for the </font><font style="font-family:Arial;font-size:10pt;">three and six</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;">, respectively, and </font><font style="font-family:Arial;font-size:10pt;">1,453</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">1,218</font><font style="font-family:Arial;font-size:10pt;"> shares for the </font><font style="font-family:Arial;font-size:10pt;">three and six</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">October 29, 2016</font><font style="font-family:Arial;font-size:10pt;">, respectively, were excluded from the calculation of diluted earnings per share because their effects were anti-dilutive.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Recently Issued Accounting Pronouncements</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-09, "Revenue from Contracts with Customers (Topic 606)". ASU No. 2014-09 supersedes the revenue recognition requirements in "Revenue Recognition (Topic 605)," and requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In July 2015, the FASB deferred the effective date of this pronouncement by one year to December 15, 2017 for annual reporting periods beginning after that date. Companies may use either a full retrospective or a modified retrospective approach to adopt the standard. We plan to adopt the new guidance in the first quarter of fiscal 2019 and are currently evaluating the standard, including the method we will use for adoption and the effect it will have on our financial statements. We do not expect the standard to materially affect our consolidated net earnings, financial position, or cash flows. We are currently evaluating the new standard as it relates to certain sales transactions in which products are shipped directly from the vendor to our customers. We currently report these sales on a gross basis, and are evaluating if we will be required to report these sales on a net basis. Such sales represent approximately </font><font style="font-family:Arial;font-size:10pt;">2%</font><font style="font-family:Arial;font-size:10pt;"> of our consolidated net sales. Any change to net presentation would not impact gross margin or earnings.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In July 2015, the FASB issued ASU No. 2015-11, "Inventory (Topic 330), Simplifying the Measurement of Inventory." ASU 2015-11 requires inventory measured using any method other than LIFO or the retail inventory method to be subsequently measured at the lower of cost or net realizable value, rather than at the lower of cost or market. Subsequent measurement of inventory using the LIFO and retail inventory method is unchanged. During the first quarter of fiscal 2018, we adopted ASU No. 2015-11 and it had no material impact to the condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In January 2016, the FASB issued ASU No. 2016-01, "Financial Instruments- Recognition and Measurement of Financial Assets and Financial Liabilities (Subtopic 825-10)", which amends certain aspects of recognition, measurement, presentation and disclosure of financial instruments, including the requirement to measure certain equity investments at fair value with changes in fair value recognized in net income. We are required to adopt the ASU No. 2016-01 in the first quarter of fiscal 2019, with early adoption permitted. We are evaluating the impact of adopting this pronouncement.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, "Leases (Topic 842)," which requires lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by most leases, as well as requires additional qualitative and quantitative disclosures. We are required to adopt ASU 2016-02 in the first quarter of fiscal 2020, with early adoption permitted. We are evaluating the impact of adopting this pronouncement.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Comprehensive Income</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Comprehensive income is computed as net income including certain other items that are recorded directly to stockholders’ equity. Significant items included in comprehensive income are foreign currency translation adjustments and the effective portion of cash flow hedges, net of tax. Foreign currency translation adjustments do not include a provision for income tax because earnings from foreign operations are considered to be indefinitely reinvested outside the U.S.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Fair value is the price at which an asset could be exchanged in a current transaction between knowledgeable, willing parties. The fair value hierarchy of measurements is categorized into one of three levels based on the lowest level of significant input used:</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;padding-left:72px;text-indent:-48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Level 1</font><font style="font-family:Arial;font-size:10pt;"> - Quoted prices in active markets for identical assets and liabilities at the measurement date.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;padding-left:72px;text-indent:-48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Level 2</font><font style="font-family:Arial;font-size:10pt;"> - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;padding-left:72px;text-indent:-48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Level 3</font><font style="font-family:Arial;font-size:10pt;"> - Unobservable inputs for which there is little or no market data available. These inputs reflect management’s assumptions of what market participants would use in pricing the asset or liability.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our hierarchy for assets and liabilities measured at fair value on a recurring basis is as follows:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 28, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Deferred purchase price receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">129,098</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">129,098</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Derivative instruments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">967</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">967</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">133,065</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">967</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">129,098</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Derivative instruments</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">967</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">967</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">April 29, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6,798</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6,798</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Deferred purchase price receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">119,798</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">119,798</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Derivative instruments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,188</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,188</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#cceeff;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">127,784</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6,798</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,188</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">119,798</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#cceeff;">Derivative instruments</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,188</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,188</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Cash equivalents</font><font style="font-family:Arial;font-size:10pt;"> – We value cash equivalents at their current market rates. The carrying value of cash equivalents approximates fair value and maturities are less than three months.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Deferred purchase price receivable</font><font style="font-family:Arial;font-size:10pt;"> – We value the deferred purchase price receivable based on a discounted cash flow analysis using unobservable inputs, which include a forward yield curve, the estimated timing of payments and the credit quality of the underlying creditor. Significant changes in any of the significant unobservable inputs in isolation would not result in a materially different fair value estimate. The interrelationship between these inputs is insignificant.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Derivative instruments</font><font style="font-family:Arial;font-size:10pt;"> – Our derivative instruments consist of interest rate cap agreements and interest rate swaps. These instruments are valued using inputs such as interest rates and credit spreads.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Certain assets are measured at fair value on a non-recurring basis. These assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments under certain circumstances, such as when there is evidence of impairment. There were no fair value adjustments to such assets during the </font><font style="font-family:Arial;font-size:10pt;">six</font><font style="font-family:Arial;font-size:10pt;"> month periods ended </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;"> or </font><font style="font-family:Arial;font-size:10pt;">October 29, 2016</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our debt is not measured at fair value in the condensed consolidated balance sheets. The estimated fair value of our debt as of </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">April 29, 2017</font><font style="font-family:Arial;font-size:10pt;"> was </font><font style="font-family:Arial;font-size:10pt;">$1,022,779</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$1,025,761</font><font style="font-family:Arial;font-size:10pt;">, respectively, as compared to a carrying value of </font><font style="font-family:Arial;font-size:10pt;">$1,005,986</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$1,013,026</font><font style="font-family:Arial;font-size:10pt;"> at </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">April 29, 2017</font><font style="font-family:Arial;font-size:10pt;">, respectively. The fair value of debt was measured using a discounted cash flow analysis based on expected market based yields (i.e., level 2 inputs).</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The carrying amounts of receivables, net of allowances, accounts payable, and certain accrued and other current liabilities approximated fair value at </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">April 29, 2017</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Fiscal Year End</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We operate with a 52-53 week accounting convention with our fiscal year ending on the last Saturday in April. The </font><font style="font-family:Arial;font-size:10pt;">second</font><font style="font-family:Arial;font-size:10pt;"> quarter of fiscal 2018 and 2017 represents the 13 weeks ended </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;"> and the 13 weeks ended </font><font style="font-family:Arial;font-size:10pt;">October 29, 2016</font><font style="font-family:Arial;font-size:10pt;">, respectively. The </font><font style="font-family:Arial;font-size:10pt;">six</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">October 29, 2016</font><font style="font-family:Arial;font-size:10pt;"> each included 26 weeks. Fiscal 2018 will include 52 weeks and fiscal 2017 included 52 weeks.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table summarizes the changes in AOCL as of </font><font style="font-family:Arial;font-size:10pt;">October 28, 2017</font><font style="font-family:Arial;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Cash Flow</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Currency</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Translation</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">AOCL at April 29, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(14,989</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(77,680</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(92,669</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Other comprehensive loss before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,119</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,119</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Amounts reclassified from AOCL</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">875</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">875</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">AOCL at October 28, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(14,114</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(69,561</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(83,675</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table presents the pre-tax effect of derivative instruments in cash flow hedging relationships on the condensed consolidated statements of income and other comprehensive income ("OCI"):</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income (Effective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Three Months Ended </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;text-decoration:underline;">Derivatives in cash flow hedging relationships</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;text-decoration:underline;">Income statement location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 28, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 29, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 28, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 29, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Interest rate swap</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Interest expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(703</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(702</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(1,405</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(1,397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following presents the fair value of derivative instruments included in the condensed consolidated balance sheets:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:32%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;text-decoration:underline;">Derivative type</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;text-decoration:underline;">Classification</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 28, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">April 29, 2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Interest rate cap agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Other noncurrent assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">967</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,188</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#cceeff;">Liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Interest rate cap agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Other noncurrent liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">967</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,188</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table sets forth the computation of the weighted average shares outstanding used to calculate basic and diluted earnings per share ("EPS"):</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Three Months Ended </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 28, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 29, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 28, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 29, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Denominator for basic earnings per share – weighted average shares</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">92,722</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">95,290</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">93,037</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">95,510</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Effect of dilutive securities – stock options, restricted stock and stock purchase plans</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">629</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">614</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">646</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">628</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Denominator for diluted earnings per share – weighted average shares</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">93,351</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">95,904</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">93,683</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">96,138</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our hierarchy for assets and liabilities measured at fair value on a recurring basis is as follows:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 28, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Deferred purchase price receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">129,098</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">129,098</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Derivative instruments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">967</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">967</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">133,065</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">967</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">129,098</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Derivative instruments</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">967</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">967</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">April 29, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6,798</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6,798</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Deferred purchase price receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">119,798</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">119,798</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Derivative instruments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,188</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,188</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#cceeff;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">127,784</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6,798</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,188</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">119,798</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#cceeff;">Derivative instruments</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,188</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,188</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table presents information about our reportable segments:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Three Months Ended </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 28, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 29, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 28, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 29, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Net sales</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Dental</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">553,630</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">601,553</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,072,437</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,156,568</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Animal Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">823,583</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">807,146</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,599,719</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,569,777</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,524</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">9,542</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">17,696</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">24,332</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Consolidated net sales</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,385,737</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,418,241</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,689,852</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,750,677</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Operating income (loss)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Dental</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">65,207</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">77,043</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">124,726</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">137,338</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Animal Health</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">23,217</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">21,854</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">39,893</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">36,683</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(16,665</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(19,094</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(36,027</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(28,802</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Consolidated operating income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">71,759</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">79,803</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">128,592</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">145,219</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 28, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">April 29, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Dental</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">903,155</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">863,970</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Animal Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,171,844</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,119,512</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">453,480</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">524,431</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,528,479</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,507,913</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Segment Reporting</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We present </font><font style="font-family:Arial;font-size:10pt;">three</font><font style="font-family:Arial;font-size:10pt;"> reportable segments: Dental, Animal Health and Corporate. Dental and Animal Health are strategic business units that offer similar products and services to different customer bases. Dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals throughout North America. Animal Health is a leading, full-line distributor in North America and the U.K. of animal health products, services and technologies to both the production-animal and companion-pet markets. Our Corporate segment is comprised of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources and facilities. In addition, customer financing and other miscellaneous sales are reported within Corporate results. Corporate assets consist primarily of cash and cash equivalents, accounts receivable, property and equipment and long-term receivables. We evaluate segment performance based on operating income. The costs to operate the fulfillment centers are allocated to the operating units based on the through-put of the unit.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table presents information about our reportable segments:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Three Months Ended </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 28, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 29, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 28, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 29, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Net sales</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Dental</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">553,630</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">601,553</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,072,437</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,156,568</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Animal Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">823,583</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">807,146</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,599,719</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,569,777</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,524</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">9,542</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">17,696</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">24,332</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Consolidated net sales</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,385,737</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,418,241</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,689,852</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,750,677</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Operating income (loss)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Dental</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">65,207</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">77,043</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">124,726</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">137,338</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Animal Health</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">23,217</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">21,854</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">39,893</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">36,683</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(16,665</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(19,094</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(36,027</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(28,802</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Consolidated operating income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">71,759</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">79,803</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">128,592</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">145,219</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 28, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">April 29, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Dental</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">903,155</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">863,970</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Animal Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,171,844</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,119,512</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">453,480</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">524,431</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,528,479</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,507,913</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table presents sales information by product for all of our reportable segments:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Three Months Ended </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 28, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 29, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 28, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">October 29, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Net sales</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Consumable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,116,091</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,112,232</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,196,196</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,188,453</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Equipment and software</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">181,337</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">217,194</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">318,286</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">378,140</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">88,309</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">88,815</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">175,370</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">184,084</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Consolidated net sales</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,385,737</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,418,241</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,689,852</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,750,677</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

EX-101.SCH 7 pdco-20171028.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2107100 - Disclosure - Accumulated Other Comprehensive Loss ("AOCL") link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Accumulated Other Comprehensive Loss ("AOCL") - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Accumulated Other Comprehensive Loss ("AOCL") - Summary of Accumulated Other Comprehensive Loss (Detail) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Accumulated Other Comprehensive Loss ("AOCL") (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Customer Financing link:presentationLink link:calculationLink link:definitionLink 2402401 - Disclosure - Customer Financing (Detail) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Derivative Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Derivative Financial Instruments - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2403404 - Disclosure - Derivative Financial Instruments - Effect of Interest Rate Contracts on Condensed Consolidated Statements of Income and Other Comprehensive Income (OCI) (Detail) link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - Derivative Financial Instruments - Fair Value of Interest Rate Contracts Included in Condensed Consolidated Balance Sheets (Detail) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Derivative Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Fair Value Measurements - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - General link:presentationLink link:calculationLink link:definitionLink 2401403 - Disclosure - General - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2401404 - Disclosure - General - Computation of Basic and Diluted Earnings Per Share (EPS) (Detail) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - General (Policies) link:presentationLink link:calculationLink link:definitionLink 2301302 - Disclosure - General (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2405401 - Disclosure - Income Taxes (Detail) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Legal Proceedings link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Segment Reporting - Information about Reportable Segments (Detail) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Segment Reporting - Narrative (Detail) link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - Segment Reporting - Sales Information by Product (Detail) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 pdco-20171028_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 pdco-20171028_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 pdco-20171028_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Accounting Policies [Abstract] General Business Description and Basis of Presentation [Text Block] Equity [Abstract] Income tax expense related to cash flow hedges Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax Increase in interest expense Increase (Decrease) in Interest Expense Increase decrease in interest expense. Fair Value Disclosures [Abstract] Assets and Liabilities Measured at Fair Value on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Derivative Instruments and Hedging Activities Disclosure [Abstract] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Other Noncurrent Assets Other Noncurrent Assets [Member] Other Noncurrent Liabilities Other Noncurrent Liabilities [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Interest Rate Contracts Interest Rate Contract [Member] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Interest rate contracts, assets, fair value Interest Rate Derivative Assets, at Fair Value Interest rate contracts, liabilities, fair value Interest Rate Derivative Liabilities, at Fair Value Estimated fair value of debt Debt Instrument, Fair Value Disclosure Carrying value of debt Long-term Debt Earnings Per Share [Abstract] Denominator for basic earnings per share – weighted average shares (in shares) Weighted Average Number of Shares Outstanding, Basic Effect of dilutive securities - stock options, restricted stock and stock purchase plans (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Denominator for diluted earnings per share – weighted average shares (in shares) Weighted Average Number of Shares Outstanding, Diluted Commitments and Contingencies Disclosure [Abstract] Legal Proceedings Legal Matters and Contingencies [Text Block] Statement of Cash Flows [Abstract] Operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net income Net Income (Loss) Attributable to Parent Adjustments to reconcile net income to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation Depreciation Amortization Amortization Bad debt expense Provision for Doubtful Accounts Non-cash employee compensation Share-based Compensation Change in assets and liabilities, net of acquired Increase (Decrease) in Operating Capital Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Additions to property and equipment Payments to Acquire Property, Plant, and Equipment Collection of deferred purchase price receivables Proceeds from Collection of Deferred Purchase Price Receivables Proceeds from Collection of Deferred Purchase Price Receivables Other investing activities Payments for (Proceeds from) Other Investing Activities Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Dividends paid Payments of Dividends Repurchases of common stock Payments for Repurchase of Common Stock Retirement of long-term debt Repayments of Long-term Debt Draw on revolver Proceeds from Lines of Credit Other financing activities Proceeds from (Payments for) Other Financing Activities Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations Effect of exchange rate changes on cash Effect of Exchange Rate on Cash and Cash Equivalents Net change in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents at beginning of period Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents at end of period Derivative Financial Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Statement of Financial Position [Abstract] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Receivables, net of allowance for doubtful accounts Receivables, Net, Current Inventory Inventory, Net Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property and equipment, net Property, Plant and Equipment, Net Long-term receivables, net Notes, Loans and Financing Receivable, Net, Noncurrent Goodwill Goodwill Identifiable intangibles, net Intangible Assets, Net (Excluding Goodwill) Other Other Assets, Noncurrent Total assets Assets LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Accrued payroll expense Employee-related Liabilities, Current Other accrued liabilities Accrued Liabilities, Current Current maturities of long-term debt Long-term Debt, Current Maturities Borrowings on revolving credit Line of Credit, Current Total current liabilities Liabilities, Current Long-term debt Long-term Debt, Excluding Current Maturities Other non-current liabilities Other Liabilities, Noncurrent Total liabilities Liabilities Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Common stock Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital, Common Stock Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Retained earnings Retained Earnings (Accumulated Deficit) Unearned ESOP shares Unearned ESOP Shares Total stockholders’ equity Stockholders' Equity Attributable to Parent Total liabilities and stockholders’ equity Liabilities and Equity Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Operating Segments Operating Segments [Member] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Dental Dental [Member] Dental [Member] Animal Health Animal Health [Member] Animal Health [Member] Corporate Corporate Segment [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Net sales Revenue, Net Operating income (loss) Operating Income (Loss) Total assets Assets, Excluding Assets Held For Sale Assets, Excluding Assets Held For Sale Derivative [Table] Derivative [Table] Interest Rate Cap Interest Rate Cap [Member] New Interest Rate Cap New Interest Rate Cap Agreement [Member] New Interest Rate Cap Agreement [Member] Interest Rate Swap Interest Rate Swap [Member] Interest Rate Swap Two Interest Rate Swap Two [Member] Interest Rate Swap Two [Member] Interest Rate Swap Agreement Interest Rate Swap Agreement [Member] Interest Rate Swap Agreement [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] 5.17% Senior Notes Five Point One Seven Percentage Senior Notes [Member] Five Point One Seven Percentage Senior Notes [Member] Senior Notes 3.48% Senior Notes Seven [Member] Senior Notes Seven [Member] Derivative [Line Items] Derivative [Line Items] Notional amount of derivatives Derivative, Notional Amount Number of interest rate swap agreements Number Of Interest Rate Swap Agreements Number Of Interest Rate Swap Agreements Notional amount of derivative asset Derivative Asset, Notional Amount Increase to other comprehensive income Derivative, Gain on Derivative Percentage of senior notes Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate Maturity date of long-term loan Debt Instrument, Maturity Date Aggregate principal amount Long-term Debt, Percentage Bearing Fixed Interest, Amount Settlement of swap Payment For Settlement Of Interest Rate Swap Payment for settlement of interest rate swap. Effective portion of gains or losses recognized in OCI Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net Ineffectiveness recorded during period Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Increase (decrease) in interest expense Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Summary of Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Accumulated other comprehensive loss expected to be reclassified into earnings Income Tax Disclosure [Abstract] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Fair Value Measurements Fair Value Disclosures [Text Block] Computation of Basic and Diluted Earnings Per Share (EPS) Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Accumulated Other Comprehensive Loss (AOCL) Comprehensive Income (Loss) Note [Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Fiscal Year End Fiscal Period, Policy [Policy Text Block] Comprehensive Income Comprehensive Income, Policy [Policy Text Block] Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Document And Entity Information [Abstract] Document and Entity Information [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Cash Flow Hedges Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Currency Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Total AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCL Beginning Balance Other comprehensive loss before reclassifications Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Amounts reclassified from AOCL Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax AOCL Ending Balance Receivables [Abstract] Customer Financing [Table] Customer Financing [Table] Customer Financing [Table] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] The Bank of Tokyo-Mitsubishi UFJ, Ltd. Bank Of Tokyo Mitsubishi Ufj Limited [Member] The Bank Of Tokyo Mitsubishi UFJ Limited [Member] Fifth Third Bank Fifth Third National Bank [Member] Fifth Third National Bank [Member] Investment Type [Axis] Investment Type [Axis] Investments [Domain] Investments [Domain] Unsettled Financing Arrangements Unsettled Contracts [Member] Unsettled Contracts [Member] Customer Financing [Line Items] Customer Financing [Line Items] Customer Financing [Line Items] Maximum credit financed for equipment purchases for any one customer Financing Receivable Maximum Amount Per Customer Financing Receivable, Maximum Amount Per Customer Number of customer financing contracts Number Of Customer Financing Contracts Number Of Customer Financing Contracts Percentage of principal amount of financing contracts held as collateral (at least) Percentage Of Principal Amount Of Financing Contracts Held As Collateral Percentage Of Principal Amount Of Financing Contracts Held As Collateral Capacity under agreement Capacity Under Agreement Capacity under agreement. Financing contracts sold under ASC 860 Servicing Asset at Fair Value, Disposals Revenues from Sale of Financing Contracts Revenues from Sale of Financing Contracts Revenues from Sale of Financing Contracts Current receivables of finance contracts not yet sold Financing Receivable, Net Unearned income Deferred Unearned Financing Fees Deferred Unearned Financing Fees Finance contracts receivable sold and outstanding Contract Receivable Deferred purchase price Deferred Purchase Price Receivable Deferred Purchase Price Receivable Bad debt write-offs, percentage (less than) Rate Of Bad Debts Written Off Maximum Rate Of Bad Debts Written Off, Maximum Income Taxes Income Tax Disclosure [Text Block] Income Statement [Abstract] Cost of sales Cost of Revenue Gross profit Gross Profit Operating expenses Operating Expenses Operating income Other income (expense): Nonoperating Income (Expense) [Abstract] Other income, net Other Nonoperating Income (Expense) Interest expense Interest Expense Income before taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income tax expense Income Tax Expense (Benefit) EX-101.PRE 11 pdco-20171028_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Oct. 28, 2017	Nov. 30, 2017
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Oct. 28, 2017
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q2
Trading Symbol	PDCO
Entity Registrant Name	PATTERSON COMPANIES, INC.
Entity Central Index Key	0000891024
Current Fiscal Year End Date	--04-28
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		94,824,000

XML 13 R2.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Oct. 28, 2017	Apr. 29, 2017
Current assets:
Cash and cash equivalents	$ 101,456	$ 94,959
Receivables, net of allowance for doubtful accounts	849,205	884,803
Inventory	796,369	711,903
Prepaid expenses and other current assets	96,578	111,928
Total current assets	1,843,608	1,803,593
Property and equipment, net	286,715	298,452
Long-term receivables, net	111,184	101,529
Goodwill	814,224	813,547
Identifiable intangibles, net	406,641	425,436
Other	66,107	65,356
Total assets	3,528,479	3,507,913
Current liabilities:
Accounts payable	634,594	616,859
Accrued payroll expense	57,151	56,881
Other accrued liabilities	152,132	156,437
Current maturities of long-term debt	14,754	14,754
Borrowings on revolving credit	92,000	59,000
Total current liabilities	950,631	903,931
Long-term debt	991,232	998,272
Other non-current liabilities	219,676	211,277
Total liabilities	2,161,539	2,113,480
Stockholders’ equity:
Common stock	949	966
Additional paid-in capital	88,069	72,973
Accumulated other comprehensive loss	(83,675)	(92,669)
Retained earnings	1,429,668	1,481,234
Unearned ESOP shares	(68,071)	(68,071)
Total stockholders’ equity	1,366,940	1,394,433
Total liabilities and stockholders’ equity	$ 3,528,479	$ 3,507,913

XML 14 R3.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 28, 2017	Oct. 29, 2016	Oct. 28, 2017	Oct. 29, 2016
Income Statement [Abstract]
Net sales	$ 1,385,737	$ 1,418,241	$ 2,689,852	$ 2,750,677
Cost of sales	1,069,994	1,099,281	2,075,061	2,114,539
Gross profit	315,743	318,960	614,791	636,138
Operating expenses	243,984	239,157	486,199	490,919
Operating income	71,759	79,803	128,592	145,219
Other income (expense):
Other income, net	1,160	1,622	2,672	3,986
Interest expense	(11,468)	(10,097)	(22,671)	(20,259)
Income before taxes	61,451	71,328	108,593	128,946
Income tax expense	21,207	25,572	37,502	44,284
Net income	$ 40,244	$ 45,756	$ 71,091	$ 84,662
Earnings per share:
Basic (in USD per share)	$ 0.43	$ 0.48	$ 0.76	$ 0.89
Diluted (in USD per share)	$ 0.43	$ 0.48	$ 0.76	$ 0.88
Weighted average shares:
Basic (in shares)	92,722	95,290	93,037	95,510
Diluted (in shares)	93,351	95,904	93,683	96,138
Dividends declared per common share (in USD per share)	$ 0.26000	$ 0.24	$ 0.52	$ 0.48
Comprehensive income
Net income	$ 40,244	$ 45,756	$ 71,091	$ 84,662
Foreign currency translation gain (loss)	(3,965)	(14,001)	8,119	(34,258)
Cash flow hedges, net of tax	438	437	875	870
Comprehensive income	$ 36,717	$ 32,192	$ 80,085	$ 51,274

XML 15 R4.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Oct. 28, 2017	Oct. 29, 2016
Operating activities:
Net income	$ 71,091	$ 84,662
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation	22,458	18,010
Amortization	19,375	23,997
Bad debt expense	3,716	58
Non-cash employee compensation	16,635	14,693
Change in assets and liabilities, net of acquired	(56,167)	(196,726)
Net cash used in operating activities	77,108	(55,306)
Investing activities:
Additions to property and equipment	(16,431)	(29,377)
Collection of deferred purchase price receivables	24,581	26,210
Other investing activities	11,626	(3,095)
Net cash provided by (used in) investing activities	19,776	(6,262)
Financing activities:
Dividends paid	(49,969)	(47,655)
Repurchases of common stock	(71,254)	(50,000)
Retirement of long-term debt	(7,377)	(8,250)
Draw on revolver	33,000	143,000
Other financing activities	3,561	974
Net cash provided by financing activities	(92,039)	38,069
Effect of exchange rate changes on cash	1,652	(3,567)
Net change in cash and cash equivalents	6,497	(27,066)
Cash and cash equivalents at beginning of period	94,959	$ 137,453
Cash and cash equivalents at end of period	$ 101,456

XML 16 R5.htm IDEA: XBRL DOCUMENT

General

6 Months Ended

Oct. 28, 2017

Accounting Policies [Abstract]

General

Basis of Presentation

Fiscal Year End

Comprehensive Income

Earnings Per Share

The following table sets forth the computation of the weighted average shares outstanding used to calculate basic and diluted earnings per share ("EPS"):



	Three Months Ended		Six Months Ended
	October 28, 2017	October 29, 2016	October 28, 2017	October 29, 2016
Denominator for basic earnings per share – weighted average shares	92,722	95,290	93,037	95,510
Effect of dilutive securities – stock options, restricted stock and stock purchase plans	629	614	646	628
Denominator for diluted earnings per share – weighted average shares	93,351	95,904	93,683	96,138

Recently Issued Accounting Pronouncements

XML 17 R6.htm IDEA: XBRL DOCUMENT

Customer Financing	6 Months Ended
Customer Financing	Oct. 28, 2017
Receivables [Abstract]
Customer Financing	Customer Financing As a convenience to our customers, we offer several different financing alternatives, including a third party program and a Patterson-sponsored program. For the third party program, we act as a facilitator between the customer and the third party financing entity with no on-going involvement in the financing transaction. Under the Patterson-sponsored program, equipment purchased by creditworthy customers may be financed up to a maximum of $1,000. We generally sell our customers’ financing contracts to outside financial institutions in the normal course of our business. These financing arrangements are accounted for as a sale of assets under the provisions of ASC 860, Transfers and Servicing. We currently have two arrangements under which we sell these contracts. First, we operate under an agreement to sell a portion of our equipment finance contracts to commercial paper conduits with The Bank of Tokyo-Mitsubishi UFJ, Ltd. ("BTMU") serving as the agent. We utilize PDC Funding to fulfill a requirement of participating in the commercial paper conduit. We receive the proceeds of the contracts upon sale to BTMU. At least 9.5% of the proceeds are held by the conduit as security against eventual performance of the portfolio. This percentage can be greater and is based upon certain ratios defined in the agreement with BTMU. The capacity under the agreement with BTMU at October 28, 2017 was $575,000. Second, we maintain an agreement with Fifth Third Bank ("Fifth Third") whereby Fifth Third purchases customers’ financing contracts. PDC Funding II sells its financing contracts to Fifth Third. We receive the proceeds of the contracts upon sale to Fifth Third. At least 11.0% of the proceeds are held by the conduit as security against eventual performance of the portfolio. This percentage can be greater and is based upon certain ratios defined in the agreement with Fifth Third. The capacity under the agreement with Fifth Third at October 28, 2017 was $100,000. We service the financing contracts under both arrangements, for which we are paid a servicing fee. The servicing fees we receive are considered adequate compensation for services rendered. Accordingly, no servicing asset or liability has been recorded. The portion of the purchase price for the receivables held by the conduits is deemed a deferred purchase price receivable, which is paid to the applicable special purpose entity as payments on the customers’ financing contracts are collected by Patterson from customers. The difference between the carrying amount of the receivables sold under these programs and the sum of the cash and fair value of the deferred purchase price receivables received at time of transfer is recognized as a gain on sale of the related receivables and recorded in net sales in the condensed consolidated statements of income and other comprehensive income. Expenses incurred related to customer financing activities are recorded in operating expenses in our condensed consolidated statements of income and other comprehensive income. During the three months ended October 28, 2017 and October 29, 2016, we sold $95,588 and $62,663 of contracts under these arrangements, respectively. During the six months ended October 28, 2017 and October 29, 2016, we sold $151,711 and $172,257 of contracts under these arrangements, respectively. We recorded net sales in the condensed consolidated statements of income and other comprehensive income of $5,967 and $4,331 during the three months ended October 28, 2017 and October 29, 2016, respectively, related to these contracts sold. We recorded net sales in the condensed consolidated statements of income and other comprehensive income of $10,227 and $14,516 during the six months ended October 28, 2017 and October 29, 2016, respectively, related to these contracts sold. Included in cash and cash equivalents in the condensed consolidated balance sheets are $32,187 and $17,902 as of October 28, 2017 and April 29, 2017, respectively, which represent cash collected from previously sold customer financing contracts that have not yet been settled. Included in current receivables in the condensed consolidated balance sheets are $70,193, net of unearned income of $0, and $124,098, net of unearned income of $940, as of October 28, 2017 and April 29, 2017, respectively, of finance contracts we have not yet sold. A total of $612,216 of finance contracts receivable sold under the arrangements was outstanding at October 28, 2017. The deferred purchase price receivable under the arrangements was $129,098 and $119,798 as of October 28, 2017 and April 29, 2017, respectively. Since the internal financing program began in 1994, bad debt write-offs have amounted to less than 1% of the loans originated. The arrangements require us to maintain a minimum current ratio and maximum leverage ratio. We were in compliance with those covenants at October 28, 2017.

XML 18 R7.htm IDEA: XBRL DOCUMENT

Derivative Financial Instruments

6 Months Ended

Oct. 28, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

In March 2008, we entered into two forward starting interest rate swap agreements, each with notional amounts of $100,000 and accounted for as cash flow hedges, to hedge interest rate fluctuations in anticipation of the issuance of the senior notes due fiscal 2015 and fiscal 2018. Upon issuance of the hedged debt, we settled the forward starting interest rate swap agreements and recorded a $1,000 increase, net of income taxes, to other comprehensive income (loss), which is being amortized as a reduction to interest expense over the life of the related debt.

The following presents the fair value of derivative instruments included in the condensed consolidated balance sheets:



Derivative type	Classification	October 28, 2017		April 29, 2017
Assets:
Interest rate cap agreements	Other noncurrent assets	$	967	$	1,188
Liabilities:
Interest rate cap agreements	Other noncurrent liabilities	967		1,188

The following table presents the pre-tax effect of derivative instruments in cash flow hedging relationships on the condensed consolidated statements of income and other comprehensive income ("OCI"):



		Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income (Effective Portion)
		Three Months Ended						Six Months Ended
Derivatives in cash flow hedging relationships	Income statement location	October 28, 2017			October 29, 2016			October 28, 2017			October 29, 2016
Interest rate swap	Interest expense	$	(703	)	$	(702	)	$	(1,405	)	$	(1,397	)

We recorded no effective portion of gains or losses on derivative instruments in cash flow hedging relationships in OCI during the current period.

- Definition

The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5580258-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624181-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41638-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

XML 19 R8.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

6 Months Ended

Oct. 28, 2017

Fair Value Disclosures [Abstract]

Fair Value Measurements

Level 1 - Quoted prices in active markets for identical assets and liabilities at the measurement date.

Our hierarchy for assets and liabilities measured at fair value on a recurring basis is as follows:



	October 28, 2017
	Total		Level 1		Level 2		Level 3
Assets:
Cash equivalents	$	3,000	$	3,000	$	—	$	—
Deferred purchase price receivable	129,098		—		—		129,098
Derivative instruments	967		—		967		—
Total assets	$	133,065	$	3,000	$	967	$	129,098
Liabilities:
Derivative instruments	$	967	$	—	$	967	$	—



	April 29, 2017
	Total		Level 1		Level 2		Level 3
Assets:
Cash equivalents	$	6,798	$	6,798	$	—	$	—
Deferred purchase price receivable	119,798		—		—		119,798
Derivative instruments	1,188		—		1,188		—
Total assets	$	127,784	$	6,798	$	1,188	$	119,798
Liabilities:
Derivative instruments	$	1,188	$	—	$	1,188	$	—

Cash equivalents – We value cash equivalents at their current market rates. The carrying value of cash equivalents approximates fair value and maturities are less than three months.

The carrying amounts of receivables, net of allowances, accounts payable, and certain accrued and other current liabilities approximated fair value at October 28, 2017 and April 29, 2017.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 20 R9.htm IDEA: XBRL DOCUMENT

Income Taxes	6 Months Ended
Income Taxes	Oct. 28, 2017
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The effective income tax rate for the three months ended October 28, 2017 was 34.5% compared to 35.9% for the three months ended October 29, 2016, and for the six months ended October 28, 2017 was 34.5% compared to 34.3% for the six months ended October 29, 2016. The decrease in the rate for the three months ended October 28, 2017 compared to the prior year was primarily due to a geographical shift in earnings.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Segment Reporting

6 Months Ended

Oct. 28, 2017

Segment Reporting [Abstract]

Segment Reporting

The following table presents information about our reportable segments:



	Three Months Ended						Six Months Ended
	October 28, 2017			October 29, 2016			October 28, 2017			October 29, 2016
Net sales
Dental	$	553,630		$	601,553		$	1,072,437		$	1,156,568
Animal Health	823,583			807,146			1,599,719			1,569,777
Corporate	8,524			9,542			17,696			24,332
Consolidated net sales	$	1,385,737		$	1,418,241		$	2,689,852		$	2,750,677
Operating income (loss)
Dental	$	65,207		$	77,043		$	124,726		$	137,338
Animal Health	23,217			21,854			39,893			36,683
Corporate	(16,665		)	(19,094		)	(36,027		)	(28,802		)
Consolidated operating income	$	71,759		$	79,803		$	128,592		$	145,219



	October 28, 2017		April 29, 2017
Total assets
Dental	$	903,155	$	863,970
Animal Health	2,171,844		2,119,512
Corporate	453,480		524,431
Total assets	$	3,528,479	$	3,507,913

The following table presents sales information by product for all of our reportable segments:



	Three Months Ended				Six Months Ended
	October 28, 2017		October 29, 2016		October 28, 2017		October 29, 2016
Net sales
Consumable	$	1,116,091	$	1,112,232	$	2,196,196	$	2,188,453
Equipment and software	181,337		217,194		318,286		378,140
Other	88,309		88,815		175,370		184,084
Consolidated net sales	$	1,385,737	$	1,418,241	$	2,689,852	$	2,750,677

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

+ Details

XML 22 R11.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Loss ("AOCL")

6 Months Ended

Oct. 28, 2017

Equity [Abstract]

Accumulated Other Comprehensive Loss (AOCL)

Accumulated Other Comprehensive Loss ("AOCL")

The following table summarizes the changes in AOCL as of October 28, 2017:



	Cash Flow Hedges			Currency Translation Adjustment			Total
AOCL at April 29, 2017	$	(14,989	)	$	(77,680	)	$	(92,669	)
Other comprehensive loss before reclassifications	—			8,119			8,119
Amounts reclassified from AOCL	875			—			875
AOCL at October 28, 2017	$	(14,114	)	$	(69,561	)	$	(83,675	)

- Definition

The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e689-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e640-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e716-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e709-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e681-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Reclassification Adjustments
-URI http://asc.fasb.org/extlink&oid=6522872

+ Details

XML 23 R12.htm IDEA: XBRL DOCUMENT

Legal Proceedings	6 Months Ended
Legal Proceedings	Oct. 28, 2017
Commitments and Contingencies Disclosure [Abstract]
Legal Proceedings	Legal Proceedings In September 2015, we were served with a summons and complaint in an action commenced in the U.S. District Court for the Eastern District of New York, entitled SourceOne Dental, Inc. v. Patterson Companies, Inc., Henry Schein, Inc. and Benco Dental Supply Company, Civil Action No. 15-cv-05440-JMA-GRB. SourceOne, as plaintiff, alleges that, through its website, it markets and sells dental supplies and equipment to dentists. SourceOne alleges in the complaint, among other things, that we, along with the defendants Henry Schein and Benco, conspired to eliminate plaintiff as a competitor and to exclude them from the market for the marketing, distribution and sale of dental supplies and equipment in the U.S. and that defendants unlawfully agreed with one another to boycott dentists, manufacturers, and state dental associations that deal with, or considered dealing with, plaintiff. Plaintiff asserts the following claims: (i) unreasonable restraint of trade in violation of state and federal antitrust laws; (ii) tortious interference with prospective business relations; (iii) civil conspiracy; and (iv) aiding and abetting the other defendants’ ongoing tortious and anticompetitive conduct. Plaintiff seeks equitable relief, compensatory and treble damages, jointly and severally, punitive damages, interest, and reasonable costs and expenses, including attorneys’ fees and expert fees. In June 2017, Henry Schein settled with SourceOne and was dismissed from this litigation with prejudice. We are vigorously defending ourselves in this litigation. We do not anticipate that this matter will have a material adverse effect on our financial condition. Beginning in January 2016, purported class action complaints were filed against defendants Henry Schein, Inc., Benco Dental Supply Company and Patterson Companies, Inc. Although there were factual and legal variations among these complaints, each alleged that defendants conspired to foreclose and exclude competitors by boycotting manufacturers, state dental associations, and others that deal with defendants’ competitors. On February 9, 2016, the U.S. District Court for the Eastern District of New York ordered all of these actions, and all other actions filed thereafter asserting substantially similar claims against defendants, consolidated for pre-trial purposes. On February 26, 2016, a consolidated class action complaint was filed by Arnell Prato, D.D.S., P.L.L.C., d/b/a Down to Earth Dental, Evolution Dental Sciences, LLC, Howard M. May, DDS, P.C., Casey Nelson, D.D.S., Jim Peck, D.D.S., Bernard W. Kurek, D.M.D., Larchmont Dental Associates, P.C., and Keith Schwartz, D.M.D., P.A. (collectively, “putative class representatives”) in the U.S. District Court for the Eastern District of New York, entitled In re Dental Supplies Antitrust Litigation, Civil Action No. 1:16-CV-00696-BMC-GRB. Subject to certain exclusions, the putative class representatives seek to represent all persons who purchased dental supplies or equipment in the U.S. directly from any of the defendants, since August 31, 2008. In the consolidated class action complaint, putative class representatives allege a nationwide agreement among Henry Schein, Benco, Patterson and non-party Burkhart Dental Supply Company, Inc. not to compete on price. The consolidated class action complaint asserts a single count under Section 1 of the Sherman Act, and seeks equitable relief, compensatory and treble damages, jointly and severally, interest, and reasonable costs and expenses, including attorneys’ fees and expert fees. Putative class representatives have not specified a damage amount in their complaint. While the outcome of litigation is inherently uncertain, we believe the consolidated class action complaint is without merit, and we are vigorously defending ourselves in this litigation. On August 31, 2012, Archer and White Sales, Inc. (“Archer”) filed a complaint against Henry Schein, Inc. as well as Danaher Corporation and its subsidiaries Instrumentarium Dental, Inc., Dental Equipment, LLC, Kavo Dental Technologies, LLC and Dental Imaging Technologies Corporation (collectively, the “Danaher Defendants”) in the United States District Court for the Eastern District of Texas, Civil Action No. 2:12-CV-00572-JRG, styled as an antitrust action under Section 1 of the Sherman Act, and the Texas Free Enterprise Antitrust Act. Archer alleges a conspiracy between Henry Schein, an unnamed company and the Danaher Defendants to terminate or limit Archer’s distribution rights. On August 1, 2017, Archer filed an amended complaint, adding Patterson Companies, Inc. and Benco Dental Supply Company as defendants, and alleging that Henry Schein, Patterson, Benco and non-defendant Burkhart Dental Supply Company, Inc. conspired to pressure and agreed to enlist their common suppliers, including the Danaher Defendants, to join a price-fixing conspiracy and boycott by reducing the distribution territory of, and eventually terminating, Archer. Archer seeks injunctive relief, and damages in an amount to be proved at trial, to be trebled with interest and costs, including attorneys’ fees, jointly and severally. Trial is currently scheduled for February 2018. We are vigorously defending ourselves in this litigation. We do not anticipate that this matter will have a material adverse effect on our financial statements. On August 17, 2017, IQ Dental Supply, Inc. (“IQ Dental”) filed a complaint in the United States District Court for the Eastern District of New York, entitled IQ Dental Supply, Inc. v. Henry Schein, Inc., Patterson Companies, Inc. and Benco Dental Supply Company, Case No. 2:17-cv-4834. Plaintiff alleges that it is a distributor of dental supplies and equipment, and sells dental products through an online dental distribution platform operated by SourceOne Dental, Inc. IQ Dental alleges, among other things, that defendants conspired to suppress competition from IQ Dental and SourceOne for the marketing, distribution and sale of dental supplies and equipment in the United States, and that defendants unlawfully agreed with one another to boycott dentists, manufacturers and state dental associations that deal with, or considered dealing with, plaintiff and SourceOne. Plaintiff claims that this alleged conduct constitutes unreasonable restraint of trade in violation of Section 1 of the Sherman Act, New York’s Donnelly Act and the New Jersey Antitrust Act, and also makes pendant state law claims for tortious interference with prospective business relations, civil conspiracy and aiding and abetting. Plaintiff seeks injunctive relief, compensatory, treble and punitive damages, jointly and severally, and reasonable costs and expenses, including attorneys’ fees and expert fees. We are vigorously defending ourselves in this litigation. We do not anticipate that this matter will have a material adverse effect on our financial statements. From time to time, we may become a party to other legal proceedings, including, without limitation, product liability claims, intellectual property claims, employment matters, commercial disputes, governmental inquiries and investigations (which may in some cases involve our entering into settlement arrangements or consent decrees), and other matters arising out of the ordinary course of our business. While the results of any legal proceeding cannot be predicted with certainty, in our opinion none of these other pending matters is anticipated to have a material adverse effect on our financial statements.

XML 24 R13.htm IDEA: XBRL DOCUMENT

General (Policies)	6 Months Ended
General (Policies)	Oct. 28, 2017
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Patterson Companies, Inc. (referred to herein as "Patterson" or in the first person notations "we," "our," and "us") as of October 28, 2017, and our results of operations and cash flows for the periods ended October 28, 2017 and October 29, 2016. Such adjustments are of a normal recurring nature. The results of operations for the periods ended October 28, 2017 and October 29, 2016 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the financial statements included in our 2017 Annual Report on Form 10-K filed on June 28, 2017. The unaudited condensed consolidated financial statements include the assets and liabilities of PDC Funding Company, LLC ("PDC Funding") and PDC Funding Company II, LLC ("PDC Funding II"), which are our wholly owned subsidiaries and separate legal entities formed under Minnesota law. PDC Funding and PDC Funding II are fully consolidated special purpose entities established to sell customer installment sale contracts to outside financial institutions in the normal course of their business. The assets of PDC Funding and PDC Funding II would be available first and foremost to satisfy the claims of its creditors. There are no known creditors of PDC Funding or PDC Funding II.
Fiscal Year End	Fiscal Year End We operate with a 52-53 week accounting convention with our fiscal year ending on the last Saturday in April. The second quarter of fiscal 2018 and 2017 represents the 13 weeks ended October 28, 2017 and the 13 weeks ended October 29, 2016, respectively. The six months ended October 28, 2017 and October 29, 2016 each included 26 weeks. Fiscal 2018 will include 52 weeks and fiscal 2017 included 52 weeks.
Comprehensive Income	Comprehensive Income Comprehensive income is computed as net income including certain other items that are recorded directly to stockholders’ equity. Significant items included in comprehensive income are foreign currency translation adjustments and the effective portion of cash flow hedges, net of tax. Foreign currency translation adjustments do not include a provision for income tax because earnings from foreign operations are considered to be indefinitely reinvested outside the U.S.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-09, "Revenue from Contracts with Customers (Topic 606)". ASU No. 2014-09 supersedes the revenue recognition requirements in "Revenue Recognition (Topic 605)," and requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In July 2015, the FASB deferred the effective date of this pronouncement by one year to December 15, 2017 for annual reporting periods beginning after that date. Companies may use either a full retrospective or a modified retrospective approach to adopt the standard. We plan to adopt the new guidance in the first quarter of fiscal 2019 and are currently evaluating the standard, including the method we will use for adoption and the effect it will have on our financial statements. We do not expect the standard to materially affect our consolidated net earnings, financial position, or cash flows. We are currently evaluating the new standard as it relates to certain sales transactions in which products are shipped directly from the vendor to our customers. We currently report these sales on a gross basis, and are evaluating if we will be required to report these sales on a net basis. Such sales represent approximately 2% of our consolidated net sales. Any change to net presentation would not impact gross margin or earnings. In July 2015, the FASB issued ASU No. 2015-11, "Inventory (Topic 330), Simplifying the Measurement of Inventory." ASU 2015-11 requires inventory measured using any method other than LIFO or the retail inventory method to be subsequently measured at the lower of cost or net realizable value, rather than at the lower of cost or market. Subsequent measurement of inventory using the LIFO and retail inventory method is unchanged. During the first quarter of fiscal 2018, we adopted ASU No. 2015-11 and it had no material impact to the condensed consolidated financial statements. In January 2016, the FASB issued ASU No. 2016-01, "Financial Instruments- Recognition and Measurement of Financial Assets and Financial Liabilities (Subtopic 825-10)", which amends certain aspects of recognition, measurement, presentation and disclosure of financial instruments, including the requirement to measure certain equity investments at fair value with changes in fair value recognized in net income. We are required to adopt the ASU No. 2016-01 in the first quarter of fiscal 2019, with early adoption permitted. We are evaluating the impact of adopting this pronouncement. In February 2016, the FASB issued ASU No. 2016-02, "Leases (Topic 842)," which requires lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by most leases, as well as requires additional qualitative and quantitative disclosures. We are required to adopt ASU 2016-02 in the first quarter of fiscal 2020, with early adoption permitted. We are evaluating the impact of adopting this pronouncement.

XML 25 R14.htm IDEA: XBRL DOCUMENT

General (Tables)

6 Months Ended

Oct. 28, 2017

Accounting Policies [Abstract]

Computation of Basic and Diluted Earnings Per Share (EPS)

The following table sets forth the computation of the weighted average shares outstanding used to calculate basic and diluted earnings per share ("EPS"):



	Three Months Ended		Six Months Ended
	October 28, 2017	October 29, 2016	October 28, 2017	October 29, 2016
Denominator for basic earnings per share – weighted average shares	92,722	95,290	93,037	95,510
Effect of dilutive securities – stock options, restricted stock and stock purchase plans	629	614	646	628
Denominator for diluted earnings per share – weighted average shares	93,351	95,904	93,683	96,138

XML 26 R15.htm IDEA: XBRL DOCUMENT

Derivative Financial Instruments (Tables)

6 Months Ended

Oct. 28, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Fair Value of Interest Rate Contracts Included in Condensed Consolidated Balance Sheets

The following presents the fair value of derivative instruments included in the condensed consolidated balance sheets:



Derivative type	Classification	October 28, 2017		April 29, 2017
Assets:
Interest rate cap agreements	Other noncurrent assets	$	967	$	1,188
Liabilities:
Interest rate cap agreements	Other noncurrent liabilities	967		1,188

Effect of Interest Rate Contracts on Condensed Consolidated Statements of Income and Other Comprehensive Income (OCI)

The following table presents the pre-tax effect of derivative instruments in cash flow hedging relationships on the condensed consolidated statements of income and other comprehensive income ("OCI"):



		Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income (Effective Portion)
		Three Months Ended						Six Months Ended
Derivatives in cash flow hedging relationships	Income statement location	October 28, 2017			October 29, 2016			October 28, 2017			October 29, 2016
Interest rate swap	Interest expense	$	(703	)	$	(702	)	$	(1,405	)	$	(1,397	)

XML 27 R16.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

6 Months Ended

Oct. 28, 2017

Fair Value Disclosures [Abstract]

Assets and Liabilities Measured at Fair Value on Recurring Basis

Our hierarchy for assets and liabilities measured at fair value on a recurring basis is as follows:



	October 28, 2017
	Total		Level 1		Level 2		Level 3
Assets:
Cash equivalents	$	3,000	$	3,000	$	—	$	—
Deferred purchase price receivable	129,098		—		—		129,098
Derivative instruments	967		—		967		—
Total assets	$	133,065	$	3,000	$	967	$	129,098
Liabilities:
Derivative instruments	$	967	$	—	$	967	$	—



	April 29, 2017
	Total		Level 1		Level 2		Level 3
Assets:
Cash equivalents	$	6,798	$	6,798	$	—	$	—
Deferred purchase price receivable	119,798		—		—		119,798
Derivative instruments	1,188		—		1,188		—
Total assets	$	127,784	$	6,798	$	1,188	$	119,798
Liabilities:
Derivative instruments	$	1,188	$	—	$	1,188	$	—

XML 28 R17.htm IDEA: XBRL DOCUMENT

Segment Reporting (Tables)

6 Months Ended

Oct. 28, 2017

Segment Reporting [Abstract]

Information about Reportable Segments

The following table presents information about our reportable segments:



	Three Months Ended						Six Months Ended
	October 28, 2017			October 29, 2016			October 28, 2017			October 29, 2016
Net sales
Dental	$	553,630		$	601,553		$	1,072,437		$	1,156,568
Animal Health	823,583			807,146			1,599,719			1,569,777
Corporate	8,524			9,542			17,696			24,332
Consolidated net sales	$	1,385,737		$	1,418,241		$	2,689,852		$	2,750,677
Operating income (loss)
Dental	$	65,207		$	77,043		$	124,726		$	137,338
Animal Health	23,217			21,854			39,893			36,683
Corporate	(16,665		)	(19,094		)	(36,027		)	(28,802		)
Consolidated operating income	$	71,759		$	79,803		$	128,592		$	145,219



	October 28, 2017		April 29, 2017
Total assets
Dental	$	903,155	$	863,970
Animal Health	2,171,844		2,119,512
Corporate	453,480		524,431
Total assets	$	3,528,479	$	3,507,913

Sales Information by Product

The following table presents sales information by product for all of our reportable segments:



	Three Months Ended				Six Months Ended
	October 28, 2017		October 29, 2016		October 28, 2017		October 29, 2016
Net sales
Consumable	$	1,116,091	$	1,112,232	$	2,196,196	$	2,188,453
Equipment and software	181,337		217,194		318,286		378,140
Other	88,309		88,815		175,370		184,084
Consolidated net sales	$	1,385,737	$	1,418,241	$	2,689,852	$	2,750,677

XML 29 R18.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Loss ("AOCL") (Tables)

6 Months Ended

Oct. 28, 2017

Equity [Abstract]

Summary of Accumulated Other Comprehensive Loss

The following table summarizes the changes in AOCL as of October 28, 2017:



	Cash Flow Hedges			Currency Translation Adjustment			Total
AOCL at April 29, 2017	$	(14,989	)	$	(77,680	)	$	(92,669	)
Other comprehensive loss before reclassifications	—			8,119			8,119
Amounts reclassified from AOCL	875			—			875
AOCL at October 28, 2017	$	(14,114	)	$	(69,561	)	$	(83,675	)

XML 30 R19.htm IDEA: XBRL DOCUMENT

General - Additional Information (Detail) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 28, 2017	Oct. 29, 2016	Oct. 28, 2017	Oct. 29, 2016
Accounting Policies [Abstract]
Income tax expense related to cash flow hedges	$ 265	$ 265	$ 530	$ 527
Securities excluded from calculation of diluted earnings per share (in shares)	1,581	1,453	1,272	1,218

XML 31 R20.htm IDEA: XBRL DOCUMENT

General - Computation of Basic and Diluted Earnings Per Share (EPS) (Detail) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Oct. 28, 2017	Oct. 29, 2016	Oct. 28, 2017	Oct. 29, 2016
Earnings Per Share [Abstract]
Denominator for basic earnings per share – weighted average shares (in shares)	92,722	95,290	93,037	95,510
Effect of dilutive securities - stock options, restricted stock and stock purchase plans (in shares)	629	614	646	628
Denominator for diluted earnings per share – weighted average shares (in shares)	93,351	95,904	93,683	96,138

XML 32 R21.htm IDEA: XBRL DOCUMENT

Customer Financing (Detail)	3 Months Ended		6 Months Ended
Customer Financing (Detail)	Oct. 28, 2017 USD ($)	Oct. 29, 2016 USD ($)	Oct. 28, 2017 USD ($) finance_agreement	Oct. 29, 2016 USD ($)	Apr. 29, 2017 USD ($)	Jul. 30, 2016 USD ($)	Apr. 30, 2016 USD ($)
Customer Financing [Line Items]
Maximum credit financed for equipment purchases for any one customer	$ 1,000,000		$ 1,000,000
Number of customer financing contracts \| finance_agreement			2
Financing contracts sold under ASC 860	95,588,000	$ 62,663,000	$ 151,711,000	$ 172,257,000
Revenues from Sale of Financing Contracts	5,967,000	$ 4,331,000	10,227,000	$ 14,516,000
Cash and cash equivalents	101,456,000		101,456,000		$ 94,959,000	$ 110,387,000	$ 137,453,000
Current receivables of finance contracts not yet sold	70,193,000		70,193,000		124,098,000
Unearned income	0		0		940,000
Finance contracts receivable sold and outstanding	612,216,000		612,216,000
Deferred purchase price	129,098,000		$ 129,098,000		119,798,000
Bad debt write-offs, percentage (less than)			1.00%
Unsettled Financing Arrangements
Customer Financing [Line Items]
Cash and cash equivalents	32,187,000		$ 32,187,000		$ 17,902,000
The Bank of Tokyo-Mitsubishi UFJ, Ltd.
Customer Financing [Line Items]
Percentage of principal amount of financing contracts held as collateral (at least)			9.50%
Capacity under agreement	575,000,000		$ 575,000,000
Fifth Third Bank
Customer Financing [Line Items]
Percentage of principal amount of financing contracts held as collateral (at least)			11.00%
Capacity under agreement	$ 100,000,000		$ 100,000,000

XML 33 R22.htm IDEA: XBRL DOCUMENT

Derivative Financial Instruments - Additional Information (Detail)		1 Months Ended			3 Months Ended		6 Months Ended
	Mar. 25, 2015 USD ($)	Mar. 31, 2015 USD ($)	Jan. 31, 2014 USD ($)	Mar. 31, 2008 USD ($) agreement	Oct. 28, 2017 USD ($)	Oct. 29, 2016 USD ($)	Oct. 28, 2017 USD ($)	Oct. 29, 2016 USD ($)
Derivative [Line Items]
Effective portion of gains or losses recognized in OCI							$ 0
Ineffectiveness recorded during period					$ 0	$ 0	0	$ 0
Increase (decrease) in interest expense							(2,862,000)
Interest Rate Cap
Derivative [Line Items]
Notional amount of derivatives					575,000,000		575,000,000
New Interest Rate Cap
Derivative [Line Items]
Notional amount of derivatives					100,000,000		100,000,000
Interest Rate Swap
Derivative [Line Items]
Number of interest rate swap agreements \| agreement				2
Notional amount of derivative asset				$ 100,000,000
Increase to other comprehensive income				1,000,000
Increase (decrease) in interest expense					$ (703,000)	$ (702,000)	$ (1,405,000)	$ (1,397,000)
Interest Rate Swap Two
Derivative [Line Items]
Notional amount of derivative asset				$ 100,000,000
Interest Rate Swap Agreement
Derivative [Line Items]
Settlement of swap		$ 29,003,000
Interest Rate Swap Agreement \| 5.17% Senior Notes
Derivative [Line Items]
Notional amount of derivatives			$ 250,000,000
Percentage of senior notes			5.17%
Maturity date of long-term loan			Mar. 25, 2015
Interest Rate Swap Agreement \| Senior Notes 3.48%
Derivative [Line Items]
Percentage of senior notes	3.48%
Maturity date of long-term loan	Mar. 24, 2025
Aggregate principal amount	$ 250,000,000

XML 34 R23.htm IDEA: XBRL DOCUMENT

Derivative Financial Instruments - Fair Value of Interest Rate Contracts Included in Condensed Consolidated Balance Sheets (Detail) - USD ($) $ in Thousands	Oct. 28, 2017	Apr. 29, 2017
Derivatives, Fair Value [Line Items]
Interest rate contracts, assets, fair value	$ 967	$ 1,188
Interest rate contracts, liabilities, fair value	967	1,188
Other Noncurrent Assets \| Interest Rate Contracts
Derivatives, Fair Value [Line Items]
Interest rate contracts, assets, fair value	967	1,188
Other Noncurrent Liabilities \| Interest Rate Contracts
Derivatives, Fair Value [Line Items]
Interest rate contracts, liabilities, fair value	$ 967	$ 1,188

XML 35 R24.htm IDEA: XBRL DOCUMENT

Derivative Financial Instruments - Effect of Interest Rate Contracts on Condensed Consolidated Statements of Income and Other Comprehensive Income (OCI) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 28, 2017	Oct. 29, 2016	Oct. 28, 2017	Oct. 29, 2016
Derivative Instruments, Gain (Loss) [Line Items]
Accumulated other comprehensive loss expected to be reclassified into earnings			$ (2,862)
Interest Rate Swap
Derivative Instruments, Gain (Loss) [Line Items]
Accumulated other comprehensive loss expected to be reclassified into earnings	$ (703)	$ (702)	$ (1,405)	$ (1,397)

XML 36 R25.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands	Oct. 28, 2017	Apr. 29, 2017
Assets:
Cash equivalents	$ 3,000	$ 6,798
Deferred purchase price receivable	129,098	119,798
Derivative instruments	967	1,188
Total assets	133,065	127,784
Liabilities:
Derivative instruments	967	1,188
Fair Value, Inputs, Level 1
Assets:
Cash equivalents	3,000	6,798
Deferred purchase price receivable	0	0
Derivative instruments	0	0
Total assets	3,000	6,798
Liabilities:
Derivative instruments	0	0
Fair Value, Inputs, Level 2
Assets:
Cash equivalents	0	0
Deferred purchase price receivable	0	0
Derivative instruments	967	1,188
Total assets	967	1,188
Liabilities:
Derivative instruments	967	1,188
Fair Value, Inputs, Level 3
Assets:
Cash equivalents	0	0
Deferred purchase price receivable	129,098	119,798
Derivative instruments	0	0
Total assets	129,098	119,798
Liabilities:
Derivative instruments	$ 0	$ 0

XML 37 R26.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Additional Information (Detail) - USD ($) $ in Thousands	Oct. 28, 2017	Apr. 29, 2017
Fair Value Disclosures [Abstract]
Estimated fair value of debt	$ 1,022,779	$ 1,025,761
Carrying value of debt	$ 1,005,986	$ 1,013,026

XML 38 R27.htm IDEA: XBRL DOCUMENT

Income Taxes (Detail)	3 Months Ended		6 Months Ended
Income Taxes (Detail)	Oct. 28, 2017	Oct. 29, 2016	Oct. 28, 2017	Oct. 29, 2016
Income Tax Disclosure [Abstract]
Effective income tax rate	34.50%	35.90%	34.50%	34.30%

XML 39 R28.htm IDEA: XBRL DOCUMENT

Segment Reporting - Narrative (Detail)	6 Months Ended
Segment Reporting - Narrative (Detail)	Oct. 28, 2017 Segment
Segment Reporting [Abstract]
Number of reportable segments	3

XML 40 R29.htm IDEA: XBRL DOCUMENT

Segment Reporting - Information about Reportable Segments (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 28, 2017	Oct. 29, 2016	Oct. 28, 2017	Oct. 29, 2016	Apr. 29, 2017
Segment Reporting Information [Line Items]
Net sales	$ 1,385,737	$ 1,418,241	$ 2,689,852	$ 2,750,677
Operating income (loss)	71,759	79,803	128,592	145,219
Total assets	3,528,479		3,528,479		$ 3,507,913
Operating Segments \| Dental
Segment Reporting Information [Line Items]
Net sales	553,630	601,553	1,072,437	1,156,568
Operating income (loss)	65,207	77,043	124,726	137,338
Total assets	903,155		903,155		863,970
Operating Segments \| Animal Health
Segment Reporting Information [Line Items]
Net sales	823,583	807,146	1,599,719	1,569,777
Operating income (loss)	23,217	21,854	39,893	36,683
Total assets	2,171,844		2,171,844		2,119,512
Operating Segments \| Corporate
Segment Reporting Information [Line Items]
Net sales	8,524	9,542	17,696	24,332
Operating income (loss)	(16,665)	$ (19,094)	(36,027)	$ (28,802)
Total assets	$ 453,480		$ 453,480		$ 524,431

XML 41 R30.htm IDEA: XBRL DOCUMENT

Segment Reporting - Sales Information by Product (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 28, 2017	Oct. 29, 2016	Oct. 28, 2017	Oct. 29, 2016
Segment Reporting Information [Line Items]
Net sales	$ 1,385,737	$ 1,418,241	$ 2,689,852	$ 2,750,677
Consumable
Segment Reporting Information [Line Items]
Net sales	1,116,091	1,112,232	2,196,196	2,188,453
Equipment and software
Segment Reporting Information [Line Items]
Net sales	181,337	217,194	318,286	378,140
Other
Segment Reporting Information [Line Items]
Net sales	$ 88,309	$ 88,815	$ 175,370	$ 184,084

XML 42 R31.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Loss ("AOCL") - Summary of Accumulated Other Comprehensive Loss (Detail) $ in Thousands	6 Months Ended
	Oct. 28, 2017 USD ($)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
AOCL Beginning Balance	$ 1,394,433
AOCL Ending Balance	1,366,940
Cash Flow Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
AOCL Beginning Balance	(14,989)
Other comprehensive loss before reclassifications	0
Amounts reclassified from AOCL	875
AOCL Ending Balance	(14,114)
Currency Translation Adjustment
AOCI Attributable to Parent, Net of Tax [Roll Forward]
AOCL Beginning Balance	(77,680)
Other comprehensive loss before reclassifications	8,119
Amounts reclassified from AOCL	0
AOCL Ending Balance	(69,561)
Total
AOCI Attributable to Parent, Net of Tax [Roll Forward]
AOCL Beginning Balance	(92,669)
Other comprehensive loss before reclassifications	8,119
Amounts reclassified from AOCL	875
AOCL Ending Balance	$ (83,675)

XML 43 R32.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Loss ("AOCL") - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 28, 2017	Oct. 29, 2016	Oct. 28, 2017	Oct. 29, 2016
Equity [Abstract]
Income tax expense related to cash flow hedges	$ 265	$ 265	$ 530	$ 527
Increase in interest expense			$ 1,405

EXCEL 44 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

XS(/OK,M0@;GE"@\@A"=R:?Q:./$JZ0.W^S?VQU"[J^7"##PH\GY[@?F6YP1C-,0WBZ5:?_(=A'"?:!8/]7 MB?2FQ!@FC8MD49$L0K"_$8EALAL1LFFWU_-;G@VKAF5,R?JO M*/\ 4$L#!!0 ( -%ZADL]RH.3MP$ -(# 9 >&PO=V]R:W-H965T MV>6IZ+UL-9TM;X^G?B!DA(JT4O_9(9'F.I)*)F*_PY7D @/F6",PD@75U+TSALUJ6 J M2KR->ZOC/HPW23+1U@E\(O"9<(AQV!@H9OY%>)&GU@S$CKWO1'CB[9%C;XK@ MC*V(=YB\0^\UWR:W*;L&H0ES&C%\B9D1#-7G$'PMQ(G_1^?K]-UJAKM(WRVC M\V1=8+\JL(\"^W]*O/M4XAKF\"D(6_14@:WC-#E2F%['25YXYX&]Y_%-_L+' M:?\A;-UJ1R[&X\O&_E?&>,!4-C&ULC57M;ILP%'T5Q /4?#G)(H+4?%2;M$E1IVZ_'7(34&U, M;2=T;S_;$$J(E_4/MB_GG'N/C2]IP\6K+ "4]\YH)1=^H50]1TCF!3 B'W@- ME7YSX((1I9?BB&0M@.PMB5$4!<$$,5)6?I;:V%9D*3\I6E:P%9X\,4;$GR50 MWBS\T+\$GLMCH4P 96E-CO 3U$N]%7J%>I5]R:"2):\\ 8>%_QC.-]C@+>!7 M"8TSK "2HV0+N.MT_3[E(8XG%_4GZQW M[65')*PX_5WN5;'P9[ZWAP,Y4?7,FZ_0^<&^UYG_#F>@&FXJT3ER3J5]>OE) M*LXZ%5T*(^_M6%9V;#K]"\U-B#I"U!-"?)<0=X3X@Y#<)20=(?EL!MP1\"@# M:KW;S5P31;)4\,83[>=0$_/5A7.LCRLW07LZ]IW>3ZFCYRS$7U)T-D(=9MEB MH@$&3Z\AZUM(V".0+J"O(G)5L8QNZ-%U@M4M L]&-?Q79'-7Y*K,V+E9L>7' M0Y?!U"V0. 42*Y ,!2;!:+=;S-1BJM;&!(]VXQ.8]2T&QZ-<&P!#M^^%C9.[7*+X,YZO0$5_K_MFVNP_YMOG^(.)85M+;<:5OM;U[!\X5Z-J# M!UUVH?M]OZ!P4&8ZU7/1=KUVH7C=-734_U6ROU!+ P04 " #1>H9+^0>6 MR%$" ^!P &0 'AL+W=O'3 ):@ZGMA.W?US:$31PW[4NPAW/.S!F3 M<=8Q_B9* .F]U[01"[^4LITC)(H2:B*>6 N->G-@O"92;?D1B98#V1M235$4 M!"FJ2=7X>69B6YYG["1IU<"6>^)4UX3_7@)EW<(/_4O@I3J64@=0GK7D"-]! MOK9;KG9H5-E7-32B8HW'X;#PG\/Y)M5X _A102>NUIYVLF/L36^^[!=^H L" M"H74"D0]SK "2K60*N/7H.F/*37Q>GU1_V2\*R\[(F#%Z,]J+\N%/_6]/1S( MB

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

XML 45 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 46 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 48 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 78 131 1 false 26 0 false 7 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.pattersoncompanies.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.pattersoncompanies.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME Sheet http://www.pattersoncompanies.com/role/CondensedConsolidatedStatementsOfIncomeAndOtherComprehensiveIncome CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME Statements 3 false false R4.htm 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.pattersoncompanies.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 4 false false R5.htm 2101100 - Disclosure - General Sheet http://www.pattersoncompanies.com/role/General General Notes 5 false false R6.htm 2102100 - Disclosure - Customer Financing Sheet http://www.pattersoncompanies.com/role/CustomerFinancing Customer Financing Notes 6 false false R7.htm 2103100 - Disclosure - Derivative Financial Instruments Sheet http://www.pattersoncompanies.com/role/DerivativeFinancialInstruments Derivative Financial Instruments Notes 7 false false R8.htm 2104100 - Disclosure - Fair Value Measurements Sheet http://www.pattersoncompanies.com/role/FairValueMeasurements Fair Value Measurements Notes 8 false false R9.htm 2105100 - Disclosure - Income Taxes Sheet http://www.pattersoncompanies.com/role/IncomeTaxes Income Taxes Notes 9 false false R10.htm 2106100 - Disclosure - Segment Reporting Sheet http://www.pattersoncompanies.com/role/SegmentReporting Segment Reporting Notes 10 false false R11.htm 2107100 - Disclosure - Accumulated Other Comprehensive Loss ("AOCL") Sheet http://www.pattersoncompanies.com/role/AccumulatedOtherComprehensiveLossAocl Accumulated Other Comprehensive Loss ("AOCL") Notes 11 false false R12.htm 2108100 - Disclosure - Legal Proceedings Sheet http://www.pattersoncompanies.com/role/LegalProceedings Legal Proceedings Notes 12 false false R13.htm 2201201 - Disclosure - General (Policies) Sheet http://www.pattersoncompanies.com/role/GeneralPolicies General (Policies) Policies 13 false false R14.htm 2301302 - Disclosure - General (Tables) Sheet http://www.pattersoncompanies.com/role/GeneralTables General (Tables) Tables http://www.pattersoncompanies.com/role/General 14 false false R15.htm 2303301 - Disclosure - Derivative Financial Instruments (Tables) Sheet http://www.pattersoncompanies.com/role/DerivativeFinancialInstrumentsTables Derivative Financial Instruments (Tables) Tables http://www.pattersoncompanies.com/role/DerivativeFinancialInstruments 15 false false R16.htm 2304301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.pattersoncompanies.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.pattersoncompanies.com/role/FairValueMeasurements 16 false false R17.htm 2306301 - Disclosure - Segment Reporting (Tables) Sheet http://www.pattersoncompanies.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://www.pattersoncompanies.com/role/SegmentReporting 17 false false R18.htm 2307301 - Disclosure - Accumulated Other Comprehensive Loss ("AOCL") (Tables) Sheet http://www.pattersoncompanies.com/role/AccumulatedOtherComprehensiveLossAoclTables Accumulated Other Comprehensive Loss ("AOCL") (Tables) Tables http://www.pattersoncompanies.com/role/AccumulatedOtherComprehensiveLossAocl 18 false false R19.htm 2401403 - Disclosure - General - Additional Information (Detail) Sheet http://www.pattersoncompanies.com/role/GeneralAdditionalInformationDetail General - Additional Information (Detail) Details 19 false false R20.htm 2401404 - Disclosure - General - Computation of Basic and Diluted Earnings Per Share (EPS) (Detail) Sheet http://www.pattersoncompanies.com/role/GeneralComputationOfBasicAndDilutedEarningsPerShareEpsDetail General - Computation of Basic and Diluted Earnings Per Share (EPS) (Detail) Details 20 false false R21.htm 2402401 - Disclosure - Customer Financing (Detail) Sheet http://www.pattersoncompanies.com/role/CustomerFinancingDetail Customer Financing (Detail) Details http://www.pattersoncompanies.com/role/CustomerFinancing 21 false false R22.htm 2403402 - Disclosure - Derivative Financial Instruments - Additional Information (Detail) Sheet http://www.pattersoncompanies.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetail Derivative Financial Instruments - Additional Information (Detail) Details 22 false false R23.htm 2403403 - Disclosure - Derivative Financial Instruments - Fair Value of Interest Rate Contracts Included in Condensed Consolidated Balance Sheets (Detail) Sheet http://www.pattersoncompanies.com/role/DerivativeFinancialInstrumentsFairValueOfInterestRateContractsIncludedInCondensedConsolidatedBalanceSheetsDetail Derivative Financial Instruments - Fair Value of Interest Rate Contracts Included in Condensed Consolidated Balance Sheets (Detail) Details 23 false false R24.htm 2403404 - Disclosure - Derivative Financial Instruments - Effect of Interest Rate Contracts on Condensed Consolidated Statements of Income and Other Comprehensive Income (OCI) (Detail) Sheet http://www.pattersoncompanies.com/role/DerivativeFinancialInstrumentsEffectOfInterestRateContractsOnCondensedConsolidatedStatementsOfIncomeAndOtherComprehensiveIncomeOciDetail Derivative Financial Instruments - Effect of Interest Rate Contracts on Condensed Consolidated Statements of Income and Other Comprehensive Income (OCI) (Detail) Details 24 false false R25.htm 2404402 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Sheet http://www.pattersoncompanies.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Details 25 false false R26.htm 2404403 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://www.pattersoncompanies.com/role/FairValueMeasurementsAdditionalInformationDetail Fair Value Measurements - Additional Information (Detail) Details 26 false false R27.htm 2405401 - Disclosure - Income Taxes (Detail) Sheet http://www.pattersoncompanies.com/role/IncomeTaxesDetail Income Taxes (Detail) Details http://www.pattersoncompanies.com/role/IncomeTaxes 27 false false R28.htm 2406402 - Disclosure - Segment Reporting - Narrative (Detail) Sheet http://www.pattersoncompanies.com/role/SegmentReportingNarrativeDetail Segment Reporting - Narrative (Detail) Details 28 false false R29.htm 2406403 - Disclosure - Segment Reporting - Information about Reportable Segments (Detail) Sheet http://www.pattersoncompanies.com/role/SegmentReportingInformationAboutReportableSegmentsDetail Segment Reporting - Information about Reportable Segments (Detail) Details 29 false false R30.htm 2406404 - Disclosure - Segment Reporting - Sales Information by Product (Detail) Sheet http://www.pattersoncompanies.com/role/SegmentReportingSalesInformationByProductDetail Segment Reporting - Sales Information by Product (Detail) Details 30 false false R31.htm 2407402 - Disclosure - Accumulated Other Comprehensive Loss ("AOCL") - Summary of Accumulated Other Comprehensive Loss (Detail) Sheet http://www.pattersoncompanies.com/role/AccumulatedOtherComprehensiveLossAoclSummaryOfAccumulatedOtherComprehensiveLossDetail Accumulated Other Comprehensive Loss ("AOCL") - Summary of Accumulated Other Comprehensive Loss (Detail) Details http://www.pattersoncompanies.com/role/AccumulatedOtherComprehensiveLossAoclTables 31 false false R32.htm 2407403 - Disclosure - Accumulated Other Comprehensive Loss ("AOCL") - Additional Information (Detail) Sheet http://www.pattersoncompanies.com/role/AccumulatedOtherComprehensiveLossAoclAdditionalInformationDetail Accumulated Other Comprehensive Loss ("AOCL") - Additional Information (Detail) Details http://www.pattersoncompanies.com/role/AccumulatedOtherComprehensiveLossAoclTables 32 false false All Reports Book All Reports pdco-20171028.xml pdco-20171028.xsd pdco-20171028_cal.xml pdco-20171028_def.xml pdco-20171028_lab.xml pdco-20171028_pre.xml http://fasb.org/us-gaap/2016-01-31 http://xbrl.sec.gov/dei/2014-01-31 http://xbrl.sec.gov/invest/2013-01-31 true true ZIP 50 0000891024-17-000020-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000891024-17-000020-xbrl.zip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
5Z''.M9YM:[:/F,99^='EW:VRLDMS,_PG5.L3Y3"* ;8@K+),.-G./AEF9 M,_>>;P$ @6G,9 /(*89":%@[,)(3P)P9VOL_ +5_=7$^KWX/P599WQYPW3R[ M/'WIV>4^>4US X:G-,\->,!F0+1S",Y]?/D96DXH53<:QZ%,'6UX6^ID4I* M:0RGCFL(A*#G>+6KQI+[E&L.-VFB,1@M>5JQ@U$KQ;D?8=U3<$(76C$U#CEH M!_W)$ZJM[4\_-%S&2]7<]_@0=1FBR% QI *#"47"$P].V<6XA%N<&XR?Y5]5G5JP<; M$KEGA7M@.DUASDURGO T_&[AU?1NC@(_VL4X]RG@%TD[(55]4CX.!>O5HB M:"8#&;>F//^N7?2Y$#$"8^4(85P(!*DA=COLK5,L*\-RLB$-O9(J?)U#26W0 M/>N0?O7_VIM>?!\YL/7,R\08YVB MZ:0CTP.[XQ"A?DQY>CE)7_PDWT12K$HMCR^&;R>795YDO:B0TB!GD$,,,/9<4.:]%)X :+$VBB'+LYZ9:B%9 M^^L9EX^VD#.O$>F%W#3E.CNO>0I6PWM5U.AJ^=I? K('N]U7W@,^\_4?"12> M4+=>>V <*M>O28\O[.B?KU35^^>JNOY]-I]/I'?&:4*#C@8Q1#(T^KTBE)TZ-!V,C3G!>) M&$1%FE9/*$4V-^-0@WS85<Q'"_A^&F'L6A GOG>AQ3> M3F;%>J1]'*K5KTE/LFB]\Y6J=@?;V@?^$M8BWA^!((748 !]<)6:Z2>1S+H) M_/D6B+<:.^V(1)9ZS:7@7F#E 5.42.@&UK,:5)YNM60J3:B&)RE/F1YFNRX5 M2CW+R@G=Z<;B.(2FHPU5G^.J3>)J$F2).>T]589A9@DWHBG&M1KBK.NSMI\T MU#)&C>(*>HH,##%<\/&,HM01P07,$HNVJ:KV*:J7*?PV>/FS^>:UR,5U_1C2UVH>"%G%G>3UC_VQ0D ( M0UA[YI UFH25KTFY6N1\UO7\R8T"%&(#1[SD4L>@3P9W"*FP_DJHF%-YCXRW MV-1]H_2;MV\^O7$?"_6++3Y^>F?^]Y_?O;7NP\?_]G<"0?X_"OB=]'&+6OUG5P(.UM2 ^/O6D MG3,:4LZ$8\8201&3._=>Q"8;:@#:PF[_,G'XPRE259;6D M3W_$C=A='2(DEB)/ $-.>NJD$LWE DX8G'?SPO--Q)H8032T! -JH EV6&D M8P0$]X,-?3:B057<;6!E1F$M:4N,RH9G+#-*:\C:(KI4$>&SO)P*Y+H1.0Z9 MZ6K$XT"O#TZ2GYFXO9M7/\KR0SFOWW5](F\3@Y#2W#F%J!$6:NA)HNN$4/5']3@TJT=['C_]T#-3&8Y2 MG+K/M.\=V)'F<;:"JZE]/'>6JZ:9+'C#N;M%CWS?6,!!!![3JVG MDCFE %4\%D<9*;C+NHVRPS;1[71]O]SLVU8WQ7Q7!GU]ZI7Z_DA,W"\:F+_, MC:(=21'/?J_H+SLJS[Q7])2=4YM$';@[&Z:TE0" M:+QS6C.K(8,*-,EF1QVT>5O2SS1@'&8$AZ]3#"FT4 #@G.1.,LJ<=D.7[NAJ MN:Q^GRV^U$_Z+ M& (-PH8&>Y1"S%-*G8=($9)WS5?7\^BM8Z8VO+5-WJ/0L%"1ZZ1JBGB">'M/R@9R"^NL4]^Y,/8XJ DHJ/.W([$IWI M:,2)4*@U)UE'&0[4[;!*WR-.C5$H_-UH&-9=WYR.]MB K%><3C2C!!$F1';$ M2DK##%40,BPH@51Z+OC0M8F;;=]%M7C=V8WIPF6:%)V)QCPYVC#XP+FYZ-F' M9_DYH4$]D#H.'>K#D.>.0O3!38L0:@*@L4PKPC!F0,5(#31O$GGJ+&\9.TTL MHQ(RYDQ\]!43JX*_YH2E)&9F@K=PEJ"ICV#I98:RHZ1>R6D='ETL*DH+AY)) M&H4?&8V:S+!)]\G%#MJ3 (Q0LZA;/:*&J5-I0"A*T> M^AF'#9YB%0'E:5 ^36G*,RA#>7JS):?&\JJHT;PJWJQ6]^6Y7^9^Q,D)*6E- MWS@$I#W\QT_"=.,AN:3N^KI^5'(Z?S^=7;]9F.G=+#C_!ZU/F($T^$Q(2J<] M]L8JW!Q-] 3PK*=@$IISTCAG"2("QTN]D+2($H8(@X1(#+,>N&]3'KQ#6,2; MHE_/%L75!F1FE5T/Q*8)SIDYS9.@ SHCNB+0N<7WJCB4IS/7X+U(V:EBO/[X M'H=F]6G0X_*\OKG**!6^O[VORY/K':+0XMVR_%HN5O7#UU?5;?FV6L4K>=[= M?)I^GV#'L)!,A47?&*XY)+8I??6 $YU90)S5-F#(.N %\<;3P(5V6#(=HAX0 M9%T._MCE =SFM8E#P,4\8,VN,.Z7_$0AO"#OF:IX0/EF<_H!UF(#MO@IPOWC MYO:PZJ8(F,]>JIQ#Z"G-'*AK1B*@0UGWM-AY0!;3'PQ<3V>+\MI-EXM8KW> MRI8WLZM9//P-- ,("L<44\ :1]1N0E.0I:8)S3&, ?98D> 74ZN9I YK)RV! MVA/M], "VB LRBW$W(<"N_.9)I!GIC)/$WYQZ%R?!CUY=[!GKE+5[*^+.&M#PQ_?O?_X=1H&Z,00+17E4%$%F*,$(K@] MBH )C=< \;2W(N1FDAUB M29YK#:8B@BI6-:H\T6I#6YI(#<57*U%Z2-3'TT0-HD!/Z3BA.!VX&X?"=#&@ MZFT<=4T+3@0*0@6QDHA":[52LKF# H$8[>;4!3SW>>*$YE9QAPAUEFKMJ 8A M8M8H>'8Z[QQJV_* U=%D8-=?EB)D_)SE+Y);Y9]J&\JY;K$.CM:B$88$IC89DT7& )P\+O8(CX-*,Q MTYGZ-$3K[P^X\F\@%3M,EZOM.4+.J06_*Y_CF$;=S7B\^/?#2_*TN?I:7M_/ MRW-%[6G%2_(A M_+MR.8T.UM:G6OVEO/U<+B<"&D:5M%0*Z1D'6'BYTSJ"LXZ6M&UC8.W9P6KB MD=PS]VVI2Q.<<["6IS=/"2M^W8 ZL]P:$VG0EV$E/9T^ M#7(6FM'WJW@QVJII=>-< 8L\<=I+A+W#2%*-FC8I-#+OH&V7EH;>OMK-G191 M54<.4]/KYZ*OU7[[90*KDZ2<3*SW0>8X]*4<:H MQ-HBHC&S=M<&-5D/\N1]^6Q:TRJFRF0I*Y$W $%MU>0B(=,#&E[.TV72-1*] M:(?]^8Q<*P9>TH.[ZZMJ8L/7I_.M[P.T)1IAR!DDG $$K!#-]R6"24^IYW]U M8!W88$F;_"TH.3WQAV4C;])O8+PHX!$C40O?$N&=$KCT!EQ6X#KBKKEV?(6QJ,;N=SO]<3N?KK]M6M)-2,28P MAE"PX%1Y:II6N 0X6=Y:?'M@D=L@*C:0,F9V&Y82%&]@@O)T[P$W;>2O#4D9 M(C@P6>VD,).T-$5\:NDQ7>S R0C4L0OZJI^1D9N'6]Y5RQ"*;EMQP6+,J+'2 M>R$HD,+L-L$T5YGIM[QO#YYUV\+)3;%E,I2:61N.G-R$VA;)OD+I(OO;CQ@Y MF45KQ]TXXL/6Z)_DS+JPT+;"^: DZ>UL4=:YNHGDPJ+0!O&>,\:%P49OFW9> MTJS7?'II\#P[3,\7^Q6_1IR;S'2[K:>.9&?M2)V/YU8;55TH/DO1^7.TO;RQ MU0_KX]"S?DUZH3"]![Z2E6\Z+U:5)T#"(C)MW+YNK0?WGEVH6&A/24JA4 L"QZ$C MG2PX5B#4FHVT?>K5JERO=F]);?[QS^7\VE?+*&<3 [5'E%A E85.N!#9-7OC MGAB7%%7UT]+ [L?F$/RTAI6S.]N9P)0-[7-RE[F]76,Y?(YL\Y,BPBL"OB(" M/"NA.9O?YR2VY59X-X(3M\9?X.'H1GE?_(UAV[PW6ZHA1EB>DVC+Y>Q;&&C? MRLU1/4.)L)YK+C$WG ='E"-,J$&:.0JMR(D;'W];&@E"A(L%)I@:"R77Q&@. M'9,:>97EY;2JL&C@M#MIG$U5FC\X)$MY$IU!T"!NX",F3KB ;3D;A_O7&GW5 MS\C)4X@WBS#7RM7ZPW1=FNE=D^#CB)G0C,4.&"NXEXHW@Y] E/4PP?,M&,^- M8H0+C0!%ABAC M=:6]%2;OKB,B&V/"^- M>0+T+(/%#E^;:JH>2,V(+\]+;KL LS/):2'FBU0 M:DG]T.\3/)PP$5=[/S*'N'Q';P)2"AB4E@BN*5( M2TVDH8P! 1SUQ@Y]6OF9.1.P9;@Z'X%'+CWF!W:D:@??7@Q%5K\.G@Q0_=C Q##X*P@VD.RVIMT]Q[.O\!"JHRW)6^$8M[:E%.2WHV?]&SQY_6;Q6J] MK =;??F'!,PXX0'UU# ? E+*63-CL*(H+V'\Y//!:0*88*$)@Q0CKS5QF#GE M)<,*X*SGIUKEC#^OBSVD5A<"M2$M-74\*%^YV>,LJ@;*(#\FY&02N35[XXC6 MNQCP))7;Z M XRH(BB^:*BHEHP#M]MGDH*E;X(>^;XB'!'-),2:4DF@LE![SRU03DC$A@Z; M'\PC_"0O# Z(V^;Z0' MW&&!(!-4:B44)X(KIE#]YDY8=S[*\;7N!2RO>4G\ M3;AZI0N!8]DGZ&#!T9,N;=EX24MFBV_E:GW04-"NL Q-Y^JVNE^L)S+(DV5, M<6V("--#6PB;>6$] 2EZ\E(;L;K>(:<49Y!Z1Q2F6A-A! /6>C'T#<0-FF): MPXGO1%[OH";N G2F\;2\G)/!MA+SJM@1N4'51F96Y=6?OE3??MX8'$4&;_\< MY04?R,L+E#PC,7V1>%F9Z]NCN9R5Q-&C*+&"6!PO$)= M0+JO1[ D+;N:VA9 5@!!' ?,4 2%UAQ!&QY7 ML2QANH.91CFW'L='[/W3!NM+=CMUQ.0]\[? MZ9:"0X8=A\Z88%)H2!'A+%2>2F>5L^B2#NCFQIVV 6XK7G-#W:$I;1WTUL!Z M\4O["'^?H2DI$.Y"[]A"XDZV' V.NS.4KUC_/)TMWBWV_SPQ! +KF]X5(: 9 ! VO5F\75LIRNRF)= M%=7Z:UC\KZK;NV7YM5RLXI3;W#W85J[R2K(3:HRO:T67SZ5R]M85;3/]>IRNIPMOOC9]_+ZT+V; M<* \8PARSXF&'& I7#.QD&-998>932-J&?" 2N$-A23:+H._;Z2V(6#B?& % M.RA["([6:I-&6Z07_ Q%>)J279#K/'6+0%\')+=%A/KJL-IDB[:HX>XBQP>_ M\N'4"R"#*& >L2=4<: >&H=2#F5<=991WJ5D^R_3]?URMOYA8X/6ZN"08$:1 ML<)* HQG^U(RF^GK'6U&"N*U L1*0R@07F*B@;5"2.RQH&1@I6RP%-=Q3R>( MY7PWI^?5=-&E;CN/S50G[RQ$YCIYCVJW=Z3:LTO<<8)..GF=61V'=/5AR,D* M[@[N@@"(BH#SB&OK!:??FR++]$Z;H+"*]F=[L=MGQ'KU_2TUV]B_$]N+-WB;VX M7$9?\/(&Z9QQB.5PYCWCZ0W(8U(^^OWT1]3O>.%TN5[/ZY3'TVQ(<%, PS$7 M#I%&%@C*].YB$T%(>NUR8GL&,L6)]<9Q&!Q<+JWBP;4-9E-'B1GZVN@]MCI. M3K[!JU=*$]+0%V S3QRW #=7T>])?39I>@&*,W+2%Z"Z75ZZH?PF4+YZ,(Z? MUEC\J6-V.HV48QGJGBD=09:Z;XNJX09@V]S/WN=?Q=W=^/;,A_*J^K*8_6=< MK][%O(@Y3(MLWJAQ-S?EU;H^F+.,PSD^@05A"!"8-W'S@CF&I8:[NF-K'6^7 M->H1(%408P,4Y9902Z$RT@E&%(,(6FZ&SHWO(!5W&TQQ$G\)-JW","[B"U?E MJECN; OSNWAGWK3-/YVS8W,S5R/MT];)^0-[MOFOS1-'O5DG&1\8]O#) MKE?%?HQL;;S 4X!#]%-2ZNT"PV(<(^] W._R+X\*4NBZN[^O]E+M 1G4]T$)W MGJ[O>04<7:\/O31N#'Y5')C5C7C#[Z-8^ M5M*S#J^_L27VO-RT77LOT(-]+F?DE=U3Y>?2VO[^?ENYM# M+$-O504Z8DM\Y8Q%G.XM45"].Q M%%U@KH/D6@B5U< "*!GS4E,W^,U"][>WT^6/N/OY0+">V1V+X//6JL'[*6U) M&E,7Y:T\#?*4[GFP>;E]<+:(1A2U%6>^G:,CYR?6D'/UYCB6BK-96UUFSO08 MSN@??RZOOX1PZD,YK].ZJZ^S._UC _'C.A@0?_UM[-#P+_6/YS[V8;;Z;?/X M+R%4$Q]K["0$D#HF3/,BNMWRX>W#8"&L).78$2$Z9EB&@])A:KA@G7IJA MG]Y,<94[/A9^^9[O(1 :;Z?W'QI=^.WSH=EO&^Y<9@B,8U4;(S$Y(=$E^ZZ7 MM?+M[MHOSHUG5B-E@-/(4P>MVJH=0P(D7<25V:05B#OA$3> 4 6#B< KI8@Q M*%Z=//2-W$F:];;[)8#=:.]AD1F&\0$6B!2RS[]*O,VZ5K 7_O\&U+F%43G* MVI:SBR=$$-/"0RZ)"Q-8@H#4-W59C&KD)M_*Y>?JXBD1 62(RA22# ,J+->. M"ZJ D9Z$D:)N9@&^.YBQYBZ5V=&;F*O[&NBL]EK%'8;Z[7^^CE M=+D(RV_R#5#__XYYVX'P-R!)9Z'A7#OF>?V2_EY\;._3]+N=K:["%+M?ENIS MP#V]6D\TL\IJK@Q$C@&/0X,62&(EYDP0DAKO=FEB./]CNRL:8!5[7,6O#;*S MOX)^E*,3&M 'L^.8QKU8\N11]+[829U,NVF[:SJ>$##58CU;W(=5Z=U=N=Q$ MA3&#P94@5H26N7',.*L: )SIK$Q3C\V>K;A^ M/OKI;/FOT_E]N5?DU3XS1"A4TBCL;'1IC-=06\JEP 0RK;'*D<33+7%LK2*0 MZ& ?15@I3345V&@L,/1BZ'VF"*ZHT15_*:<16\;5P#UQF29[YZ,Q3^D.&#Q M5OQZL:SV2:).R%D_!(]#P7JRI1IB"+8M(W+;[82P8'[\.EV6>KJ:7:G%M9W- M[T/0]BBW#22@GGE('<5QJUY#QZV63$IEB#=)[UAVQ6 P=G8VU*C;4^&[!%6S361!^DJ.TI?G+O/_ZQ;0%1SSV4 M6SATN/=-1XRD4RN(XJ4!HF%X;APP/;N71@J A64V5[F>*D.+C M: >>$4)0$TDX9P@$AXAZ[X-GQ*@!A%N;=?[]Q<8855PCR#FEF$*)%:)$84"- MT=1 G+6IWN9"JH3"S>(G]Q9"S/G&J@@9FG;E%15W7E93P]%K3V?36?7?W8_'7?N"!>&8%PB-B!$! " MAU%05XL]4\KD/621VB0G !"E'%.0>N"E9L(:+K4P0HC!-Q9KE-&W>1]^J;F] M)T_3^N(V3=DN0&N>ONT8W4-\56S@%;]N_WXQA4MC[X3.]4S_.-2N;Z.J08=L MYM9AB/ZG\_?U'003;2RS)L1LA ,DI7$0J?T%6V3>M9#'4.+^WU#D9&[W;7C9X!B/"AVR\.'EG /1."06),TQN3Y_4\T*;O-/IR8TJ3R!5 MEA,C/=4<2VNQ<4 ;S%CXLS[#EMSC2*5SN->2WM9AW_#,=@__QJ-,J03F18+= M^F CB-F-Q[PRM,@P2Q0ECFF)H3'2Q0)X;OW0+_-\*&,5Q/Q'\6:UNB^O M#T*=XB'Z/+GLOP_29/.B].?)9X!ZG.WQZ&@NHR?T=+#.&8>N#F=>=:9!GG%_ MN]W>$:T6UR[@6/]XL[BIEK?UIM.NQ)!$W\=KI3!U1@M-!,*6:F09("HD$22L)3JXU91R!0<]Y+F%5P1\Q09@<8 PI9IV*'(S+AD_ M.\GMKAC?D3UM37;:_>(I?#PC=/US.8*[Q?NUIQIJU*5IUW4YVS7[*?P7DQ"J M><*1M\0%S\,B39'=S"*.J#%)#TP\^2A!Q =OEF(K"95(:QK?PL5<>!DD5^*! M?;K=-(E@TF0GGY?3TCTH)2T5^B0;)WRG57GUIR_5MY^#3=%M(O$/43/(@;?T MV-YGQ*$U)9?5@/:PJXY#(7U&J_#MZ_J1@OGTRP0A0F/0P*% #%F)#6R&+O:8 MT]0I_?"K%C+C%5-*:D&A=!)8;:406D."PU^&KF-HP!013?JDSJ3FY5D]'"MY MTSJ1D![F]0.+CTSL=JQFQ,]:&>$E)JHT2B +DH/"A7>QY5M*YU5'@W:JUP15S M8:=?K^R+N/1U?3C&6B[PJ53UN-8_X."%1;\=7Y?7B([XGW$#NC"1HQF;M%O, M)?OPD]6$.T!#.($# UQS*X#EJAG\BM.DHJ!3W[=4 A-\&NTDHHX[+0#"GI!@ M"I>4#^TC[";"81*]1I:O&MG4I>O&D*RU5(YTPGK4CD<\O* >;5D;CWZTMN 9 M!>G&1KZ&;!1KTY8.>H4(8(!HPH34%CFZG0K$(914/GVZ!0F\@-0@8)6B#&H) M 3;*A9GGPU_PT'>S/YX6VW6UDY)D$9BK)4-QUTU-DFCK74\.N$A2E#;?J_F$.Y/%^%!^F<7DQ6+]R_2VG!AB##,4*JZ5 M$!X9$OSG[3A62"55ZA[]N)=,",0M<2:$]W!U5$ M5.DSOAUA+T_\P;G*F_^9-/6@ \\1<$0..G%U>57H!K_J:R24L5BB'Y:J44Z53UIA6/.#@I%FWY&HM: MM,;_1"ZZ,9&B%^9^N7RPX=%LFQ+J=>C,L#1: AVSALJ=?VPM2*Y<.-H Y$*1 M,+N$ISQH'Q%(>T:-050;2@9_?6>+JWAT(B@S"]*>OI?%XRS,Y>E'*])ZT)!C M5!R1D<[,75Y)NIM0]3B2 MW:]7Z^DB;IQ,@"7$*,,0E!QH (C?+YH4BF2?(Z$I+# CPA!B@^!1+P4+-EHA M-5$^./U#>Q^-(UY#+&J,KS871:V* YC9(4PG=I/CF7,1VRZX:K'F*2L$U\M8#;9N+"$!!E7?%ZLB6E$050.PBMI@1#K92$.JP7C*L0:&4]C='& M!ZPQ%7M0Q:\15J8H=B0S307/QV.FRY=+X3#WJ)YBYX24]WWS: M(T/)3XP\;,I6M]/98H*,$=(Y2:DF# DD3,S8;2:29B(I@_9""\1())P 6 J* M+9>*:X 0(4 X1\3@.UF/IE+QZP97IARU9"]-AH8GKIO\O,S9,,]^/$?+"=WI M1N,X]*:C#8_?[>B!D1;1Y"_ENGFW++Y59LO5[,NB]LR6_W(_G<]N?H2@UDQ7 M7_V\^CT^>UNN_E+>?BZ7$Z\)Y\H "*56@"DOB6HF%/4DZXGT7@"A6$WGH62" MA#@+ L&!QC3>O(-HK((:.IL7,!415+%!U3JP'+!+L@/.KV5R06IK]M."U^$[=QQ"?5Z3CP>[ MY^*[Q3+P:3E=K#:/F:OK?[]?K:/'NVW<((8]A"$*]]Y09) 5.U41G(J\MVT3 M&P7282$ D]@#JK 24!MA!!3QU0!)L@XYM#J>NDE8QWNI]BB+/YVAU^02K:,3EM[,>JX>O;'68])EVW[P4/W MC#&/(3 ^!/_2$]1,7 EY5FB>WJJ1!"$>7]Y0@%(@ @,<8F:-M9@S,O1AW$_5 M>IIX]F4 1GO+G0Q 9J8:OC-O1BMUIUGKEB3)9'YT@M>77?GID5;,]9QK?CM; ME&_6Y>UJ0J&G2")#E+%*:$T1A\U<90[WK7X/&S>8(<:54(0P"B01MI8,HXVA M1-*ASP=E9CTC[J(&/DSB.:-3>DT^#],?@R:@4[KBDEGH':7=,]'YO?,WH[4M MS6N7D6[+8[+R!D_@T!'X5&W<@%_*];N;^))S-9^'>.GWZ?)Z0F!]QQR2\8XY M%-Q=A%@SOSWT.$MT,]KE#FD.@=!>2(H0EEI2CIGDG@L !W\]Y82S]*K>[:MN MZA?1?XV8BRWH7*WMLQL29?9"/=";I]J&_&'4-9W)4\(Z0'^,1%.'L.RQG [& M7GI]3W7UV]=J'LA<;3)K$XN9( I"YS42SDEGW;X:#PDRN:MOQ?BXGB[7J:4] M3QJAUOH ._S5">J55HX83YRWC&DI?9;W\QA/SC1]6^CRRVP17VHM]#3\VZM6 MAZ.Z%*0\YN9D%4IK(LI",7J5/DE*.CRYMJ67XHK^;3U6IV,[NJ MM]U6S?R=*&85%A+'S3:.E44(D%TQA4R[\:$/'*%1;9QS##A (8*:A4B842:\ MY-* H=]!WT095P^BC'E\;O=SC;M8/@:>YX<,VD-I?LE8.B?/3WDQ^GO5]- 3 M](=^S'D5LP/5)Z3U'!TX#@T^BZ75^:='GJH_;B\FFA.BV^WQW,W%8#N(7GH' ML*&0 &8,XMXHT(@(#D'O9%%^B5]-$_I>H3'"E/7> ZD).;L3ET(IT)^LV/D^S.M#X\GI37A+=KSRA/V^GI2G_^'JKU5+PV(QM%R5M M%;XJFLL&FD=)+[4V]-D9)Q:+B_3Y.%:/RYA>C6#.=0ZLC>%66&FQ,I(0)9C; M9QH,@7(;6+M%XCKQ3!/> "(-D0IB3"544FI G9;<:TL!S2HF?(@F+ZAV]1G/ MO\V(.I7#<Y6S;W'#:[5[W$DIZCU"$D AK3#A;TH#2>+# M)%I!E7KZJ+K.=&0CZ05%<[]: MA^5IZ6>+()=!.# M4?-.U)U6DW.QEJEE^F\\W%)/615&RE\UXX Q0RGD,)G6A:()PDO?7=YKL#RVH-IWD2 M->>4>BN.3NOHT/3DZ6<.,SU<,/3(\&?4H L]E[\ZJ#7RJOO@R+W*;'M*E&B MK"!&,,@U"C(B.-A^WEAJ,^]63OSHP/.]&<]91\#SF7EYH@]&2MXL3^6CMRO$ MCI[A;DW*Y>=V.]A/+@!K97=2R*2GB]_>W7RJ?OM1_66V7MU_GJV^SOYZ\^]O M9[>S=7G=G//EE!$@ .,,4NR4([B1$Q-D)NF"KQZ;&U@)/GTMBPBTWGF/4%_O ML19_]?_K5?%V??VGC%BA)Y(38JWS\YLG*C6M[[:T%H>TWOQ[L07Y\AF4P1C. M",[.SW2[6&TWF)]EW?^O=-;30K@D7HY%=/V2.H( KV>#JL$&8,:2X6(&EM1@ZOG M5H90=2,O804X&V]YPG](60-LHTLMU+X;B1DB?S8RVVE[!U+3Q/R4_<41$AM;I>L@UI:5G5@?G*D^1,J@9)JCXEY$1.M0-[XTBI=C&@ZFTD M=5&0[5L)L_^L!6PK75(AJ@A0$$JA/#2"J%W#D/FD_&J/S9U-858M[XOL@](V M>C,XFVWU)X'(,ZC/<_0DJU$G;L>H3MT,.JE6/7"5%*C^=;$JU^MY>6VJ15US MTMQN!CRT"B*M*18<.@V1LDU;0#F:'*2V;F%@C=KA.LC0J^4R_$I]LW#BL:". M)"8$JV?A+T^5]M3M,+4)4=O3EA&>GH6^=J%I*QK3@M)C5A\+2#NS-()@M+L- M59_CIDM-WMO=G1:6A&8$(TQ2R1S7DAC2M,9XVJL'7=NX0&W>V]PK>3KSF*#$ M9Z(P3XO'P5Z7BKUA6.RO:B^%S9:E>V]/7"?4%UDC4.8^K#A9QM>6E<1I3#3C +OF BKH98> M4M<4M!L?%L+D9:B'M@9>?38(8QE:LY9L5Z X%:\:E!ERUP>]"7?S%,*?R_FU6IEJ'F\L6$[G$R[B>^T".$0< M09;R@*>!I"E+.IMP%B #+QY[^'$!N6L,**8;=RW\[)FUI/@:K"BFJ_"3QH[B MI^FZF)?3U?J/&:(X>"\F+$-CZL"\->J@[X*$[K WKG;XV3-J6D0#"K4J]B:, MJ<,REK@Q=5R[]6_P#DQ;(3L2>6SY/%?_C&!M/9NIU07&?TX:9WHWO9JM?_QU M$=A67Y9EG4B>8,>PYE8X(IDU4EC,S.Y$$G3IBVW+[P^=OMFB*NXCK&+:X,K) M/+0D+B5G,SQGF?F:AJX:4:'.2%=.DF9XVEHF:(Z,MN-'S1)3,\\:?#0MTXV> M$6AV5PNJ_@9+YEUGY?+;+$J[6JW*M5K[Z6SYK]/Y?6EGJ[MJ-9VO)I X+J@Q M5"L+@L!;H7=EXI+RI)QYC\T-K+_^F0AE504G:3-#U$=3" ;RJB_[(/FT.%^( MWSRMWH$K:G1%"/(BOJ(&^*K803SSG7,O4G:B(K-'OL=1D=FG08_OJ.N;JR0O M\D/YK5S\68G04V#A&+)C6$((XF5<#OOU?OT(X2]M#:PPC48 M-]?$1I1Q9Z;;AG0_+"3[P+]6Z7.V3S[^4ZXFDP 4W&SF,H2.(22/0SMGV,.M\48O/ M#UXBNKGR>WEPQ^EN<[X\<'P7U;KX$3RUZ #GN;QM.$US<0>F,T_OGR]3"9C. MZ\,^Y>2$S]J!P''XJ%T,J'H;3!D^J"UORC#CKO^Z**?+17F]&S6^+%<3'&]' M8U9"$KY/X9_D]']A*;R*T\Y&8X3V>C\QV;F-K4M.\Q9/F'W,3^^%L!/YA3X94O8^G[.?!ZY=O M]BN#GLWGH>UJ^;9:?/E4+F]W3NF[Y?ME]64YO5U-.*'8QNH4(*$R"'-!FLOR MXAUZ,O.1\"$@G&7W]-"%W/N8FVW4Z>*ZJ.[7J_6T?FV: Z/J=H%T;&EA%=RY*<\HGUM*=>(MG "8SO.9SD-C2 M;VZ@%36V%!D<@,H6OO,Y*.WH/>=3F^<_'Z'@)0^Z*W,C\J$[F_*<%]T//VF9 MM^FZ?'>CI]>V_+Q>_=MRMEZ7BWU#K;^-O%,66#C@YF( M*Z8T U!1+@4F0$N*DS:XDQI2W#+LM,%&4LHHE,HK;70P"R(&L1I8Z+?/KP=P MJ5NS_="7MGMQ-N;RE'Q/6K$'5OP:H14UMK-?T'>7(= M7V_\Y&G2Q[#VU06TNU<@H2"8>DN$HJ%%@FU0/TRT9)I)!Q3)FD]//R\8L1IS M8"DP5%$DI5?*!,%5T#B-X.!3:0?I8N^6'J'FQ>G3GLPQS9P.5CP[:;JRDCI? M3+5:O[O9UN%,-&?&>XIHF"J8*$V-A,TL(=Z*G$7[X9>9=< +3'(R4T6;'C9(CFO8CP@X81.M"-K M'.K0$GO5QW#)4X)_7E:KU?ME=3-;3[S'G" G#6$X: PE8C_*A8-TLJ[6TWF: M#AQ^EPF,# "*4LK M_SEA8-9WQ!#%-B>::,0I" XY HB3* M4X!\/V 'J"BWB/)TH 5=:6HP+%-YFK GR;U$TB#*\(2+$_K0GK=QJ$0'_%5? M(ZBE8FP"E;=!H2:: @@@4J$599@)'P=L-PD4P3G^PG/?IQ9 !1Q4% !J58B# M/%)&&NL5Q\SE[?'E^PW["?%"'>NPTV%/2,J$:$'?R*9$&PN.38K6;*2?)UE4 M#QO;SL-= (\%X A*@(C%5!,HP^38;4&AM'MMTUN# @A/'.? :.JHU +B>)&B MEQ9)#H:^4O#=^FNYW$Z7XJ?_K[IK:V[C5M+OYU?,8U*EVL+]L@^G"M><5.6L MO7%VST,>5+0XLKA+DUY>G/C?+S"<&5*R2 %S(2=QE2T[$O'UA\'7W<"@NW:V M/_Y[[GV2WIRF>=_KTIGGC4^Q%?5NWP\UO!]OMMOW)F,7)&HXMJ'?Q>BD#-* J_G)146BX, MRN6%VXXC4*CXFYP_4HS$PD*O8N"MB50ZF+3%V*JH:A M>!IZ-90Q+V.M(3E*/^\+J[K<[II1K+62&T2,(&%"L$C"=E_TE*2AZ5T"B3CM.\ J-F^R'WC M().LU$/1$5CJ>!A:T^/>H&>D$]!G/%P\^>S&V#3THS/Z[TXZ^["0]T9 S/Q\ ML"1>:EBL]D&=ZM1PO=KJ\G&]*=N7%;*T;3B:%LS MMZ=OP]T5S\TI&GMN\5[**!/SYKLMMWT6+6,QKYN%<:[HD)9%8VH<=[LF".1OPN"-O0,3$/@!K=J M/>YS.X WB/ON6&$2$V#[@:I!;1YTT>%O_+[K^7FX[J7X-W#$#<*&Y8]<)Z" MV(7502.I$DI1)4%6!/31M4.8&4K ) M2%6N,"73.&$92KDJ,;6PW9LP$L72:!]?T<(**2N:-4*1RCI:/3<& M9((PXZ&U7E!)B8)A03IK+ VY*\W;G^]2Z*3VZ4.+3#*%W61F#/;Z"TV-ZK92 M4X/($)M<,JW#(/% (06V("0QHR3'4%EDH!39.C'VM MN\%;S Z #PJUSJ+5$UUB+8S/B ]SB!._=S1/"7&8O:.)H MDS0-L1S/O/65'O9QY/4051KD/*'> B@YBU=X!6\ND2F-@1]#6P\C4T\81((! MJTF(8K%6DB B/;78"F?PR,)Z3# /BGKE'>DLK@98O'F<_[56;J9M'9=M%P9[ MKMG:R7P'Y5XS3Z W!'MG -= (]*F%DBZK/OQN6-[B15D2 IK'#72:JJ(QQP) M[[% :.R=[].L;4HK]QQ?^6NW-_.37KW]K4M;OP.QF%Z_XO/G]>K#;OWPOW;Q M=3$O5_-C.E4^+,,?\W@DCRW%#GKDE)?*'V]L*\!!5B*3-"#DC@ML@;)$ASKZ6JV!%?,:4;7)\E!!/ZS>WKLOPQ"?ELYD_RMV[Q]]F?[9Y#[-6$(\HYU@Y)JD)?S:KT5F7=5Z?,IZ*376$I)X#0D/X M)H)U.B0[A &"K![[O:%G$+,ZT Q*:K+$797/;(4[H?+92Z%5XZNX6Q.0WA5J MM]LL/NYW5>N'W;IX/]OK]S MO0EQZNK0_.[AVV^;V6H;D"S6*[6:5W];5B]\JOG_[+>[6'"M 7WOD072$XD4 M-H8Z;!%M2@8JY6%68Y>1(%IM*1%0*L4CGTS%(!MHX*'SV/FQ<\(:>?%00R]V M1[3%IUF(,']81HWH<&GR!M.9)M1_@9G,T_;#)YZ#3](%5W'CIV(:WN76)+QV'_76?&D M&S2#\G?5C9G)[,9TVX5))GX:XC>()>F[+IGLI K6AX<04NV7Y;O'HVS^O-KN M-E7/H>W/J[9T_;O'NFWO;/E^O5W$>-K/%IO_GBWW)WT@ -6Q]0.6F&"*F,18 M QN69XB:%&((Y<2M0V/C$&+@G:'8(6IA8%-R(9VD0? 9QV-7JXV(B@I27,=M M<9.J4U/;G3.N^N5^7C59C_\ZCQ<$Y_&K[7JYF,<:,X6>+:L.O1^>RG*767OA MZO.=IL=3GNH\#6\LB7-\M*4X,2;.[+'!1_BVUJ"BL>BN.'E8?O^MDOF;M=,9 M>&XN.(=;/073<"@WLWX]C;4XJ./Z:;98Q<#I#-IR\[C>?(XJ>M*DRT&(*,(4 M: ^H0) YTTH9P'9 U]4!'33.8$.DBDI$)#Y10PEEHZ=E=X]_A8/NPN M.:[U67_5VK@]_'P5UL:-YDL;">_,SYDG#3=X(@9Q;C=^&/+[N\L:<6[_$DYK3/OSW-;H,Y%<6KQ^M?+7\LMZ4V7P'\I/%<1[ M;ZAAU ,/274B(90XE(E0! F$LMYLO#!,;!BJI8 .<$T]8LJ($+8S0J4TP)JQ M+V,=KP1M6FS%M@:765*\!Y=IVGTE&O-$^,C@$5;QX2T&QZD65R0=BGB&Y#R::C8H!:]C,H&9^LM7:M:J)O]=A?2R$T=X*T^'4=SS"B, M58@!%-+6D:"* 7[XOFKG9_=4%O.C^H?8=;;9A)^J-X;VJR!RQ1]/BX>GZEOCIM!L]2WD M!"$62$Q(0:%&)H M!37/B5V3!@P!.M+<"0R)ILA;(3S54&(>N_R&N/UJQXQWQ<=OSP\+BP9IO4>7 MJ&S#\IT6V5Z=ZCR/,0S+HX2W*ZP)JU'?% [ZU_[Y3\6Y2;\ M_-.W7\JO@=X_%]M[3)Q%C$GM?(BNF:3*X79%:DPZ*N"E(>,5.FBT9(@1BJ"0 M#!,L %96AZA>F"MJ8(NN^#U"ZRYYO2C.%KUKL=M=]I*)'5OE+E"5IG-#<#TY MI1O$J/-:-QQGV6KWSW(6AEU_GBU6]\1P@8457!)B";06>-ZL2.I0 MU@6*O)$91X@9C+TUB@I!I"52:(J8%7)[NK M%.;P/*X6IE"6(HF#4C\Q91S6MG,".0*#V3KY\^K+?K>M9!G^LXS'2O?2(&41 M-5YZ*A1WCI%VC3IDNJGB*^, ZR7R7/OPQ%*"L% (&\VL9DA@*<[$!*R/)>?DJC<[ M?<0)U2-:1Y$)8:)5A"A/ 24AH*@7%$9Y%6TNC2,!#'++(: ,4JNQ#I]. ( 0 M:269T3<3)]1?G)*Y["Y.8] XE#BA"8D3ZB1.N>Q.5YRR+4D0IV[L]!$G7(^H MI5)&$&$8$9 "#X6BS8*"Q&9=;+HTCG=:(!)^*1Z6K6)*(J%"..B4"F::ZV6/ M+Y<6[B].R5QV%Z5!3!T2@%OEC6GW9P#KEOMU!0,4UDX01J&$ MU(2L5VGBK!/ .(PM';W6U M-4Q@"KM+['BS-_*Q13?6DPXT1I[0B:GZZ.:>/02Y"L^I_D%MM^5NVQ9GY$I; M1@P62#OC((3&M#$60#:SO^&+#S=0.:BA=1!8ZK15.!BB/ M?2TMH5M>)3HT- M#WC.]^\99>T^)^'"2NS(UC3655?PZT&>F,QR.[/MDUK-XQ_N__:+K[/EL_WV MX\O&]UXR*A#G(2)C 0<5(1YKEX.U69W5TT?E6#JJ -)<>XH,U32DJ#">B>J0 MK)JQ*\=7==/*(\3,,CS#D9L6D=R&U[S0HZ(TWEVNOCB!^:QDPQ'JE6ORI#)X M0;R&GX5IZ-H(=KVLWC,2'"?9MOR_6;Q4/Y:/I0!Q\=E M^1H*(#FWC(?D-+:=UU9JXIMEBTS:K:ZN8U,"'*+$.Q[,E9Y)+[WQG@$-L5!R M['(&#>+B2PVY^!(Q%YL6=,8[_V-0?UDQI\!ZGFZVA#=HBPIN<<2;*Z#7F8>, M.QDWGH]N=S6&GY>T.Q?Y9+WBLL:F?0)W-,:T;GV=ASAD1::,HM0:R-.9TS*B>@3QTS!%T">JJTP"#X;"V=T8@&XY4/ MT2\"HSNMMO;*XEC8XKH19B)5%^++H1G0YN%7K<1_1+GM+KXF ,".5;T5P "F(.N$(&M@#X!E%$DA#8F; M@8)H&8S'6#'KM!S[C:_I9A6O\Y6=6O2D?1H+V^65&> /&\RO$ORQ"]_.J*O8;,>EO]?\\UBJ2UGF. AYM MO5>:JW)5[BK"J\73$(Z;5&@D5.0CQL!$"0:T",L5PX-W;]C!-PQ>SC M>K_+*C1[W=E(T_TI3$2>TI\V$OF^D.8)ZJH 4?,=TZF]GL7S!5$?>^:F(>.C M6WFV6OJ8K.9+M0L.9??M7XMY>8+CU_)KN=J7T9VX/X.;>L!# MZ2M,$2;.<8(!%Y!SBPC$&&@>[RF+K.2ATP CNXHS0M*ALEXW^M)4?G3F\@2Z M$VFC*.YKQ%P0RUX\3D/G^IFP'O"YZJ0NIX+6U%FCR@/BC!,$6B_B57K;C!<2 MY2X2TV&4V^A,IS)V/:C,DIN161Q$QX781Z,Y/6 M2&.]VNX_QS1A6U^GJ0,+JBZ?TSLC]Z9,TY LII^)!/ MT&51N0(W>4IR@N7M B:#$)33"&-4HKK=J<@B++%%Q4LS7U'.GGQ,X+)##_#K M09Z)#&&,-_R^Q&W#7H:X7HG%;BK[_!%, M9S--<,^;?DYY!R!K A(\A!7K81^A#%&N&HK7\7$K_1A@@KBWQE*ME7 0-Z, MX5RR&'?X[)%%N$*4H1I=V$G0VI&)R=/80TOY&DT7:>U"4H:DCDQ6-RG-)"U- M0;^W])QR]N!D HK9!_UZF"?CI4*>SMPOX:N__ZWYE_#;Q]FV_/O?_A]02P,$ M% @ T7J&2XY6 F-R-P #WL" !4 !P9&-O+3(P,3Q[I;&=N^9?:J@R9+,;8JE*5)N M>W[])DA1DB5>BD15D:(G.MJ6*0 $,C_D#8G$O_[[UYO)FR]E/1M7T[_^A/^" M?GI33H?5:#R]_NM/OW_XV7QP;]_^].__]D__^K]^_OD_[?MW;WPUO+LII_,W MKBX'\W+TYL_Q_/.;?XS*V1]OKNKJYLT_JOJ/\9?!SS\O.[U9_# 93__XE_3' MI\&L?/-U-OZ7V?!S>3-X5PT'\\5W?Y[/;__EEU_^_///OWS]5$_^4M77OQ"$ MZ"\/O3:V2/_Z>=7LY_31SYC\3/%?OLY&/[V!%4YGB^]N\"6KYE]?M/^3+EIC MK?4OB]\^-)V-US6$8?$O__GKNP^+=?X\GL[F@^FP_.G?_NG-FR4YZFI2OB^O MWJ2_?W__]KM!;@?S.7"E E[>ZO/KK3[>C806$P1(CHA)9_GFO0>;?;LN_ M_C0;W]Q.@$*_]+0$,QJ-$S8&D[?3JZJ^60#%E_/!N)W5-1C_. O_<'=S,ZB_ M75SM;-TB-0[]TN.0Z./@TZ2C6^C1]68-9,P=6W7]C MTANS>;VPAG;BOUGOGB>=H6&S!^YYJ>'JJAS.TPZ$ '?SZ9FP MS4RB?<9H?P'WOB/ ,TSGX_FW)])AY\0;]&U]P@_@^+4_'YGYXUZ>OB^'=W4-5H$=S,8-!45W MW]@/<9I)@ 9=6Y_NW\II60]V,N!9LZZFD;$[FH_0U>232K^;+[[PXBI!;0C8 M]./)'2BC,*BG ,#995E_^#RHRW#;$/EMC-W5@B]!U0['NW&]H7E7TVJVV=8V M;GU*2\ONX^#K[@FM:=KE=)K!;V.'UJ?VKKP&B-35L"Q3C'LGN3:U;WUB'\KK M)(C?E[=5/6_@GF]JW_G$G@@\\ZFZN_]%PO=]RX8\SQVW\X7^-JCKA:%\V'HV M=.]\VA\&(&F>$--^ _B.[H;SPY;1<+C.E]5,W&[O== DGYX3Z>7[,7P[9]IRK^6#2\IQ?#-G>G \ QOSE M-!NBX+8N9R 2%\+['7QPWSZ-V\V)\W(FY==Y.1V5H\5Y]VHNDVJX;M&+!5\- M9I\6J[Z;_7P]&-P"Q;#XI9S,9ZM/DJ@7/R-\?[+_S_V.\7-$F9"E5]3]MN M5[0F;/M;-2\_ E$M?.,?6]:XJVLAN)&68"DYIQQK:@AGAB+NG.4.T]!DU4\Q M9>KAFZH>E?5??\(_O8'?7)5U?:_.MB1<+' U?R(8;D&ZU<">O_Y$5E,8U,,7 M,/U^E/L6O]R"0SJ=_SS\/)Z,5KU3,DH[_*\Z)3&L8;5A?UF[8X^PEQO'-U[! M-A>8(&4H83@0KF4P0DE.@O5>F!!Q(\!WLZ)-1S3+)(M5G'[V'W>#R?CJ&YBS M9O;W5@N5MC-+;6 M*R$-U4B=,;2ZP435'?7[0MJSJ?KJ9C">[I3=S]H7A#E-5%"(:@7*5FIPZ1 A MC"$5 E/RC)'5$M.K]LG<%X2>[*W?ROG?8*)I*T6@E"]GX^OI8M/5CQ;\*G=Y M:DA,P;KVGDK! M+-*:/U>6"QF!D7%Q]''Q]7TTF ML:K_'-2C;>AL/DHA [$2; \;E>:$4&TUEV"8R"@5PCA'(&:9A$?%X@$P>8[' MSEC07_"E&O[QN9H *V=+/;(UXO*\<<&]CS!]^#,H'HTU@;G(0O1"6*UCCL3; M&UBW&])@6H=7%UQ_$5[))'5? -JVP6QY5=7E^W(X&+! 6NLYXCEQ1G:8[G^>P/L:@9=-Z%,\UU^7;?\* M3NN-0]I1:G4PG"MAK,:*A.A\M-RST.@0L:.]._Q.=Y,TT&RFHV7%\]VRHXFW8L4AP]*.DLL,LX]H@3AG6(1 2@D?418E$S@G/J>_W=CG^/+:40^;>(IF+2=X; MO8VQ\ZQ]833W1(&!;#&82DP9YWR@(*[ -B;*G'-&Q:%<7@N6/+KVA9ET2FZF MH_174IA?!I-%!LG<#>HZG:(O*E!LN\?2I']!.$4L<".CD*!\@PG.:$53UBUR MSIQU_E<>&)[?:>F W#U&=DJ8^U=[AM5>-IO:)?13SNJE971"CG+/6>>,$EQ(4 M,0>?PTJ9;HM%@C* P_<&SI/+\J\..#ED[4\.5;=E/?]V.1DL*R""C79[LXQ) M;Q5 F[L5%D>CC6-> KT\[ L?B D:4PMVG60Y(;S78?!D^V,MDKM8&4 M#:P.R-P7P/Y65:,_QY/)%A"MFA3&:NF$HYA8S(E"1G&5KI!0#TM + 3Z\; *5)]\*!/$7@)T3P*;EG3&%/ M&/,&/A!.>].K'?0J0=0!F7O-2[N?=1/]M;9]P:*W--C -/$\6JF5C(J:B(3A M3#>K$+(!0N+'@% ;=.W7W=KI9Q6.>R&X,]+@R(G#H&1!FCK#>;I8H7*RJ>6K M<+!:.J_8DY!]P>!).6^PM%[FXS0XYVHZ1(%(H#*PE/]HDW;6($2)(3BE^8A@ MSCE9M=/3TXX8< 0(-C])H]S]Z@%G[ M2-@,M3RR]WA#KKJ;SF>7@V_)=VP07ES;H: &I#2SV+-4P0X[6)77#@G!D$)* MY!QWO")0'+Y+27Y-B68[FK;T$\9<(C+3"C M'-:MF08E8#B1$3F9=5OMU)5B!\!JF]X]BJGZ;D]L;>Q3:"' ,752(.^XPE83 M)1"UR 7EJ8_G''KL1EBU0N?>[*EJ>OVQK&]\^:E!&LB:UH7S""-,H^0^<@WV M #@\1J:0F@/G-31*W'RE$K^]0,!FCUV#2>1FXD,$R$K0-S#$D M#-AZ/X8=W9'7WP;)>ST,>4*2YB&03@V\ 5D+[@%GQ KG3(Y:V]^6/II: MZSP:N2>=CW?MO-'ENHV4HEC*5#@YZFAX*HWO,;9,LFBD5X3D1(M>D77=#9I: M(WMOEXNJFYMJNICVSGM$SYH6C-O(E2/$6L15\-89[HUUG"-"O3WOFXSY?'[Y M%DX.>7N+,CZ\9W,Y&*>GW >WX_GBO=O5[+>%&W=V+H)V(7A&F*(I%X]HG^J\ M$R8P8YKBG!+WIVZ#=P"JU@G>8S"[R4W^!F6$]ARI0(+X@*)BT44.E+&!@JOL ME46PYW36Y=I3M]6[ &"GU._O7N1\,)X^OMS]9%6^O!H/Q]LO2>[J7 A*$8W4 M,)#SW%NA>: V:,^PC M+CG_$F0'T[R_6.7JK9_9Q^I].01U-%[<_7U2"K)J3_1U\74%$4H*28UVX*F" MWV%2FF!@'$L>$6$YH8%3CX?VB.838%U?F\*7P/3A> &&+6!^VJQ0W(!-JCVQ M G')D:9*& P6*GA(R1<^8PU]7&14K3&E?YD;J]K<5/5\_-^[L+:Q3\$5)81Y MY;E(.:[26BR4IEIB(%C,*H!QZM+OI(#7%H=ZK/+S93Q+SQ!4M:_N/LVO[B:K M"T-;@+BM6T$Y!EIA@J(%VJ5'XS5&7D='@N4HYM07._6#H9/"8HM,ZBT^FX+' M=K"(>=RDJFJ[).+Z#D5R""DWAGN".#+8$.>59)%([A#7.97*3OVYF1- MG_ZITTG!LG5F]1CH:4BC5B*/A68\!)%J6#*@K+-6$.6)DEP81%W6A=G]5?DY MAXBZ81>*T,R[G#.W4O9\^ M ^/ML: W]V;P[5[EF.%_W8WK>9 M$X'F7,AL'O\YEHKO$C7/79NN6+(;F+>C897@)C$B:@&V]$ERMH9E.9HELKAJ M,BF'B7_5E;]GV>5=/?P,IL9E/1Z63^K5K\%=UGB%!0L(!2IBD(H;'77DX.M) M<.V$\QP?[5&!5XNY/MG1MUR,5;U:67J'2, M:9T\/RTU0MPCEE6 ]?3?%SV"A.R&+Z=G6+9B4!9!2VX1Q21XQEG$1G-$"6@* M,.)]9#E'XJ=^@;!';';&D"/#\K[:8#O^SI;!"DYU8!:'@"GCV"G+B0DV8.6Q M-D&<SH7=U^@BX^[.A72.!9N*PH%4#T99 MPP2*. 6U"&8XYZRFN+!17KWM S8]AR(]7T*JCGL&R.T M4)YK%#3R&A;HK(O$^1KZ-$1>@Y$*9"WQA!K. M&>>$&0.4D)(JIB-5,DOHG7HADR/AL7VNG)YKZZHI..MW\-G]064U/2 *TW#@ M0CEG@"RPE1.UX V8!LD"3GV>53OR;7(X9[95)?D Y75^5P?G$5OH+) M.[TNWX/5=3%=__ST%@#O,TQA%18L>F5,8-R ^B'2ZF!EU-A&:7-NF)^Z"=!) MA*9#XO=606KM9"]+X,CH>4+2%ACN,TS!#>$18:[34SHT<*624^>$P)YHK',L MT5-_L;43&'9(_./"T(#V"/8"'>GZ6\,NC_7GA+H*9PS0L77G$J6&6^A!%",HS8;7,N2*] M]PMJ2]R%::^U78Z&NOTH?VJE%)99R*LGW-<4W_I^^CV66%A^_<-<&QPH;NA1 M@$CPEDKD.7+<<*)U!*>38&RP"[99/=..KGT I&;ORR_E]*[<_KSXLY:%HBP0 M:KG0BS)HT0CO(PM.8F(TRWI1_-0O7&:S^?E=C2S2]J9&JAD(M_MI;E,73]L5 M8E$KSW)E..9&8)!5\$\KG>/2>77.UR/;ADD.8?L"R=_J:C:[K*NKK0'\)ZT* MH2AQ"*4'0@782DKIX!FRQDJ/A!(YX:53O^C0-D .)VM?\'BX6!&^ICMI6V/M M+]H60E!F@HN,",N9E58(CB*A@6%F=%8D\M1#.VU#)9>XO0.F496=-:T+[A$V M*&##4T*E 6I% MZ8\]%(*K+2:DX]$-,9: XF;V]G*=6T^GZR]SAODA6XJV^! MP;T'>TQ*Y"P/7%N%*<%11^V)EBCGX;A3?T*^;4BU3>S>Y%)R5C=.?IN(VMJQ M8-@*3N"_H#777BI'0F#,R&C20^HYYO*I>U4M0F'=^SMMT;R_._% _W(VWPVI M9RV+Z'#0@B(0R[ JR[4Q0JFH# AE9GC.5;A7D-;7&8KRR-QC*85[U1P7%Z9> MGA7;\JJJ[V-K'P=?RUGX"H0!!H^G@_K;6Q#LBP>JH">0?;(@XW+A.P-?G7QK M 49IX,)18T5(SSY8K]/IHO:8.]BL.=IV[\#R*S?@3H=-_6X'6,G]KK7EM-P> MF]C0HW D%2:.0@I8G[3!D.BYDBAHXS&).3!4)ZZ9NX%A+HE[S,LZH,1K4)9H M%11ER/)(J=%*!ZRLH=)BFI6&HG\PJ95#V-XRG>X?\K@LZU7EI?'03$=^/+D# M^Z>!V]EPA()PF1[Z(Q*,5,X1,X8RH8-U#KE@?-:39N@'$T3=T/RHF-L7804& ME:T\$02%R!%52@3L-#?*&&XTRJG@LK?'^:6L/U5] JIU #0!V)XD/Q:<[FFP M!Z#N>Q18*"9>@Y'(>W) CR.A^@;4823O"U+_*,?7G].R M86,/KLO?[FX^E?7%U?*AHHN[^6P^F(Y2[)CXIP;'78ITKW$*'IG 1(GT/"#(>&J-9H3IR#WU M*KB2_A7RQE?WQN&JF(FAHLP*OR+G"GO>6&12J) MBI$J0HY6N.H'0&A+/.DO!^SAROI#\80'4Z0<3N"O;09CD^X%ED$JZA%8009L M&*N9M$88&S!%Q&8]CG/J)59Z0V,'C.@1@L\SA%=/\S8P(QOT+@Q'02O-HT2, M@Z90L%8K<*K(P(BW.9%>?.KRL/VVXY5#:)P MZNZ >=/AMX_U8#H;+ H_@B^]^-=DR>Z'VN8-GEGOY@L+;SUG"FMC9.*1,$EU M(XLB#I&&>,[64Y<0/@ENG<)>\&4]_@++^5+._N-N,!E?I9L_9O;W@$T$.Y ;E/! KHU(!#(RHF,-9"#]UB^Q8".^",2=@H1UFF168>*-M MM$8*P:W#6@"9)8L*&8[!$NDU\?M\K(3V2-[WI4*0ZC#9Q^(NW\^FQSN"3PI. M-_ ^UK0NI,::.NH0? &W5!@N"-'("HJEXZ11HL#SM6VHE/Z";!^!4G:ROH[@ MCAZ%BI9ZQK7P1'$KC6((.>U$*F#L5-XY](DKA2PV5EV0]]C[SY?SP7CRBG>A M,3S&Q#"LM%<._C(6:>:!I]9@T^TN3%-IO@-3ZU3"BFGD L=!:.^T%E&LYJN< M:O14^QGMOL;LV[[[#B#M?D;5K!S^Y;KZ\LNH'"=TL_1#@@A[ FKXJ'A77@\F M83H'2IJOXW599VM:%=3K$*,*#AGBHL0:![6:.9-9#S&?*BA:8635%DF[ <-R M.KZZ&8S7/' %!ILEL-)4TVXY9^>Y[S6CIR<89+&N:H6.NWF_ M01_8P?0/L+FK/[Y5OX[GL[M/X]GG\>]7_^_=^&8\+T>_END08)-Z:-2YB)(+ MAA024F!.@PF,KDCA@$0Y92A/&1&'<;/JF+P' R6.K^:?/WX>UZ/?%EP83-+T MMN-C6Y_"*.I#T(8"+9S5,3B!5_-6\BR?KFX'%BU2M;^+$.F)CQ0*_0C?N\&H MV-RX4*D2/B*8HN #4(A2PE>KTF!TG2%6VK0M6J/L,X.3 X&ML*I!4(?K)Q^G\[*^7RRJ/.U\,EF MVQ73IO8%BM@;3*SE5$D<+";&K^:+3,A)_WA=P,CC9M4^K0_&Q@L9^FX\+1=W M"1M'/1YZ%)[QE#'/A.9:!&DUIA5)N*J%WR9MBR]]_\&,WY M=?!U?'-W8VZJN^G\LJQ7D]QLVC8>HDCWN[T@8(\)8B*U")D'"YTHW,_KL*< MF@,87?5"\X.1M$J2>['4!V&W"4"[>Q962(11#$(!L<"6QSR(!\\.Z/3#6+V9 MN&F=U ?#!1 Z3-RX+B^N+NLQ3.)V,%F"]^+JY;3^7DY&9I;>G05M7 \FF["4 M.6PAE5>4*Q0("XQX+F'IJ]5;+G)B=J]+JV4"K5\^'&X1#6X'0R#K[U-@D;FN MRW+#2^A;6A2K<0^@"AQS,G&HYO$XPTPIY^_++/Y3UE_'B M09 9&/5F'@?C>E$&VH]GM]5L,-D6U]G=N< L/9?M'+?@"L V\,H^1*\TESGF M]:F^6-0VJ#JC]L'BYKYF[.(-]51LN%HC"C<)GR9]"]@=L"6HED 10HFF1H4' ML1EC3G0PJR+>:0.E*_KVENC7R\,"6J5<-$Q4%#AH[YFS#Q%ZA4Q.HM'^]9]> MMT3J@N"]E>&IYJE(^LKMW%ZL_F7C0J%)H!2#:2>T4^1!G4><$W ^U?I- M7<$HF[H'*S)_3^7?I^6@GI:CAT7%0\AA%;CDH<+F:/4$R*\'GAPIPMTOHPQVV],CBE1V,TLO= MLW\ !>?E].+JZC[8OM%7V]ZMP$I)+PG&G'@$7H3G/C[,WN4EB/Y0\>QV"=US M]O[CW;)[<@PF;Z>S>7VW>)'K^ZGUF,3_.*TGLP%O)=UY^^X!7#^>#2?5[*YN M4LT_8]2"4A+2'2I*%.9&!^.C)E$%Q7S:^(T\SY.AU;:[/FT,6U@D" O8!18Y MQR8HHRU23'**/ ]G_2!8+R"KCL:KDY)/9C0:+W,NWTZOJOIF\55'OG]T>J*+ ML)0/(H0WGJ;GGXR@D9+TB0+WG![QQ<''56VZ][2A9:&=1E&#MJ:,QEI8Y M*]-"+8DFY_FG"!&X00@(6ISA# MU%HP#14UCDF-G@/M="!]^T?2*CZ0LC W7KMJTJT@PDDCM4?" M$0Z.AM4":V(Q 36K.6LDAE\]DG(0L!%6V<3N+Y%^^4!&%0 H%'IW/L8E/-=FP.RG3%IE; T9#_;.C6\$C,E0Q MYSRXFL916(11.&IDL0?[+B==_E23!_L#21ZQ^_.B/LT?#?Z=7OCSQ@5C"H&O MJ2Q+=^E)M):%](YPU((:1'.BR*=Z0M6^[YU)U>-@Y;?!31-O>WV7(B 5$?.* M:20X)UQC S]+ 02T6)ASK'W3!K^W0N=@\F9<"_Q27E;CZ?QB6GY(B;&/]SD^ ME%.@Y"+U;%?)B^9C%%X$;FST0>K(#;AZE#$DJ".>$1G0.=\VSN=UU0_5#T;3 MDR]>3&D[;M:W+@R3A%FA,;6<:X:-QS9&Z9$)2I.L^\:GKY#:1$@K].T_&/QN MRUWU+:T+IR.2@2J"A>+:&F4D&/5&&.(#IC3^$)YT6X<(AY)U/[BL"K*-%W48 M$ECH_<\))O0)3):?/ID@P'IQ)KV\:K@&*CMZ%"GB&$@P)M60BH$9RD%I*Y=> M*?)1_1@G!0>PN>J"O-F7T3?Z;CLOHV_N6:1"54BQ(,&-Y 0K:R7!&A;B-%/J M>)?13Q<5W5"V?QVTN$"X4\0TZE=$3VD V>L<+-!9:Y@*'IO(=? F9%6'S-)+ MIXNB+NC:/X;^!H;;Q?3QWXT ]+Q3D4I3&8*]DIQQD\[&0(Y&)[5V"A&7DVB> M%09^3>C))&I?T%G=EDA>P*,S9\M!G2[UC+^6HZ<2=0N<]ANH(-P+%!'7*CJ. M6:*$!B7KM/682YES4>_U!)'S\=8IU8\3(?QU,+]+'/#;\;:Y4Z$5B]: ZZH= MX^#$:LHL&(!*:1JIXCEWB;/NJ;\R;+5&X3YEV;S19MAI7>T[5!&D#XPB9C"3 M7'NB<<0!(\L=CXZZG-H(IWI_O2MYUB'=#W;Y+@??TB:(5?UA460Q_>.EL[') M[6O6NW!8 )E\=&!A@J"6VAL)(AH6Q@-G+B?U^50OK[?N!W9"ZF.F.<^2(9D> M"WM?#JOKZ?B_TQ;8]*A8N+HJ4Y9X>5G5"0';ZR=T\74%-\ ;APR7GG'/L7$Z M*,&,P&#[2I?C>6;=M#]=W)X0.TX.Z,N%O9V6SY9FIJ.E @A?AY.[43F*P)J' M]4_+V>PC;'?0&2WM@#;F46!A*7/6: \F>-!((:I$5,9JJF,,68]I914 .*.] M<01&G+DT,QS>W=RE@H>C"_<6]%_5A88X]"L+[3C1R*<[B9%+ M0DTJ_TDL""OI',Y[5R[K).3U;X6>>')2UT67R_G>SGNL_S&%'T>@*!>ET6?5 M9#Q*]'AX_GR6^B6B@(S8I%HOAN/_N7WZ[,HA)A9;$HPT7G*DG!&$$2LQ10L; MH]'9]Q$DI?UVO[CWY?+]Z-GG\:W]MN3S RC>I>G"+^VW35>"ZUWS35QFDI!3,>H^X1T)%:E,1<6=] MB,Z?=R)I&PC8YZ;O?L1^;7?PE&4*!820=>DN&"@?&1@62!,7HQ4_1BI8#M>; MW<';C\PGX7LOY4]1:.:@=X?46H M]N/3246H'IZ%V!"D@D4OPM)OUP>K[& "0Y8?/I?E?/8_D:AGCGR@W%$,BATA MPY$4@%',G>*1A,"Y:71[IQM:/;!]]KB^V5-FKM,Q3ZVB!TWER]GX>KIHNROR MU-V7%DX;V(*8<9>"UB(:KX4F"OE #./^Q[!:.P1H=:*<[,NJ6+>V'5&E35V* M&#B61&J#@>A"8RT)$\$(F[*$O,TJEWWB6#T%W%2=L.F80-P9.]KP&N_J1+#%Q9+- M]]L;]"HD%3@Z3-*[&CQRHR22Z65QA6)$".6DF[Y&..W+_:HK2A\)4>_&@T_C MR<+ZV!=6+[H643H&=@GX6(:F=$@;$6/1,^9X,F!RTE!//6C4/;9RR?V:C_BH MD;!2Z:+G@@>"%,,>":\C13;=@3IC8)V@0=8BJU[SD5XDEC "M#.&)'/$&L^H M-TK 9J0Q*T1^ZIJT'03LHS[[G>JMZ9?$94R 8/I*9'G8(IJ1"-G M%B&1BFJS'+OLU&O-G+3ZS.?5,03=LSH'LR4>EM&*()S3CL5A1>&>VVU M@']J+5'@*8T^YWIWYHE:KT(P"QI;I&![I#\N])YX0SGX6S],09%W&H/#KK#E M'AFCG#',2$)@PR/3:_;#68.P%?J?U''M0C?\SRMY3QXPP]@((;DEA'/+@M(F M&"RLI!;AR!OMI6YH]6'XN1S=3SM]R.>YN'I@]64U6[PO]@#6)@_G MM?Q-A<28HA@BW;'*51K.AM66 M]>*U/3"K6]@0^W]7@5UP-##-.-8\8*8U5Q8#?Y'SW/._][R+5NT=..^A25,*N4HBXAPI9EB5'N+ M%.5<&MSLNM-RD885%2S:D' M>&AB+4\%]*A440MO]3D^;]4!4ZM6J'M8S=Q=B# PF]&B_LID<+T!$M^U*3P6 M+AIA0'LJ$!E!(V^]5LI:S"C\<88"OUM,Y)"W&U"LE@KZ8ES!:D<;*KMM;%OH M2(/SWC-8![?.*,(1"5A%'P*-,JJ98E[1,VAY.Z&^!\K 8 _CUJ!*6:]TI:9&*G,D3AYQ1I?.8I:)'K/!RD/IZ&_EH-T$/7= MHU>]9TL\S.;Q9&S6(!UB6[?"2ZF$#!;I8+D%'Q41%FE@QAF*&6YDF/6WVB:' MM5O[%9)Z;QAF +' "34&5LT5=19PB*,ZYS3X=G"PZ>9V"]0^A, -BW9I&SGM7.6%/GV-IDBRYH4>! M%0Z8G=V/^5E=WM\"0QF6#MG0O0*01*P.8*N. MQJC89">V1_2^%,F3J3_\^/=Q6 M+2BC"E'CK45"984?7@OD6D''9NBU1_[>P?=42;U^4.0&L\]F.DI_A?^Z M&W\93+[3%(^1IBT :SQ&(:D.W"#8QC9RXKCE8&C@Y*=9,#G<.1_R'HJ&JA]: M[\;;ILNF]S2_O .#8C K+^OQL'Q?#DN8&TCM9D@Z<*2",Q0(9S& R\]U%#KJ MZ&(4R&+PEO31;FN?)(3Z(?+YE9*"[U@-)2R6MQ];0K,*+)ZCF MCF:PYY/^N,JOVV)V$2$O.-%*.Y;L2<6L!E)0:H0//5=4[%D-9@$CIX#=?C0_ MA32=(]>MZR+?QACLO%(814TYM49;@TUT6!"\*/=[O'R;Q^I)#PO8EB;U/#=J MP:O]RFRU\#V%ILPK*;%/!6]AZVCJ%3@2C'!). _G+$C:P=G&&EK]1 Z=X)Z1M$8&%LR;5A8_4I8-41JU$ MFGF0RQH^;N3[=;/2Q<-"#IA3EY_+Z6Q1N3$]G)L*-CXI_OP?=X/)^.I;JB Y M2Z4D2] X7[?0(F?8PH"OSYFED0HM T)$1K:BEHWZG%^Y:P-#ZYZ.ZH<5O07S M@$*C\>0N3?Q#LH,6ME'XNGS\.+T'G=9[M^3^Q548U%-8U^RRK!C MY\L*M\>^'-.VJM1!$LTBUUH)SJTRPB#O77HMWC'?[))8-RM] :G=Z]S4I?". MHJ"EM-02CH4T(MT&5I1C31$/F?D;O6_JQDRK.J%/7WKG'^7X^C/L0O,%]NEU M^=M=2I*[N'I1=F&Q:;? 8J]Q"H<)X]R@@+CD&,@ W@+W3&.. J4NYWS\]%_! MR4=(U1_M^SLY&"XCM0MED:I_+&9OYO-Z_ E41XH%58O/8!7EZ'+P;5%_I*X' MT^OOJVRL/4_(';R@C@E/I%8$"^X)^+5.IKQW#TI7(!/.V/)I':^]L^/(PO3> MT&E2>.C D0JEI$;:*Z2DXYI'HXBG40E"A2&&]YM%WN_I?5_BM"7:'\< 7YDW M9V-31X<50\Y%GR[6:6N<=JD$31#&4,T:W7WM*$*]C%X^F_NWY9^-HM*-!BB4 M9 @Q8V#%F$<4M17*.R"%\Y7X-K Q?-(=!=$[^WVR),:TMM.DY\T*[!F MB#@O* .)&&54&"EJX0,O"6+X'-^7Z! ^&:3M+:/^9;QT7\G4=(C"1(:Y\9(Y M';F55'M/74#642%T7B&EDT]-;1]<'9&]+^#]5O[YA"AU-84?ATL[?E\ [CM4 M(5SPV!,G/#,<"&TUQ<[I(+PETL<(0E%8Q*;PW^49,X&B-G8YY7EUSH63@LU>S'P=SUF/&67@7C*DKK M&5 Z<.FEB8KS*&@$\R!J?\24T36S;B(!MG4KC 0;/(#UXS3G*>O>1&.=)8YA M(C!MM-I7NLU; <'+L&U;M#[>9C[RT7+[6]H*;[R5QF$2!(HT2.67Q_]2*-;L M#DY'A\M75^5P_N"RP/33W0)7)>US!VKBXA;,K\45F6W'S8T'*9S!TH &4T " MZ4*R/K MEX2\+J?#M2]7;X_"-!^G .XS%H/UE&(.T#)8">K O'/<46&.&"A?,.;7)>>> M+Z2)[F_4OXCI-CCBZ(B$LECD7DT]]T^?CX;E[WSJ]C[R[ MOWNKJ+J[_T6*3=RW/+:3T*84$$@82Y5/KS\JJM/S"@%3BJQ(SUCSDP@';F&0 M_7;_RUTUV@\8K5 FQ;@L;+*H"//!*LOO:>.QSTJ:>;52HC%>-@8!NZ)_?^>D MTUDU&8\6,UX4;MA1K7U]A\)(IV1T01L;N+/I]56Q6IW7Z&CHZ@A07?+_Q7EH M"P0_'IQVEE[?U*4(%%,?C>(T)9_0R$A$JQ4&$H\6X>C*?,$N%]P]KX6==<+4E)J_WT@\B;T:-U72'8Z-B M>M&F0-:GB .6 C,I$$&IKLS]O#3)2CH]>;8?QJ"J'5(>S&(S'=\,)G\O!Y/Y MY^V,?MFRL$%K(X2B%&,ETJ,AW*WF*#7*N1)Z\FHCG]W9!.W/Q:E!)8)4VVFB M/FM9!" L%=QY':-2J9R+>["A+-CU9YPGG >0=@C:LXVPSG)ZU^ %BR;="RV5 M)[!$%J,40BI'G;U?>8B:Y]2O/7DH]6FBML^+WE XF)2S]^672PRU"0*\]BZ M8)+Y1 I/*/+.(!?$RJ@/8+GU6B>Y]W('G2(HG]J'6\:+6I;+:CV+$E/IGW\O M)Z-8U0G8&^WD'?T*AVTDG'G$C<=!!5#F*\L^,A?.6I-U@94NJ'[D(^S?!G6] MJ'%V1B?54@H--BHRPJ;WL[ .A"/G+;:((R$;A:F[6>6J L#+1($MZ]S MC'% 5T#2\DB$<>#06<&XUBY)K/,*R.^1-O+!^OK/0+^MJ=#>< MG]&F1IC*Z-/_'$?C ^5ZZ69(S+R11RQ]=OSTD_0.B(@1"4PTD\IXK^6*-H@& M\@-Y%?OCI87TD_WHWY>W<2\#+NH/9?UE/"QWG-NM:UY$R@EE(4A&D5182D_8 M_[!$+5.NU[1E5*T+Z?[.XTE(U]"L9-1"RXH!CV41E0LWZU1@+V M^!GC*X_GZP&43>&#?=B4+'%WL[@ O_UPYT7#@MHH)'4.:8H)]Y)&'.]G"%,W MYWR"VP+;JA9I>S#WTT.=MXO2>K"0ZFK^)ZQ^.PPV]RB(4XPRX1&2,BB"C':K MI9MT4GG&9WTMXZ$U(A\,C$5]]?M5;0?$RY8 7HHH(V#".<^M-2I@NIHC4B$G MW>S4PUG/[Y MGM>42&%D3%=[^]'YR.&Y(]>%:C,*1Y%*<55' MJ06'1""+N* ,7!7*I8_-+CJ=1!1NKYI0>XU8*!VM)4JDAS2XEDXA@J5%S#DO M0;$VNB=_)C)@?]SD1>,.Y$%O>N6QOM5T#ISXQWA4/EG'O7Q+S[4$$ _U=#!Q M=[-Y=0-,? CI/S4)]ZQLUNYW%NFB+F'(JH@]IX8;)T2Z$1%=Y"R8G-*<)V]' M=8?SXW*I@::\_T7ZX]-@5O[;/_U_4$L! A0#% @ T7J&2P74KHJ>EP MXOD( !$ ( ! '!D8V\M,C Q-S$P,C@N>&UL4$L! A0# M% @ T7J&2];)57S9"@ :V4 !$ ( !S9< '!D8V\M M,C Q-S$P,C@N>'-D4$L! A0#% @ T7J&2^_4@+@E$P [< !4 M ( !U:( '!D8V\M,C Q-S$P,CA?8V%L+GAM;%!+ 0(4 Q0 ( M -%ZADMKM,47LAL /H9+4;J_XQ%I "F9P0 %0 M @ $2T@ <&1C;RTR,#$W,3 R.%]L86(N>&UL4$L! A0#% @ MT7J&2XY6 F-R-P #WL" !4 ( !5CL! '!D8V\M,C Q-S$P @,CA?<')E+GAM;%!+!08 !@ & (H! #[<@$ ! end